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1. PUBLIC HEALTH STATEMENT
This Statement was prepared to give you information about zinc and to emphasize the
human health effects that may result from exposure to it. The Environmental Protection
Agency (EPA) has identified 1,350 hazardous waste sites as the most serious in the
nation. These sites comprise the “National Priorities List” (NPL): Those sites which are
targeted for long-term federal cleanup activities. Zinc has been found in at least 776 of
the sites on the NPL. However, the number of NPL sites evaluated for zinc is not
known. As EPA evaluates more sites, the number of sites at which zinc is found may
increase. This information is important because exposure to zinc may cause harmful
health effects and because these sites are potential or actual sources of human exposure
to zinc.
When a substance is released from a large area, such as an industrial plant, or from a
container, such as a drum or bottle, it enters the environment. This release does not
always lead to exposure. You can be exposed to a substance only when you come in
contact with it. You may be exposed by breathing, eating, or drinking substances
containing the substance or by skin contact with it.
If you are exposed to a substance such as zinc, many factors will determine whether
harmful health effects will occur and what the type and severity of those health effects
will be. These factors include the dose (how much), the duration (how long), the route
or pathway by which you are exposed (breathing, eating, drinking, or skin contact), the
other chemicals to which you are exposed, and your individual characteristics such as age,
gender, nutritional status, family traits, life-style, and state of health.
1.1 WHAT IS ZINC?
Zinc is one of the most common elements in the earth’s crust. Zinc is found in the air,
soil, and water and is present in all foods. In its pure elemental (or metallic) form, zinc
is a bluish-white shiny metal. There is no information on the taste and odor of metallic
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zinc. Powdered zinc is explosive and may burst into flames if stored in damp places.
Metallic zinc has many uses in industry. A common use is as coating for iron or other
metals so that they do not rust or corrode. Metallic zinc is also mixed with other metals
to form alloys such as brass and bronze. A zinc and copper alloy is used to make
pennies in the United States. Metallic zinc is also used to make dry cell batteries.
Zinc can also combine with other elements, such as chlorine, oxygen, and sulfur, to form
zinc compounds. Zinc compounds that may be found at hazardous waste sites are zinc
chloride, zinc oxide, zinc sulfate, and zinc sulfide. This profile focuses primarily on
metallic zinc and commonly found or used zinc compounds. Most zinc ore found
naturally in the environment is in the form of zinc sulfide. Zinc compounds are widely
used in industry. Zinc compounds are not explosive or flammable. Zinc sulfide is gray-white
or yellow-white, and zinc oxide is white. Both of these compounds are used to
make white paints, ceramics, and several other products. Zinc oxide is also used in
producing rubber. Zinc compounds, such as zinc acetate, zinc chloride, and zinc sulfate,
are used in preserving wood and in manufacturing and dyeing fabrics. Zinc chloride is
also the major ingredient in smoke from smoke bombs. Zinc compounds are also used
by the drug industry as ingredients in some common products, such as sun blocks, diaper
rash ointments, deodorants, athlete’s foot preparations, acne and poison ivy preparations,
and antidandruff shampoos.
Zinc is an essential food element needed by the body in small amounts. Too little zinc in
the diet can lead to poor health, reproductive problems, and lowered ability to resist
disease. Too much zinc can also be harmful to health. More information can be found
on the chemical and physical properties of zinc in Chapter 3 and on its occurrence and
fate in the environment in Chapter 5.
1.2 WHAT HAPPENS TO ZINC WHEN IT ENTERS THE ENVIRONMENT?
Zinc enters the air, water, and soil as a result of both natural processes and human
activities. Most zinc enters the environment as the result of human activities, such as
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mining, purifying of zinc, lead, and cadmium ores, steel production, coal burning, and
burning of wastes. These releases can increase zinc levels in the atmosphere. Waste
streams from zinc and other metal manufacturing and zinc chemical industries, domestic
waste water, and run-off from soil containing zinc can discharge zinc into waterways. The
level of zinc in soil increases mainly from disposal of zinc wastes from metal
manufacturing industries and coal ash from electric utilities. In air, zinc is present mostly
as fine dust particles. This dust eventually settles over land and water. Rain and snow
aid in removing zinc from air. Most of the zinc in bodies of water, such as lakes or
rivers, settles on the bottom. However, a small amount may remain either dissolved in
water or as fine suspended particles. The level of dissolved zinc in water may increase as
the acidity of water increases. Some fish can collect zinc in their bodies if they live in
water containing zinc. Most of the zinc in soil is bound to the soil and does not dissolve
in water. However, depending on the characteristics of the soil, some zinc may reach
groundwater. Contamination of groundwater from hazardous waste sites has been
noticed. Zinc may be taken up by animals eating soil or drinking water containing zinc.
If other animals eat these animals, they will also have increased amounts of zinc in their
bodies. For more information about what happens to zinc in the environment, see
Chapter 5.
1.3 HOW MIGHT I BE EXPOSED TO ZINC?
We are exposed to small amounts of zinc compounds in food every day. The average
daily zinc intake through the diet in this country ranges from 7 to 16.3 milligrams (mg).
Food may contain levels of zinc ranging from approximately 2 parts of zinc per million
(ppm) parts of foods (e.g., leafy vegetables) to 29 ppm (meats, fish, poultry). Zinc is also
present in most drinking water. Drinking water or other beverages may contain high
levels of zinc if they are stored in metal containers or flow through pipes that have been
coated with zinc to resist rust. Drinking water may also be contaminated by zinc from
industrial sources or toxic waste sites. High-level exposure to zinc may also result from
taking too many zinc dietary supplements. Fetuses and nursing children may be exposed
to the zinc in the blood or milk of their mothers.
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In general, levels of zinc in air are relatively low and fairly constant. Average levels of
zinc in the air throughout the United States are less than 1 microgram of zinc per cubic
meter (µg/m3) of air, but range from 0.1 to 1.7 µg/m3 in areas near cities. Air near
industrial areas may have higher levels of zinc. The average zinc concentration for a
l-year period was 5 µg/m3 in one area near an industrial source.
About 150,000 workers are exposed to zinc at their jobs. Jobs where people are exposed
to zinc include zinc mining, smelting, and welding; manufacture of brass, bronze, or other
zinc-containing alloys; manufacture of galvanized metals; and manufacture of machine
parts, rubber, paint, linoleum, oilcloths, batteries, some kinds of glass and ceramics, and
dyes. People at construction jobs, automobile mechanics, and painters are also exposed
to zinc.
For more information on exposure to zinc, see Chapter 5.
1.4 HOW CAN ZINC ENTER AND LEAVE MY BODY?
Zinc can enter the body through the digestive tract if you eat food or drink water
containing it. Zinc can also enter through your lungs if you inhale zinc dust or fumes
from zinc-smelting or zinc-welding operations on your job. The amount of zinc that
passes directly through the skin is relatively small. The most likely route of exposure
near NPL waste sites is through drinking water containing a high amount of zinc. Zinc is
stored throughout the body. Zinc increases in blood and bone most rapidly after
exposure. Zinc may stay in the bone for many days after exposure. Normally, zinc
leaves the body in urine and feces. More information on how zinc enters and leaves your
body can be found in Chapter 2.
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1.5 HOW CAN ZINC AFFECT MY HEALTH?
Inhaling large amounts of zinc (as zinc dust or fumes from smelting or welding) can cause a
specific short-term disease called metal fume fever. However, very little is known about the
long-term effects of breathing zinc dust or fumes.
Taking too much zinc into the body through food, water, or dietary supplements can also
affect health. The levels of zinc that produce adverse health effects are much higher than the
Recommended Dietary Allowances (RDAs) for zinc of 15 mg/day for men and 12 mg/day for
women. If large doses of zinc (10-15 times higher than the RDA) are taken by mouth even
for a short time, stomach cramps, nausea, and vomiting may occur. Ingesting high levels of
zinc for several months may cause anemia, damage the pancreas, and decrease levels of highdensity
lipoprotein (HDL) cholesterol. We do not know if high levels of zinc affect the
ability of people to have babies or cause birth defects in humans.
Eating food containing very large amounts of zinc (1,000 times higher than the RDA) for
several months caused many health effects in rats, mice, and ferrets, including anemia and
injury to the pancreas and kidney. Rats that ate very large amounts of zinc became infertile.
Rats that ate very large amounts of zinc after becoming pregnant had smaller babies. Putting
low levels of certain zinc compounds, such as zinc acetate and zinc chloride, on the skin of
rabbits, guinea pigs, and mice caused skin irritation. Skin irritation from exposure to these
chemicals would probably occur in humans. EPA has determined that zinc is not classifiable
as to its human carcinogenicity.
Consuming too little zinc is at least as important a health problem as consuming too much
zinc. Without enough zinc in the diet, people may experience loss of appetite, decreased
sense of taste and smell, decreased immune function, slow wound healing, and skin sores.
Too little zinc in the diet may also cause poorly developed sex organs and retarded growth in
young men. If a pregnant woman does not get enough zinc, her babies may have growth
retardation.
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More information on the health effects linked with exposure to higher than normal levels
of zinc is presented in Chapter 2.
1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
      EXPOSED TO ZINC?
A medical test exists that can determine whether your body fluids contain high levels of
zinc. Samples of blood or feces can be collected in a doctor’s office and sent to a
laboratory that can measure zinc levels. It is easier for most laboratories to measure zinc
in blood than in feces. The presence of high levels of zinc in the feces can mean recent
high zinc exposure. High levels of zinc in the blood can mean high zinc consumption
and/or high exposure. High zinc levels in blood or feces reflect the level of exposure to
zinc. Measuring zinc levels in additional fluids (e.g., urine and saliva) would probably
provide more information about zinc exposure. Tests to measure zinc in hair may
provide information on long-term zinc exposure. However, no quantitative correlation
has been found between hair zinc levels and zinc exposure. These tests are not routinely
used. More information on tests to measure zinc in the body can be found in Chapter 6.
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
      PROTECT HUMAN HEALTH?
The federal government has set standards and guidelines to protect individuals from the
potential health effects of excessive zinc. EPA has stated that drinking water should
contain no more than 5 mg of zinc per liter of water (5 mg/L, or 5 ppm) because of taste.
Furthermore, any release of more than 1,000 pounds (or in some cases 5,000 pounds) of
zinc or its compounds into the environment (i.e., water, soil, or air) must be reported to
EPA.
The National Academy of Sciences (NAS) estimates an RDA for zinc of 15 mg/day
(men). Fifteen mg/day is the same as 0.21 mg per kilogram (kg) of body weight per day
for an average adult male (70 kg). An RDA of 12 mg/day was established for women
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because they usually weigh less than men. Lower zinc intake was recommended for
infants (5 mg/day) and children (10 mg/day) because of their lower average body weights.
The RDA provides a level of adequate nutritional status for almost the entire population.
Extra dietary levels of zinc are recommended for women during pregnancy and lactation.
An RDA of 15 mg/day was set for pregnant women. Women who nurse their babies
need 19 mg/day during the first 6 months and 16 mg/day during the second 6 months of
nursing.
To protect workers, the Occupational Safety and Health Administration (OSHA) has set
a legal limit of 1 mg/m3 for zinc chloride in workroom air. This regulation means that
the workroom air should contain no more than an average of 1 mg/m3 of zinc chloride
over an 8-hour working shift of a 40-hour workweek. The National Institute for
Occupational Safety and Health (NIOSH) recommends that the level of zinc oxide in
workplace air should not exceed an average of 5 mg/m3 over a lo-hour period of a
40-hour work week. For more information on recommendations and standards for zinc
exposure, see Chapter 7.
1.8 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns, please contact your community or state
health or environmental quality department or:
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road NE, E-29
Atlanta, Georgia 30333
(404) 639-6000
This agency can also provide you with information on the location of occupational and
environmental health clinics. These clinics specialize in the recognition, evaluation, and
treatment of illness resulting from exposure to hazardous substances,
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2.1 INTRODUCTION
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists,
and other interested individuals and groups with an overall perspective of the toxicology of zinc.
It contains descriptions and evaluations of toxicological studies and epidemiological investigations
and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic data to
public health.
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile.
Zinc is an essential nutrient in humans and animals that is necessary for the function of a large
number of metalloenzymes. These enzymes include alcohol dehydrogenase, alkaline phosphatase,
carbonic anhydrase, leucine aminopeptidase, super-oxide dismutase, and deoxyribonucleic acid
(DNA) and ribonucleic acid (RNA) polymerase. As such, zinc is required for normal nucleic acid,
protein, and membrane metabolism, as well as cell growth and division. Zinc also plays an
essential role in the maintenance of nucleic acid structure of genes (zinc finger phenomenon).
Zinc deficiency has been associated with dermatitis, anorexia, growth retardation, poor wound
healing, hypogonadism with impaired reproductive capacity, impaired immune function, and
depressed mental function; an increased incidence of congenital malformations in infants has also
been associated with zinc deficiency in the mothers (Cotran et al. 1989; Elinder 1986; Sandstead
1981). Therefore, certain levels of zinc intake are recommended. The RDA for zinc is 15 mg/day
in men and 12 mg/day in women (NAS/NRC 1989b). Higher RDAs are recommended for women
during pregnancy and lactation (15 mg/day for pregnant women, 19 mg/day for nursing women
during the first 6 months, and 16 mg/day during the second 6 months of nursing).
Just as zinc deficiency has been associated with adverse effects in humans and animals,
overexposures to zinc also have been associated with toxic effects. This chapter contains a
description of the toxic effects that have been associated with exposures to high levels of zinc and
selected zinc compounds by the inhalation, oral, and dermal routes. Specifically, zinc chloride,
zinc oxide, zinc sulfate, and zinc sulfide will be considered. Other zinc compounds are discussed
in this chapter whenever data regarding these compounds add relevant information to the
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discussion on zinc. Any general comments regarding the lack of data on zinc refer to both zinc
and its compounds.
Because there are differences in toxicity between the various zinc compounds following inhalation
exposure, these compounds will be discussed under separate subheadings in Section 2.2.1 (Inhalation
Exposure). After oral or dermal exposure, the toxicities are comparable for all zinc compounds.
Therefore, in Section 2.2.2 (Oral Exposure) and Section 2.23 (Dermal Exposure), the discussion will
not be subdivided, but the specific zinc compounds will be identified in each case.
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals and others address the needs of persons living or working near
hazardous waste sites, the information in this section is organized first by route of exposure -
inhalation, oral, and dermal; and then by health effect - death, systemic, immunological, neurological,
reproductive, developmental, genotoxic, and carcinogenic effects. These data are discussed in terms
of three exposure periods - acute (14 days or less), intermediate (15-364 days), and chronic (365 days
or more).
Levels of significant exposure (LSE) for each route and duration are presented in tables and
illustrated in figures. The points in the figures showing no-observed-adverse-effect levels
(NOAELs) or lowest-observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of
exposure) used in the studies. LOAELs have been classified into “less serious” or “serious”
effects. “Serious” effects are those that evoke failure in a biological system and can lead to
morbidity or mortality (e.g., acute respiratory distress or death). “Less serious” effects are those
that are not expected to cause significant dysfunction or death, or those whose significance to the
organism is not entirely clear. ATSDR acknowledges that a considerable amount of judgment
may be required in establishing whether an end point should be classified as a NOAEL, “less
serious” LOAEL, or “serious” LOAEL, and that in some cases, there will be insufficient data to
decide whether the effect is indicative of significant dysfunction. However, the Agency has
established guidelines and policies that are used to classify these end points. ATSDR believes
that there is sufficient merit in this approach to warrant an attempt at distinguishing between “less
serious” and “serious” effects. The distinction between “less serious” effects and “serious” effects
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is considered to be important because it helps the users of the profiles to identify levels of exposure at
which major health effects start to appear. LOAELs or NOAELs should also help in
determining whether or not the effects vary with dose and/or duration, and place into perspective
the possible significance of these effects to human health.
The significance of the exposure levels shown in the LSE tables and figures may differ depending
on the user’s perspective. Public health officials and others concerned with appropriate actions to
take at hazardous waste sites may want information on levels of exposure associated with more
subtle effects in humans or animals (LOAELs) or exposure levels below which no adverse effects
(NOAELs) have been observed. Estimates of levels posing minimal risk to humans (Minimal
Risk Levels or MRLs) may be of interest to health professionals and citizens alike.
2.2.1 Inhalation Exposure
2.2.1.l Death
In humans, death has resulted from acute exposure to zinc compounds. When a high
concentration (estimated at 33,000 mg zinc/m3) of zinc chloride smoke resulted from the
explosion of many generators in a tunnel following a bombing raid in World War II, 10 of the
70 exposed people in the tunnel died within 4 days (Evans 1945). The smoke generated
contained mainly zinc chloride, but exposure to other constituents, namely zinc oxide,
hexachloroethane, calcium silicate, and an igniter, was also possible. Therefore, the deaths
resulting from the explosion cannot be conclusively attributed to exposure to zinc chloride only.
This is the only human study reporting an estimated exposure level that caused death. Hence,
this level is reported as a LOAEL in Table 2-l and Figure 2-1. Another study reported the death
of a fireman exposed to the contents of a smoke bomb in a closed environment (Milliken et al.
1963). The man died 18 days after exposure because of respiratory difficulty. Again, exposure to
zinc chloride was simultaneous with exposure to other substances in the smoke. Two soldiers
exposed without gas masks to zinc chloride smoke during military training developed severe adult
respiratory distress syndrome (ARDS) and died 25-32 days after the incident (Hjortso et al.
1988). Diffuse microvascular obliteration, widespread occlusion of the pulmonary arteries, and
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organs and tissues obtained during autopsy were within the normal range, and no zinc particles
were observed by scanning electron microscopy. According to the authors, the fumes from the
smoke bombs consisted mainly of zinc chloride. However, no exposure levels were estimated, and
other substances were also present in the smoke.
A case study presented by Murray (1926) reported on an infant death due to bronchopneumonia
resulting from inhalation, and possibly ingestion of an unspecified amount of zinc stearate powder
spilled from a container. However, it is unclear whether the death was due to the zinc content or
whether aspiration bronchopneumonia would result from inhalation of similar powders that do not
contain zinc.
In mice, the reported LCT50, (product of lethal concentration and time to kill 50% of animals) of
zinc chloride is 11,800 mg-min/m3 (Schenker et al. 1981). However, Schenker et al. (1981) did
not provide information on how this value was determined. Following exposure to zinc chloride
smoke for 3-20 weeks, mortality was 50% in mice exposed to 121.7 mg zinc/m3 (compared to
20% in controls) and 22% in guinea pigs exposed to 119.3 mg zinc/m3 (compared to 8% in
controls) (Marrs et al. 1988). The smoke was similar to that described by Evans (1945) and also
contained zinc oxide, hexachloroethane, and other compounds.
2.2.1.2 Systemic Effects
No studies were located regarding musculoskeletal effects in humans or animals after inhalation
exposure to zinc or zinc compounds. The systemic effects observed after inhalation exposure are
discussed below. In most cases, the effects of zinc are discussed without separating effects caused
by the individual zinc compounds. However, the respiratory effects of the individual zinc
compounds are discussed separately because the nature of the respiratory toxicity differs
depending on the particular compound to which one is exposed. The highest NOAEL values and
all LOAEL values from each reliable study for systemic effects in each species and duration
category are recorded in Table 2-l and plotted in Figure 2-l.
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Respiratory Effects
Zinc Oxide.  Metal fume fever, a well-documented acute disease induced by intense inhalation of
metal oxides, especially zinc, temporarily impairs pulmonary function but does not progress to
chronic lung disease (Brown 1988; Drinker et al. 1927b; Malo et al. 1990). Symptoms generally
appear within a few hours after acute exposure, usually with dryness of the throat and coughing
(Drinker and Drinker 1927b). The most prominent respiratory effects of metal fume fever are
substernal chest pain, cough, and dyspnea (Rohrs 1957). The impairment of pulmonary function
is characterized by reduced lung volumes and a decreased diffusing capacity of carbon monoxide
(Malo et al. 1990; Vogelmeier et al. 1987). The respiratory effects have been shown to be
accompanied by an increase in bronchiolar leukocytes (Vogelmeier et al. 1987). The respiratory
symptoms generally disappear in the exposed individual within l-4 days (Brown 1988; Drinker et
al. 1927b; Sturgis et al. 1927). Refer to the Other Systemic Effects section below for further
details on nonrespiratory effects related to metal fume fever. Inhalation of zinc oxide is most
likely to occur in occupational situations where zinc smelting or welding take place. Ultrafine zinc
oxide particles (0.2-1.0 pm) originate from heating zinc beyond its boiling point in an oxidizing
atmosphere. Upon inhalation, these small particles (< 1 pm) reach the alveoli and cause
inflammation and tissue damage in the lung periphery (Brown 1988; Drinker et al. 1927b;
Vogelmeier et al. 1987).
A number of studies have measured exposure levels associated with metal fume fever. Workers
involved in pouring molten zinc reported shortness of breath and chest pains 2-12 hours following
exposure to 320-580 mg zinc/m3 as zinc oxide for l-3 hours (Hammond 1944); the number of
workers was not reported. Two volunteers had nasal passage irritation, cough, substernal chest
pain, persistent rales of the lung base, and a decreased vital capacity for approximately 3-49 hours
following acute inhalation (10-12 minutes) of 600 mg zinc/m3 as zinc oxide (Sturgis et al. 1927).
A subject experimentally exposed to zinc oxide fumes reported mild pain when breathing deeply
the next day after a 5-hour exposure to 430 mg zinc/m3 (Drinker et al. 1927a). Minimal changes
in forced expiratory flow were observed 1 hour after a 15-30-minute exposure to 77 mg zinc/m3
as zinc oxide (Blanc et al. 1991).
Acute experimental exposures to lower concentrations of zinc oxide (14 mg/m3 for 8 hours or
45 mg zinc/m3 for 20 minutes) and occupational exposures to similar concentrations (8-12 mg
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zinc/m3 for 1-3 hours and 0.034 mg zinc/m3 for 6-8 hours) have not produced symptoms of metal
fume fever (Drinker et al. 1927b; Hammond 1944; Marquart et al. 1989). In a single-blind
experiment, exposure of subjects to 3.9 mg zinc/m3 as zinc oxide resulted in sore throat and chest
tightness but no impairment of pulmonary function (Gordon et al. 1992). It is speculated that
subjects in other studies may have been less susceptible because of the development of tolerance
to zinc (Gordon et al. 1992). Recurrent episodes of cough and dyspnea were reported in a
former mild smoker 3 years after beginning work in a metal foundry where exposure to zinc oxide
presumably occurred (Ameille et al. 1992). This case was distinguishable from metal fume fever
because of the lack of tolerance to zinc (as shown by the late emergence of symptoms).
Several animal studies have been conducted to quantitate specific effects after acute zinc oxide
inhalation. As in human exposure, the respiratory system is the primary site of injury following
inhalation exposure. Acute administration of 88-482 mg zinc/m3 as zinc oxide to rats and rabbits
resulted in the following pulmonary changes: grayish areas with pulmonaty congestion, various
degrees of peribronchial leukocytic infiltration, and exudate composed almost entirely of
polymorphonuclear leukocytes in bronchi (Drinker and Drinker 1928). A minimum effect level
could not be determined because the concentration varied widely during exposure. Cats similarly
exposed exhibited more severe effects including bronchopneumonia, leukocyte infiltration into
alveoli, and grayish areas with congestion. During the exposure period, the cats demonstrated
labored breathing and evidence of upper respiratory tract obstruction.
Guinea pigs administered 0.73 mg zinc/m3 as zinc oxide for 1 hour had a progressive decrease in
lung compliance but no change in air flow resistance. These observations reflect a response in
the lung periphery where submicrometer aerosols are likely to deposit (Amdur et al. 1982). The
authors postulated that reduced compliance may be associated with human metal fume fever.
In contrast to the results of Amdur et al. (1982), no effects on ventilation, lung mechanics
(respiratory frequency, tidal volume, pulmonary resistance, and pulmonary compliance), diffusing
capacity of carbon monoxide, or most lung volume parameters were observed by Lam et al. (1982)
following the exposure of guinea pigs to 6.3 mg zinc/m3 as zinc oxide for 3 hours. However,
functional residual capacity was significantly decreased. The discrepancy between the results of
Amdur et al. (1982) and Lam et al. (1982) may be attributable to the use of anesthetized animals
by Lam et al. (1982). In a later study, exposures of guinea pigs to 3.7 or 4.3 mg zinc/m3 as zinc
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oxide for 3 hours/day, for 6 days, resulted in transient functional, morphological, and biochemical
changes (Lam et al. 1985). Functional changes included increased flow resistance, decreased lung
compliance, and decreased diffusing capacity, all of which returned to normal within 24-72 hours
following exposure. The morphological changes (increased lung weight, inflammation involving
the proximal portion of alveolar ducts and adjacent alveoli, interstitial thickening, and increased
pulmonary macrophages and neutrophils in adjacent air spaces) were, however, still present at
72 hours. In guinea pigs with evidence of an inflammatory reaction involving the peripheral
airways, DNA synthesis increased in bronchiolar cells. Similarly, exposure of guinea pigs to
5.6 mg zinc/m3 as zinc oxide for 3 hours/day, for 5 days, resulted in gradual decreases in total lung
capacity, vital capacity, and decreased carbon monoxide diffusing capacity (Lam et al. 1988);
however, no effects were observed in guinea pigs exposed to 2.2 mg zinc/m3. The reason that
effects have been seen in the guinea pig at exposure levels lower than humans may have to do
with the structural features of the guinea pig lung. The bronchi and peripheral airways of guinea
pigs have a thicker smooth muscle layer and only a small surface area covered by alveolar sacs
compared to the bronchi and peripheral airways of other laboratory animals and humans. This
makes the guinea pig more susceptible than other laboratory animals to functional impairment of
the peripheral airways and should be noted in toxicity comparisons (Lam et al. 1982).
The bronchoalveolar lavage fluid of rats or guinea pigs exposed to 2.2 mg zinc/m3 for 3 hours
contained increased levels of lactate dehydrogenase and protein, suggesting effects on cell viability
or membrane permeability (Gordon et al. 1992). Rabbits were not affected following a similar
exposure to 4.6 mg zinc/m3 for 2 hours. Guinea pigs had foci of inflammation after exposure to
4.7 mg zinc/m3 for 3 days, and the bronchoalveolar lavage fluid contained increased levels of
protein, angiotensin converting enzyme, and neutrophils (Conner et al. 1988).
Zinc Chloride. Zinc chloride, a corrosive inorganic salt, is more damaging than zinc oxide to the
mucous membranes of the nasopharynx and respiratory tract upon contact. Zinc chloride is a
primary ingredient in smoke bombs used by the military for screening purposes, crowd dispersal,
and occasionally in military and civilian fire-fighting exercises. Reports of serious respiratory
injury have been reported to result from accidental inhalation of smoke from these bombs. These
reports are of limited use in assessing the toxicity of zinc chloride because exposure to other
compounds, usually hexachloroethane, zinc oxide, and calcium silicides, also occur. Furthermore,
the specific concentrations inhaled are usually unknown. Despite these limitations, several case
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studies have described similar respiratory effects in humans following acute inhalation exposures.
These effects include dyspnea, cough, pleuritic chest pain, bilateral diffuse infiltrations,
pneumothorax, and acute pneumonitis from respiratory tract irritation (Johnson and Stonehill
1961; Matarese and Matthews 1966; Schenker et al. 1981). In the study by Johnson and Stonehill
(1961) cough, dyspnea, burning throat, diffuse infiltrates throughout the lung, chemical
pneumonitis, and decreased vital capacity were observed at an estimated zinc chloride exposure
level of 4,075 mg/m3 (1,955 mg zinc/m3). In other studies, more severe effects have occurred,
including ulcerative and edematous changes in mucous membranes, fibrosis, subpleural
hemorrhage, advanced pulmonary fibrosis, and fatal respiratory distress syndrome (Evans 1945;
Hjortso et al. 1988; Homma et al. 1992; Milliken et al. 1963).
Focal alveolitis, consolidation, emphysema, infiltration with macrophages, and fibrosis were
observed in guinea pigs that died following exposure to 119 mg zinc/m3 as zinc chloride smoke for 1
hour/day, 5 days/week, for up to 3 weeks (Marrs et al. 1988). Thirteen months after a 20-week
exposure, rats and mice inhaling 121.7 mg zinc/m3 as zinc chloride smoke for 1 hour/day,
5 days/week, showed increased macrophages in the lungs (Marrs et al. 1988). The smoke also
contained zinc oxide, hexachloroethane, and other compounds.
Zinc Ammonium Sulfate. Zinc ammonium sulfate is a compound emitted during combustion of
fossil fuels and is, therefore, found in the ambient air. Humans acutely exposed to a
concentration of 0.0036 mg zinc/m3 as zinc ammonium sulfate for 2 hours exhibited minimal or no
short-term respiratory effects (Linn et al. 1981). However, most human exposures to an ambient air
pollutant such as zinc ammonium sulfate are chronic, and this study provides little information about
the health effects associated with typical exposures.
No studies were located regarding respiratory effects in animals after inhalation exposure to zinc
ammonium sulfate.
Zinc Stearute. Inhalation of zinc stearate powder resulted in aspiration bronchopneumonia in an
infant (Murray 1926). However, it is unclear whether the bronchopneumonia resulted from the
inhalation of zinc stearate powder specifically or from the inhalation of powders in general.
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No studies were located regarding respiratory effects in animals after inhalation exposure to zinc
stearate.
Cardiovascular Effects. No atypical heart sounds or blood pressure abnormalities were
observed in 24 employees occupationally exposed to concentrations as high as 130 mg zinc/m3 of
metallic zinc dust, zinc oxide dust, zinc sulfide dust, or lithophone dust (a combination of barium
sulphate and ≈30% zinc sulphide) for 2-35.5 years (Batchelor et al. 1926). However, this study is
limited because only selected employees were examined, and they were not compared to controls.
Extremely limited information was located regarding cardiovascular effects in animals following
inhalation exposure to zinc. Routine gross and microscopic examination of the hearts of rats and
mice revealed no adverse effects 13 months after exposure to 121.7 mg zinc/m3 as zinc chloride
smoke (also containing other compounds) for 1 hour/day, 5 days/week, for 20 weeks (Marrs et al.
1988). Similarly, no changes were observed in the hearts of guinea pigs exposed to
119.3 mg zinc/m3 as zinc chloride smoke for 1 hour/day, 5 days/week, for 3 weeks, and then
observed for an additional 17 months (Marrs et al. 1988).
Gastrointestinal Effects. Nausea was reported by humans exposed to high concentrations of
zinc oxide fumes (Hammond 1944; Rohrs 1957; Sturgis et al. 1927) and zinc chloride smoke
(Evans 1945; Johnson and Stonehill 1961; Schenker et al. 1981). The zinc chloride smoke also
contained zinc oxide, hexachloroethane, and other compounds. In general, exposure levels
associated with nausea have not been reported. However, exposures to 320 mg zinc/m3 as zinc
oxide for l-3 hours (Hammond 1944) or 600 mg zinc/m3 as zinc oxide for lo-12 minutes (Sturgis
et al. 1927) were both reported to have resulted in nausea. Autopsies of victims who died
following exposure to very high concentrations of zinc chloride smoke revealed irritation of the
stomach and intestines (Evans 1945). The smoke also contained zinc oxide, hexachloroethane,
and other compounds. Workers in the galvanizing industry were found by McCord et al. (1926)
to have a higher than expected incidence of gastrointestinal problems; however, these individuals
may have been exposed to other chemicals (arsenic, hydrogen sulfide). Of 15 workers examined
with 7-20 years of experience, 12 had frequent episodes of epigastric or abdominal pain, nausea,
vomiting, ulcers, constipation, tarry stools, and/or gas. It is unclear whether these effects were
due to systemic zinc or were the result of direct contact with the gastrointestinal tract following
mucociliary clearance of inhaled zinc particles and subsequent swallowing. In contrast, 24 workers
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with 2-35.5 years of exposure to ≤130 mg zinc/m3 as metallic zinc dust, zinc sulfide dust, zinc
oxide, or lithophone dust reported no nausea or vomiting and only occasional mild abdominal
discomfort that could not be attributed with certainty to zinc exposure (Batchelor et al. 1926). A
study examining the acidity of the stomach contents after stimulation in controls and workers
employed in the production of brass alloys showed that stomach acidity was similar in the two
groups prior to stimulation but remained elevated for longer periods after stimulation in the
exposed workers (Hamdi 1969). This was proposed to account for the gastric complaints of
workers exposed to zinc fumes. Despite these findings, X-rays showed no lesions in the stomachs
or duodenums of exposed workers.
The only information available regarding gastrointestinal effects in animals was found in a study
by Marrs et al. (1988) in which rats and mice were exposed to 121.7 mg zinc/m3 as zinc chloride
smoke (which also contains zinc oxide, hexachlorophene, and other compounds) for 1 hour/day,
5 days/week, for 20 weeks, and then observed for an additional 13 months. In the same study,
guinea pigs were exposed to 119.3 mg zinc/m3 as zinc chloride smoke for 1 hour/day, 5 days/week,
for 3 weeks. All animals were sacrificed at the end of 18 months. Routine gross and microscopic
evaluation of the stomach and intestines at 18 months revealed no persistent adverse effects.
Hematological Effects. Leukocytosis persisting for approximately 12 hours after fever dissipates
is one of the hallmarks of metal fume fever (Mueller and Seger 1985). Such effects have been
observed in a number of case reports of occupational and experimental exposure of humans to
zinc oxide fumes (Brown 1988; Drinker et al. 1927a; Malo et al. 1990; Rohrs 1957; Sturgis et al.
1927). Increased leukocyte counts were observed following experimental exposures to
430 mg zinc/m3 as zinc oxide for 3 hours (Drinker et al. 1927a) or 600 mg zinc/m3 as zinc oxide
for lo-12 minutes (Sturgis et al. 1927). These studies are limited in that they used an inadequate
number of subjects, lacked controls, and used impure zinc oxide.
Decreased numbers of red blood cells and hemoglobin were found in several workers with
7-20 years of experience in the galvanizing industry (McCord et al. 1926). However, there were
excess tobacco use and alcohol consumption by workers and possible concurrent exposure to
other chemicals (chloride, sulfide) which limit the study results. No anemia was detected among
12 workers exposed for 4-21 years to zinc oxide fumes in the production of brass alloys (Hamdi
1969). These workers may have also been exposed to magnesium, copper, and aluminum.
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No studies were located regarding hematological effects in animals after inhalation exposure to
zinc.
Hepatic Effects. Routine blood chemistries and examinations revealed no liver disease among
12 workers with 4-21 years of exposure to zinc oxide fumes in the production of brass alloys
(Hamdi 1969).
No adverse effects were observed during gross and microscopic examination of livers of rats and
guinea pigs exposed to 121.7 mg zinc/m3 or 119.3 mg zinc/m3, respectively, as zinc chloride smoke
for 1 hour/day, 5 days/week, for 20 weeks, and then sacrificed at the end of 18 months (Marrs et al.
1988). Significant increases in the incidence of fatty liver were observed in mice exposed to 12.8 or
121.7 mg zinc/m3 as zinc chloride smoke using the same exposure paradigm; however, the incidence
did not increase with dose (Marrs et al. 1988). The smoke contained other compounds in addition to
zinc chloride.
Renal Effects. Urinalyses and histories of urinary function revealed no adverse effects in
24 workers exposed for 2-35.5 years to 5130 mg zinc/m3 as metallic zinc dust, zinc sulfide dust,
zinc oxide, or lithophone dust (Batchelor et al. 1926).
No adverse effects were observed following gross and microscopic examination of kidneys from
rats, mice, and guinea pigs exposed for 1 hour/day, 5 days/week, for 20 weeks, to concentrations as
high as 121.7 or 119.3 mg zinc/m3 as zinc chloride smoke (which also contained other compounds)
and then sacrificed 13 months later (Marrs et al. 1988).
Dermal/Ocular Effects. Reddened conjunctiva and cornea1 burns occurred in individuals
exposed to high concentrations of zinc chloride smoke (estimated at 33,000 mg zinc/m3) when
several smoke generators exploded in a tunnel during World War II (Evans 1945). The ocular
effects may have been due to direct contact with the smoke.
Other Systemic Effects. A fever appearing 3-10 hours after exposure to zinc oxide fumes and
lasting approximately 24-48 hours is characteristic of metal fume fever caused by zinc (Mueller
and Seger 1985). Elevated body temperature has been observed in a number of experimental and
occupational zinc oxide exposures (Brown 1988; Drinker et al. 1927a; Hammond 1944; Malo et al.
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1990; Rohrs 1957; Sturgis et al. 1927; Vogelmeier et al. 1987). Using a number of exposure
concentrations for various durations, Drinker et al. (1927b) found that the increase in body
temperature was dependent on the exposure duration and concentration. Based on their data,
they calculated that the threshold for pyrogenic effects was 45 mg zinc/m3 for 20 minutes. This
study is limited in that impurities were present in the zinc used and no statistical analysis was
performed. Exposure to zinc chloride smoke (which also contains other compounds) has also
been associated with fever (Hjortso et al. 1988; Matarese and Matthews 1966).
No studies were located regarding other systemic effects in animals following inhalation exposure
to zinc.
2.2.1.3 Immunological Effects
One report described hives and angioedema in a man exposed to zinc fumes at a zinc smelting
plant (Farrell 1987). The author suggested that the patient had an immediate or delayed
immunoglobulin E (IgE) response (or both) after a low dose of zinc fumes. Metal fume fever
also resulted when the exposure increased. The signs and symptoms of toxicity were repeated in a
challenge test conducted at the patient’s home.
In a group of 14 welders acutely exposed to 77-153 mg zinc/m3 as zinc oxide, significant
correlations between the concentration of airborne zinc and the proportion of activated T cells,
T helper cells, T inducer cells, T suppressor cells, and activated killer T cells were observed
20 hours after exposure (Blanc et al. 1991). In addition, significant increases in levels of
polymorphonuclear leukocytes, macrophages, and all types of lymphocytes were observed in the
bronchoalveolar lavage fluid 20 hours after exposure. Increased levels of lymphocytes, with a
predominance of CD8 cells, in the bronchoalveolar lavage fluid were reported in a case study of a
smelter exposed to unspecified levels of zinc fumes (Ameille et al. 1992).
The bronchoalveolar lavage fluid of rats or guinea pigs exposed to 2.2 mg zinc/m3 for 3 hours
contained increased levels of β-glucuronidase, suggesting a change in macrophage function
(Gordon et al. 1992). Rabbits were not affected following a similar exposure to 4.6 mg zinc/m3
for 2 hours. Rats, mice, and guinea pigs were exposed to concentrations as high as 119.3 or
121.7 mg zinc/m3 as zinc chloride smoke for 1 hour/day, 5 days/week, for 20 weeks (Marrs et al.
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1988). Routine gross and histopathologic examination of the lymph nodes, thymus, and spleen at
the end of 18 months revealed no adverse effects. The smoke also contained zinc oxide,
hexachlorophene, and other compounds.
2.2.1.4 Neurological Effects
Humans have reported nonspecific neurological effects such as headaches and malaise in
association with other symptoms following inhalation of zinc oxide and in metal fume fever
(Rohrs 1957; Sturgis et al. 1927). Staggering gait, hallucinations, and hilarity were observed in an
individual who intentionally inhaled aerosols of metallic paint containing copper and zinc (Wilde
1975). However, it is most likely that these effects were due to exposure to hydrocarbon
propellant rather than zinc.
No studies were located regarding neurological effects in animals after inhalation exposure to
zinc.
2.2.1.5 Reproductive Effects
No studies were located regarding reproductive effects in humans after inhalation exposure to
zinc.
Following an initial exposure of rats, mice, and guinea pigs to concentrations as high as 119.3 or
121.7 mg zinc/m3 as zinc chloride smoke (which also contained other compounds) for 1 hour/day,
5 days/week, for 20 weeks, no adverse effects on the mammary glands, ovaries, fallopian tubes, or
uteri were observed at 18 months (Marrs et al. 1988).
2.2.1.6 Developmental Effects
No studies were located regarding developmental effects in humans or animals after inhalation
exposure to zinc.
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2.2.1.7 Genotoxic Effects
Chromosome aberrations were observed in the lymphocytes of 24 workers in a zinc smelting plant
(Bauchinger et al. 1976). However, the workers had increased blood levels of lead and cadmium,
and the clastogenic effect was attributed to cadmium exposure.
Mice exposed by inhalation to zinc oxide had an increase in chromosomal aberrations in bone
marrow cells (Voroshilin et al. 1978).
Other genotoxicity studies are discussed in Section 2.4.
2.2.1.8 Cancer
In two epidemiological studies, workers did not have an increased incidence of cancers associated
with occupational exposure (primarily inhalation exposure) to zinc (Logue et al. 1982; Neuberger
and Hollowell 1982).
Workers in nine electrolytic zinc and copper refining plants were studied by Logue et al. (1982).
The workers at two of these plants were exposed to zinc or zinc and copper; the other workers
were exposed to copper. An association between cancer mortality and zinc exposure was not
found.
Excess lung cancer mortality associated with residence in an old lead/zinc mining and smelting
area of the midwestern United States was studied by Neuberger and Hollowell (1982). The ageand
sex-adjusted mortality rates were compared to state and national rates. The analysis
determined that lung cancer mortality was elevated in the region but was not found to be
associated with exposure to environmental levels of lead or zinc. Many confounding factors were
not considered in the analysis, such as smoking, occupation, and duration of residence in the area
in question.
Female Porton strain mice (98-l00/group) exposed to 121.7 mg zinc/m3 of a zinc oxide/
hexachloroethane smoke mixture (which produces zinc chloride), 1 hour/day, 5 days/week, for
20 weeks had a statistically significant increase in the incidence of alveologenic carcinoma (30%
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versus 8% in control) thirteen months after the end of exposure (Marrs et al. 1988). No
increased tumor incidences were seen in mice exposed to 1, 1.3, or 12.8 mg zinc/m3. Guinea pigs
and rats were also tested with similar dose levels, and no significant carcinogenic response was
observed. A number of factors limits the usefulness of this study, including the presence of
several compounds in the smoke that may have carcinogenic potential, the use of only female
animals, and the short duration of the exposure (20 weeks).
2.2.2 Oral Exposure
Zinc has been orally administered in a variety of forms, such as zinc chloride, zinc sulfate, zinc
oxide, powdered zinc, and others. Some of these compounds, such as zinc sulfate, have been
administered in both hydrated and anhydrous forms. Study authors often do not state definitely
which form was used in a particular study. Knowledge of the form used and its molecular weight
is necessary to calculate the amount of elemental zinc administered under a given set of
circumstances. If adequate information was not reported by the study authors, it was assumed
that an anhydrous compound was used.
2.2.2.1 Death
In a case report presented by Murray (1926), an infant died from bronchopneumonia resulting
from inhalation and ingestion of an unspecified amount of zinc stearate powder spilled from a
container. However, the cause of death (bronchopneumonia) suggests that it resulted from the
inhalation exposure, rather than the oral exposure, and it is unclear whether the lung damage
resulted from the inhalation of zinc stearate powder specifically or from the inhalation of powders
in general.
The LD50 values of several zinc compounds have been determined in rats and mice (Domingo et
al. 1988a). In general, mice appear to be more sensitive than rats to the lethal effects of zinc. In
rats, zinc acetate was the most lethal compound tested; zinc nitrate, zinc chloride, and zinc sulfate
(in order of decreasing toxicity) were less lethal. In mice, the most lethal compound was zinc
acetate followed by zinc nitrate, zinc sulfate, and zinc chloride. Ingestion of 390 mg zinc/kg/day as
zinc oxide in the diet for 3-13 days was lethal to ferrets (Straube et al. 1980). An equivalent dose
in humans would be approximately 27 g zinc/day (which would probably be intolerable to humans
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because of gastric discomfort). Death was reported in mice that consumed 1,110 mg zinc/kg/day
as zinc sulfate in their diet for 13 weeks (Maita et al. 1981). Mortality was also observed in 20%
of rats ingesting 191 mg zinc/kg/day as zinc acetate in drinking water for 3 months (Llobet et al.
1988a).
The LD50 values and all LOAEL values from each reliable study for death in each species and
duration category are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.2 Systemic Effects
Ingestion of zinc or zinc-containing compounds has resulted in a variety of systemic effects in the
gastrointestinal and hematological systems and alterations in the blood lipid profile in humans and
animals. In addition, lesions have been observed in the liver, pancreas, and kidneys of animals.
No studies were located regarding respiratory effects in humans or animals after oral exposure to
zinc.
Observed systemic effects after oral exposure are discussed below. The highest NOAEL values
and all LOAEL values from each reliable study for systemic effects in each species and duration
category are recorded in Table 2-2 and plotted in Figure 2-2. The effects discussed in case
reports are not included in Table 2-2 or Figure 2-2 because of the small sample size and lack of
control data.
Cardiovascular Effects. A number of studies in humans and animals have examined the effects
of zinc on serum cholesterol and triglycerides. These data are discussed below under Other
Systemic Effects. However, no studies regarding the direct relationship between excessive zinc
intake and cardiac mortality were located. No effects on electrocardiographic results were found
in a group of elderly subjects (>65 years of age) taking zinc supplements of up to
2 mg zinc/kg/day (Hale et al. 1988) or 0.71 mg zinc/kg/day (Czerwinski et al. 1974). There was
also no effect on the frequency of cardiovascular disease (heart attack, heart failure, hypertension,
or angina) in elderly subjects (>67 years of age) taking up to 2 mg zinc/kg/day (Hale et al. 198s).
In one study, patients having inoperable severe occlusive vascular disease were administered
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24 patients experienced improvement in lower extremity blood flow and unchanged or decreased
arterial pressure. Zinc’s role in these improvements was not completely understood by the study
authors. They hypothesized that when optimal zinc levels are provided to the ischemic limb, the
activity of certain zinc enzymes promotes the reversal of tissue-dependent hypoxia and/or lactic
acidemia in the muscles. It is also not known if this high dose of zinc was associated with any
toxic effects.
No studies were located regarding cardiovascular effects in animals after oral exposure to zinc.
Gastrointestinal Effects. Several studies have suggested that zinc ingestion may cause symptoms
of gastrointestinal distress or alterations in gastrointestinal tissues. For example, one individual
who ingested about 3 ounces of a zinc chloride solution described acute symptoms that occurred
almost immediately following contact with the compound, including burning and pain in the
mouth and throat and vomiting (Chobanian 1981). Later, the patient exhibited pharyngitis,
esophagitis, hypocalcemia, and elevated levels of amylase; the latter two alterations are suggestive
of acute pancreatitis. The patient received intravenous hydration and calcium supplementation
and recovered within 5 days. The material ingested was described as a “zinc chloride solution,”
and its concentration was not reported. Therefore, a dose level could not be established in this
case.
Several cases of gastrointestinal disturbances have been reported after ingestion of large amounts
of zinc as zinc sulfate (Anonymous 1983; Brown et al. 1964; Moore 1978; Samman and Roberts
1987). Vomiting, abdominal cramps, and diarrhea, in several cases with blood, have been
observed after ingestion of zinc sulfate. In one report, an English school girl ingested
440 mg zinc sulfate/day (2.6 mg zinc/kg/day) in capsules as a medically prescribed treatment for
acne (Moore 1978). After taking each capsule, she experienced epigastric discomfort. A week
later, she was admitted to the hospital after a fainting spell. She was diagnosed as anemic and
subsequently passed melanic stools, indicative of gastrointestinal bleeding. Gastrointestinal upset
(abdominal cramps, vomiting, nausea) occurred in 26 of 47 healthy volunteers following ingestion
of zinc sulfate tablets (150 mg as zinc ion in three divided doses per day, 2 mg zinc/kg/day) for
6 weeks (Samman and Roberts 1987). Ingestion of zinc oxide has also been associated with
gastrointestinal distress (Anonymous 1983; Callender and Gentzkow 1937). In one case, 80% of
the personnel of two army companies became ill with gastrointestinal distress and diarrhea after
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consuming limeade prepared in galvanized trash cans (Callender and Gentzkow 1937). The
average dose was estimated to be 6.7-7.1 mg/kg. A second example was presented in a case
involving school children in New Mexico who experienced nausea and vomiting after accidental
excessive zinc intake (Anonymous 1983). These children had consumed punch containing high
levels of zinc dissolved from galvanized hinges attached to tanks in which the punch was stored.
A 16-year-old boy who ingested 12 g elemental zinc over a 2-day period (86 mg zinc/kg/day)
experienced light-headedness, lethargy, staggering gait, and difficulty writing legibly, but no
apparent gastrointestinal disturbances (Murphy 1970).
Gastrointestinal effects have also been observed in animals. Intestinal hemorrhages were
observed in ferrets that ingested 390 mg zinc/kg/day as zinc oxide for 2 weeks (Straube et al.
1980). These ferrets exhibited a 75% reduction in food intake. No intestinal hemorrhaging was
observed in ferrets fed 195 mg/kg/day for up to 21 days. Oral zinc sulfate exposures of
intermediate duration in other experimental animals have also resulted in gastrointestinal effects.
Mice fed a diet providing 1,110 mg zinc/kg/day developed ulcers in the forestomach, but
gastrointestinal effects were not observed in rats fed 565 mg zinc/kg/day (Maita et al. 1981).
Hematological Effects. In a case report, acute exposure to 2.6 mg zinc/kg/day as zinc sulfate for
1 week resulted in anemia (Moore 1978). The authors of the report noted that the anemia may
have been secondary to the gastrointestinal hemorrhages.
Treatment-related changes in hematological parameters have been observed in humans and
animals after intermediate or chronic exposure to zinc or zinc-containing compounds. Long-term
administration (l-8 years) of zinc supplements has caused anemia in humans (Broun et al. 1990;
Gyorffy and Chan 1992; Hale et al. 1988; Hoffman et al. 1988; Patterson et al. 1985; Porter et al.
1977; Prasad et al. 1978; Ramdurai et al. 1993; Stroud 1991; Summerfield et al. 1992). Exposure
to 2 mg zinc/kg/day as zinc sulfate for 10 months resulted in anemia (Hoffman et al. 1988). A
significant reduction in erythrocyte superoxide dismutase activity (47% decrease), hematocrit, and
serum ferritin, compared to pretreatment levels, occurred in female subjects who received
supplements (as capsules) of 50 mg zinc/day as zinc gluconate for 10 weeks (Yadrick et al. 1989).
A 15% decrease in erythrocyte superoxide dismutase activity was reported in male volunteers
receiving 50 mg zinc/day as zinc gluconate for 6 weeks (Fisher et al. 1984).
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In animals, following oral administration of zinc compounds, decreased hemoglobin, hematocrit,
erythrocyte, and/or leukocyte levels were observed in rats (Maita et al. 1981; Smith and Larson
1946), mice (Maita et al. 1981; Walters and Roe 1965) rabbits (Bentley and Grubb 1991) dogs
(Drinker et al. 1927d; Meurs et al. 1991; Robinson et al. 1991), ferrets (Straube et al. 1980), and
preruminant calves (Jenkins and Hidiroglou 1991). In rats, the lowest LOAEL for decreased
hemoglobin (85% of control value) is 12 mg zinc/kg/day as zinc chloride in a 4-week drinking
water study with 2-month-old rats (Zaporowska and Wasilewski 1992). The highest NOAEL in
rats is 191 mg zinc/kg/day as zinc acetate in a 3-month drinking water study (age of rats not
specified) (Llobet et al. 1988a). The reason that the lowest LOAEL is less than the highest
NOAEL in rats is unclear, but it may be because of the use of different zinc compounds or
different rat strains or age. The second lowest rat LOAEL is 350 mg zinc/kg/day as zinc
carbonate (Smith and Larson 1946). For mice, NOAEL and LOAEL values of 104 and
1,110 mg zinc/kg/day as zinc sulfate, respectively, were identified by Maita et al. (1981) in a
13-week feeding study. A LOAEL of 68 mg zinc/kg/day as zinc oleate was observed in a 9-month
mouse feeding study (Walters and Roe 1965). It is not known if the difference in the LOAELs
identified in the Maita et al. (1981) and Walters and Roe (1965) studies is due to the use of
different zinc compounds, different basic diet formulations, different mouse strains, or different
exposure durations. Slight decreases in hemoglobin levels were observed in rabbits fed
174 mg zinc/kg/day as zinc carbonate (Bentley and Grubb 1991). Zinc oxide consumption caused
anemia in dogs (76.5 mg zinc/kg/day) (Drinker et al. 1927d), ferrets (195 mg zinc/kg/day) (Straube et
al. 1980) and preruminant calves (64 mg zinc/kg/day) (Jenkins and Hidiroglou 1991).
Hematological alterations were not observed in cats exposed to up to 83.2 mg zinc/kg/day as zinc
oxide (Drinker et al. 1927d) or in adult mink exposed to zinc at up to 297.4 mg zinc/kg/day as zinc
oxide (Aulerich et al. 1991; Bleavins et al. 1983). However, decreases in hematocrit and
lymphocytes were observed in the offspring of mink females that ingested a time-weighted-average
dose of 20.8 mg zinc/kg/day as zinc sulfate for 10 weeks prior to conception and throughout gestation
and lactation (Bleavins et al. 1983) indicating that very young mink may be more sensitive to the
hematologic effects of zinc than adults. An increased number of weanling rats had low levels of
ceruloplasmin, a copper serum protein, after administration of zinc sulfate for 6 weeks (Abbe and
Fischer 1984a).
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans
after oral exposure to zinc.
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Rib biopsies revealed no treatment-related effects in dogs given 4 mg zinc/kg/day as zinc oxide in
the diet for 9 months (Anderson and Danylchuk 1979).
Hepatic Effects. Ingestion of 3.5 mg/kg/day zinc sulfate for 18 weeks by 13 patients being
treated for chronic venous leg ulcers was reported to have no effect on the results of liver
function tests (Hallbook and Lanner 1972). However, the type of liver function tests was not
specified and results were not presented to support this conclusion.
No histopathology or changes in serum enzyme levels (serum glutamic oxaloacetic transaminase,
serum glutamic pyruvic transaminase, or alkaline phosphatase) were observed in rats receiving
191 mg zinc/kg/day as zinc acetate (Llobet et al. 1988a). Similarly, no histopathology was
observed in rats administered 98.3 mg zinc/kg/day as zinc oxide, but an insufficient number of
animals were tested (Drinker et al. 1927c). Sheep fed time-weighted-average doses of
19 mg zinc/kg/day as zinc oxide for 49-72 days developed hepatic effects, including necrotic
hepatocytes and large quantities of hemosiderin in Kupffer cells (Allen et al. 1983). Because
sheep are ruminants, it is not known if they are a good model for predicting human toxicity. No
histological damage was observed in adult or young mink fed 164.8 or 297.4 mg zinc/kg/day,
respectively, as zinc sulfate for 144 days (Aulerich et al. 1991).
Decreased hexobarbital sleeping times were reported by Kadiiska et al. (1985) in rats receiving
40 mg zinc/kg/day as zinc sulfate. This physiological response suggested an induction of
microsomal enzymes.
Renal Effects. Thirteen patients treated with zinc sulfate at 3.5 mg zinc/kg/day for 18 weeks for
chronic venous leg ulcers had normal urinalyses (Hallbook and Lanner 1972). However, neither
the specific parameters measured for the urinalysis nor the results were presented to support this
conclusion. Furthermore, urinalysis may not be a sensitive indicator of renal function.
A number of intermediate-duration studies have demonstrated renal effects in animals exposed to
zinc oxide, zinc sulfate, and zinc acetate. Zinc sulfate caused an increase in the absolute and
relative kidney weights and regressive kidney lesions (not specified) in female mice that consumed
1,110 mg zinc/kg/day in the diet for 13 weeks, but no effects occurred in rats that consumed 565 mg
zinc/kg/day under similar conditions (Maita et al. 1981). Severe diffuse
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nephrosis was observed in ferrets exposed to 195 mg zinc/kg/day as zinc oxide in the diet (Straube et
al. 1980). In rats exposed to 191 mg zinc/kg/day as zinc acetate for 3 months, epithelial cell damage
in the glomerulus and proximal convoluted tubules and increased plasma creatinine and urea levels
were observed (Llobet et al. 1988a). The NOAEL for the effects on creatinine and urea was 95 mg
zinc/kg/day. It is unclear whether the microscopic changes were observed at lower doses. No
histopathological changes in the kidneys were observed in three rats that drank water
containing 98.3 mg zinc/kg/day as zinc oxide for 35-36 weeks (Drinker et al. 1927c); however,
interpretation of the results of this study is severely limited by the small number of rats used.
Renal tubular dilation, with proteinaceous casts and hemosiderin deposits, was observed in the
kidneys of sheep that ingested 18 mg zinc/kg/day as zinc oxide for 49-72 days (Allen et al. 1983).
It is not known if sheep are a good model for human toxicity because they are ruminants. No
renal effects were observed in either adult mink consuming 326.7 mg zinc/kg/day as zinc sulfate or in
young mink consuming 323.6 mg zinc/kg/day as zinc sulfate for 144 days (Aulerich et al. 1991).
Dermal/Ocular Effects. No studies were located regarding dermal/ocular effects in humans after
oral exposure to zinc.
No dermal effects were seen in female minks given a time-weighted dose of 20.8 mg zinc/kg/day as
zinc sulfate for 10 weeks prior to mating and then throughout gestation and lactation (Bleavins et al.
1983).
Other Systemic Effects
Pancreas. Increased levels of serum amylase were observed in a man after accidental ingestion of
about 3 ounces of a zinc chloride solution (Chobanian 1981). A 16-year-old boy who ingested an
average of approximately 86 mg zinc/kg/day as metallic zinc for 2 days (114 mg/kg on the 1st day
and 57 mg/kg on the 2nd day) had increased serum amylase and lipase (Murphy 1970).
In humans receiving a single low dose of zinc sulfate (0.5 mg zinc/kg/day), no changes in blood
glucose or insulin levels were observed, and there were no differences in response to a glucose
load (Brandao-Neto et al. 1990b).
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Pancreatic abnormalities (islet cellular alterations, acinar cell necrosis, metaplasia, fibrosis,
pancreatitis) resulting from zinc ingestion have been observed in rats (Maita et al. 1981) mice
(Aughey et al. 1977; Maita et al. 1981), cats (Drinker et al. 1927d), ferrets (Straube et al. 1980)
sheep (Allen et al. 1983), and birds (Kazacos and Van Vleet 1989; Lu et al. 1990). In dogs
(Drinker et al. 1927d) and minks (Aulerich et al. I991), histological changes in the pancreas have
not been observed at doses comparable to or higher than the dose levels that caused
abnormalities in rats, mice, cats, ferrets, and sheep. Degeneration of the acinar cells of the
pancreas was observed in sheep by Allen et al. (1983) and in rats and mice by Maita et al. (1981).
Since the pancreatic acinar cells secrete digestive juices into the small intestine, the increase in
serum amylase and lipase observed in the human case reports (Chobanian 1981; Murphy 1970)
would correspond to damage in this region of the pancreas.
In 2-month-old C3H mice exposed to 70 mg zinc/kg/day as zinc sulfate, hypertrophy and
vacuolation of the β-cells of the pancreatic islets were observed beginning after 3 months of
exposure and become more severe by 12 months (Aughey et al. 1977). The pancreatic islets
secrete the hormones glucagon and insulin. No change in plasma levels of insulin and glucose was
observed in this study after 6 months of exposure. No effect on islet cells was reported in rats
exposed up to 565 mg/kg/day or mice exposed to 1110 mg/kg/day as zinc sulfate in a 13-week
study by Maita et al. (1981) and Allen et al. (1983) reported that islet cells in sheep were
generally unaffected, although occasional vacuolization occurred. Degeneration of acinar cells,
but no effects on the islet cells, were found in ducklings (Kazacos and Van Vleet 1989); however,
the relevance of this to humans is unclear. The data are too limited and contradictory to
determine whether pancreatic islet cells are a primary target cell of zinc toxicity.
Adrenal Gland. Decreased levels of serum cortisol (a hormone secreted by the adrenal cortex)
were observed in humans after a single dose of 0.5 mg zinc/kg/day as zinc sulfate (Brandao-Neto
et al. 1990b). No effects on the adrenal gland itself have been reported in humans.
In mice receiving 70 mg zinc/kg/day as zinc sulfate in the drinking water, hypertrophy and
increased lipid content of the zona fasciculata cells of the adrenal cortex were observed as early as
3 months after the start of zinc supplementation (Aughey et al. 1977).
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Pituitary. No effects on pituitary function have been reported in humans following oral exposure
to zinc. However, mice receiving 70 mg zinc/kg/day as zinc sulfate in the drinking water for
5-14 months had hypertrophy and increased granularity suggesting increased activity of the
pituitary (Aughey et al. 1977). It is unclear whether the increased activity was a direct effect of
the zinc or a reaction to decreased secretion from the adrenal cortex.
Serum Lipid Levels. Several reports described changes in the serum lipid profile of humans
exposed to zinc sulfate or gluconate for 3-12 months; however, the results are mixed. Ingestion
of 2.3-4.3 mg zinc/kg/day for 5-6 weeks (Chandra 1984; Hooper et al. 1980) or
0.71 mg zinc/kg/day for 12 weeks (Black et al. 1988) reduced levels of high-density lipoprotein
(HDL) cholesterol. In the study by Chandra (1984) a slight increase in low-density lipoprotein
(LDL) cholesterol was observed in subjects who served as their own controls; measurements were
taken prior to zinc supplementation and after a lo-week postexposure period. Serum cholesterol,
triglyceride, and LDL cholesterol levels were not affected by zinc supplementation in the study by
Black et al. (1988). However, in another study, zinc supplements depressed HDL cholesterol
levels and raised LDL cholesterol levels in elderly subjects (>60 years of age), especially in those
who exercised. This study was not well controlled, and the wide variation in doses of the
supplemented group prevented the determination of a LOAEL (Goodwin et al. 1985). Young
women with a total daily intake of 1.6 mg zinc/kg/day in a 2-month study had a transient decrease
in HDL cholesterol (Freeland-Graves et al. 1980). In a double-blind crossover study of young
men and women receiving 2.0 (men) or 2.4 (women) mg zinc/kg/day for 6 weeks, total HDL
cholesterol was not affected, and LDL cholesterol was significantly decreased in the women
(Samman and Roberts 1988). No effect on HDL cholesterol was seen in elderly men and women
(60-89-years old) with a total daily intake (dietary zinc plus a zinc acetate supplement) of
1.5 mg/kg/day for 3 months (Bogden et al. 1988) but the subjects also received copper
supplements (about 0.03 mg/kg). Another study (Hale et al. 1988) reported no differences in
triglycerides and cholesterol levels in subjects (>68-years old) given zinc supplements of up to
2 mg/kg/day for an average of 8 years.
Increases in serum cholesterol levels were observed in two studies where rats were fed either
2.8 or 10 mg zinc/kg/day as zinc acetate for 2-7 months (Katya-Katya et al. 1984; Klevay and Hyg
1973). Other studies have shown no effect on total cholesterol, HDL cholesterol, or serum
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triglyceride levels in rats ingesting 3 or 2.5 mg zinc/kg/day of unspecified zinc compounds (Fischer
et al. 1980; Woo et al. 1983).
Body Weight. No effects on body weight have been reported in humans following oral exposure to
zinc. However, body weight gain was decreased by 46% in preruminant calves that consumed
91 mg zinc/kg/day as zinc oxide for 5 weeks; there was no effect at 64 mg zinc/kg/day (Jenkins and
Hidiroglou 1991). The relevance of this effect to humans is unclear. Body weights of rabbits-
(Bentley and Grubb 1991), rats (Llobet et al. 1988a), and minks (Aulerich et al. 1991) were
unaffected by dosing with 174, 191, and 326.7 mg zinc/kg/day, respectively, for 3-12 months.
2.2.2.3 Immunological Effects
Zinc plays a role in the normal development and maintenance of the immune system, such as in
the lymphocyte response to mitogens and as a cofactor for the thymic hormone thymulin
(Delafuente 1991; Franker et al. 1986). Oral exposure to zinc at levels much higher than the
RDA has impaired immune and inflammatory responses. This was observed in in vivo
investigations of the immune competence of blood components taken from 11 healthy adult men
after ingestion of 4.3 mg zinc/kg/day as zinc sulfate for 6 weeks. The mitogenic response elicited
from peripheral blood lymphocytes and the chemotactic and phagocytic responses of
polymorphonuclear leukocytes were impaired after zinc ingestion. No effects were seen on total
numbers of lymphocytes or relative numbers of T cells, T cell subsets, or B cells (Chandra 1984).
The relationship between these observations and decreased levels of immune competence that
might lead to increased susceptibility to disease is unknown. Zinc supplements administered to
elderly populations at doses up to 1.5 mg zinc/kg/day (Bogden et al. 1988) or 2.5 mg zinc/kg/day
(Duchateau et al. 1981) resulted in either no effect or a beneficial effect on immune cell titers or
delayed cutaneous hypersensitivity responses to specific antigens.
Decreased lymphocyte activity (incorporation of 3H-thymidine in response to concanavalin A) was
reported in mink kits from dams who had ingested a time-weighted-average dose of
20.8 mg zinc/kg/day as zinc sulfate for 10 weeks prior to conception and throughout gestation and
lactation (Bleavins et al. 1983). The dose to the kits is unknown. In contrast, no effect was
observed on antibody titre (immunoglobulin G [IgG] and immunoglobulin M [IgM]) or the
mitogenic response of splenic B cells isolated from mice fed 76.9 mg zinc/kg/day as zinc sulfate
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for 4 weeks and challenged with B cell antigens either in vivo or in vitro (Schiffer et al. 1991). The in
vitro mitogenic response of T cells isolated from these mice was increased.
The highest NOAEL value in animals and the LOAEL value in humans for immunological effects
after intermediate-duration oral exposure are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.4 Neurological Effects
Zinc appears to be necessary for normal brain function (Sandstead et al. 1983), but excess zinc is
toxic. A 16-year-old boy who ingested ≈86 mg zinc/kg/day of metallic zinc over a 2-day period in
an attempt to promote wound healing, developed signs and symptoms of lethargy, lightheadedness,
staggering, and difficulty in writing clearly (Murphy 1970). Lethargy was also
observed in a 2-year-old child who ingested a zinc chloride solution (≈l,000 mg zinc/kg) (Potter
1981). It is not known whether these observations represent direct effects on the nervous system.
Very limited data were located regarding neurological effects in animals. Minor neuron
degeneration and proliferation of oligodendroglia occurred in rats dosed with 487 mg zinc/kg/day
as zinc oxide for 10 days (Kozik et al. 1980). Rats receiving 472 mg zinc/kg/day for 10 days had
increased levels of secretory material in the neurosecretory nuclei of the hypothalamus (Kozik et
al. 1981).
2.2.2.5 Reproductive Effects
Pregnant women receiving capsules containing 0.3 mg zinc/kg/day as zinc sulfate during the last
two trimesters did not exhibit any reproductive effects (no changes in maternal body weight gain,
blood pressure, postpartum hemorrhage, or infection) (Mahomed et al. 1989). No other studies
were located regarding reproductive effects in humans after oral exposure to zinc.
No measurable effect on gestational length or litter size was observed when female mink ingested
a time-weighted’average dose of 20.8 mg zinc/kg/day as zinc sulfate (Bleavins et al. 1983). No
histological alterations in the testes or ovaries were noted in mice fed zinc sulfate
(1,110 mg zinc/kg/day) for 13 weeks (Maita et al. 1981). Male and female rats receiving
50 mg zinc/kg/day as zinc carbonate in the diet were reported to reproduce normally for several
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generations in a poorly documented study by Sutton and Nelson (1937). Rats fed
250 mg zinc/kg/day for 14-17 weeks mated successfully but had a higher than normal percentage
of stillborn pups A subsequent mating of the parental generation fed 2.50 mg zinc/kg/day for
5 months was unsuccessful. No reproduction occurred in rats fed 500 mg zinc/kg/day for 5 months
(Sutton and Nelson 1937). The frequency of sperm with an altered chromatin structure was
increased in rats fed 25 mg zinc/kg/day as zinc chloride for 8 weeks (Evenson et al. 1993).
Preimplantation loss increased in rats fed diets containing 200 mg zinc/kg/day as zinc sulfate on
gestational days 0-18 (Pal and Pal 1987). When the rats received 200 mg zinc/kg/day 21 days
prior to mating, no effects on implantation or other adverse reproductive effects were observed
(Pal and Pal 1987). The highest NOAEL values and all LOAEL values from each reliable study
for reproductive effects in each species and duration category are recorded in Table 2-2 and
plotted in Figure 2-2.
2.2.2.6 Developmental Effects
Zinc is necessary for normal fetal growth and development. Fetal damage may result from zinc
deficiency. Only one report in the literature suggested adverse developmental effects in humans
due to exposure to excessive levels of zinc (Kumar 1976). Four women were given zinc
supplements of 0.6 mg zinc/kg/day as zinc sulfate during the third trimester of pregnancy. Three
of the women had premature deliveries, and one delivered a stillborn infant. However, the
significance of these results cannot be determined because very few details were given regarding
the study protocol, reproductive histories, and the nutritional status of the women. Other human
studies have found no developmental effects in the newborns of mothers consuming
0.3 mg zinc/kg/day as zinc sulfate (Mahomed et al. 1989) or zinc citrate (Simmer et al. 1991) or
0.06 mg zinc/kg/day as zinc aspartate (Kynast and Saling 1986) during the last two trimesters.
The developmental toxicity of zinc in experimental animals has been evaluated in a number of
investigations. Exposure to high levels of zinc in the diet prior to and/or during gestation has
been associated with increased fetal resorptions, reduced fetal weights, altered tissue
concentrations of fetal iron and copper, and reduced growth in the offspring.
Administration of zinc in rats at 200 mg zinc/kg/day as zinc oxide in the diet for 21 days prior to
mating and then throughout gestation resulted in resorption of all fetuses (Schlicker and Cox
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1968). Fetal resorptions ranged from 4% to 29% when 200 mg zinc/kg/day was administered only
during gestation (controls had no resorptions). When the dose was reduced to 100 mg zinc/kg/day
starting 21 days prior to mating, there were no fetal resorptions, malformations, or growth
reduction. In contrast, Kinnamon (1963) reported no resorptions, no difference in the number of
offspring per litter, and no change in average wet weight of the fetuses from female rats fed
250 mg zinc/kg/day as zinc carbonate in the diet for 53 days before mating and during gestation.
The reason for the differences in the results of these studies is unknown. No effect on fetal
viability, size, or malformations was seen in fetuses from female rats fed 25 mg zinc/kg/day as zinc
carbonate during gestational days l-18 (Uriu-Hare et al. 1989).
Administration of 200 mg zinc/kg/day to dams throughout gestation resulted in decreased growth
and tissue levels of copper and iron in fetal rats (Cox et al. 1969; Schlicker and Cox 1968). In
rats, at both 100 and 200 mg/kg/day during gestational days l-18, maternal zinc levels increased.
However, zinc tissue levels in the 22-day-old fetuses were not elevated at 100 mg/kg/day to dams,
suggesting that the placenta was able to act as a barrier to zinc at the lower dietary level. In
contrast, Ketcheson et al, (1969) showed that newborn and 14-day-old rats from mothers that had
consumed 100 mg/kg/day throughout gestation had elevated levels of total zinc and decreased
levels of iron. It is unclear whether the longer exposure to zinc during gestation or the suckling
of newborn rats prior to sacrifice may have accounted for these differences.
Animal studies suggest that exposure to very high levels of dietary zinc is associated with reduced
fetal weight, alopecia, decreased hematocrit, and copper deficiency in offspring. For example,
second generation mice exposed to zinc carbonate during gestation and lactation (260 mg/kg/day
in the maternal diet), and then continued on that diet for 8 weeks, had reduced body weight,
alopecia, and signs of copper deficiency (e.g., lowered hematocrit and occasional achromotrichia
[loss of hair color]) (Mulhern et al. 1986). Similarly, mink kits from dams that ingested a
timeweighted-average dose of 20.8 mg zinc/kg/day as zinc sulfate also had alopecia and
achromotrichia (Bleavins et al. 1983). It is likely that the alopecia resulted from zinc-induced copper
deficiency,which is known to cause alopecia in monkeys (Obeck 1978). However, no adverse effects
were observed in parental mice or mink.
The highest NOAEL values and all LOAEL values from each reliable study for developmental
effects in each species and duration category are recorded in Table 2-2 and plotted in Figure 2-2.
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2.2.2.7 Genotoxic Effects
No studies were located regarding genotoxicity in humans after oral exposure to zinc.
Chromosomal aberrations were detected in the bone marrow cells of mice administered 350 mg
zinc/kg as zinc chloride and fed a low-calcium diet (1.1% calcium), but not when the animals were
given a similar zinc dose and fed a calcium-replete diet (Deknudt and Gerber 1979). A similar effect
was observed in rats exposed to 14.8 mg zinc/kg/day as zinc chlorate in drinking water (Kowalska-
Wochna et al. 1988).
Other genotoxicity studies are discussed in Section 2.4.
2.2.2.8 Cancer
Very limited data were found regarding relationships between the ingestion of zinc and its
compounds by humans and the subsequent development of cancer. One study reported an
association between an excess rate of gastric cancer in the people of North Wales (Great Britain)
and the high zinc-to-copper ratio (≈30:1) in the soil of household gardens (Stocks and Davies
1964). However, the inference that this excess in gastric cancer is causally associated with soil
levels of zinc and copper is not consistent with another study. In a survey of cancer registry data
(1954-1978) in Shipham, Somerset (Great Britain), an area that also has a high soil zinc-tocopper
ratio (≈17:1), the gastric cancer incidence rate was significantly lower than the regional
rate (Philipp et al. 1982). It is probable that other factors, not considered by Stocks and Davies
(1964), that are associated with or coincidental to the high soil zinc-to-copper ratio confounded
the results.
The carcinogenicity of zinc in experimental animals following oral exposure was evaluated by
Walters and Roe (1965). The incidence of tumors was not increased in mice exposed to
951 mg zinc/kg/day as zinc sulfate in drinking water for 1 year compared to controls. However,
important details regarding the study protocol were lacking including the age and sex of the mice,
the number of mice at the beginning of the study, the purity of the test material, and a complete
list of the organs and tissues examined at necropsy. The control mice developed intercurrent
disease (ectromelia), which resulted in a number of deaths; supplementary control mice were
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added to the study, but they were not concurrent controls. The number of animals in treated and
control groups surviving at 1 year (study termination) was small (22-28 mice/group). The
exposure period (1 year) was less than the standard bioassay period (18-24 months). There were
no data in the study (e.g., survival or body weight data) to indicate that a maximum tolerated dose
was achieved. These limitations reduce the sensitivity of the study by Walters and Roe (1965) to
detect a carcinogenic response.
2.2.3 Dermal Exposure
2.2.3.1 Death
No studies were located regarding death in humans or animals after dermal exposure to zinc.
2.2.3.2 Systemic Effects
Zinc has been reported to promote the healing of burns and wounds when topically applied as
zinc oxide or calamine lotion (Gordon et al. 1981). The mechanism by which.this occurs was not
discussed by the authors. Zinc oxide contained in an occlusive zinc tape dressing reduced the
inflammatory reactions in the granulation tissue of wounded rats (Wetter et al. 1986). The
authors speculated that zinc acted either by a continuous release of zinc ions or by modifying
components involved in the tape’s adhesive properties.
No studies were located regarding respiratory, cardiovascular, gas train tes tin al, musculoskeletal,
hepatic, renal, or other systemic effects in humans or animals after dermal exposure to zinc. The
systemic effects observed after dermal exposure are discussed below. The NOAEL values and all
LOAEL values from each reliable study for dermal effects in each species and duration category
are recorded in Table 2-3.
Hematological Effects. A worker who had been employed making up zinc chloride solutions
(concentrations not specified) with his hands was found to have microcytic anemia and decreased
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No studies were located regarding hematological effects in animals after dermal exposure to zinc.
Dermal/Ocular Effects. No signs of dermal irritation were observed in humans after a 25% zinc
oxide patch (2.9 mg/cm2) was placed on the skin for 48 hours (Agren 1990). However, 14 out of
17 men who were employed in the bagging or packing of zinc oxide and whose skin was
frequently covered with zinc oxide dust reported having experienced zinc oxide pox at least once
(Turner 1921). The pox appeared as itchy papular-pustular eruptions in the pubic region,
scrotum, inner surface of the thigh, and occasionally on the axilla and inner surface of the arms.
The study author suggested that these lesions were due to clogging of glands by dust, perspiration,
and bacteria when skin surfaces coated with these substances were rubbed together. In contrast,
a case study of 24 workers exposed to dusts of either zinc oxide, zinc sulfide, or metallic zinc
revealed only 1 worker with papular pustular lesions on the axilla and inner thighs (Batchelor et
al. 1926). The difference in the results was attributed to differences in the personal hygiene of
the workers in the two studies.
In a case report, accidental splashing of a soldering paste containing 30% zinc chloride into the
eye of a plumber produced an immediate reduction in visual acuity, hyperemia, hemorrhaging,
conjunctival swelling, cornea1 opacity, bullous keratopathy, and spotting of the lens (Houle and
Grant 1973). Most symptoms disappeared after 6 weeks, but residual lens opacities persisted for
over a year after the exposure. Reddened conjunctivae and lacrimation were observed in
34 persons who were exposed to extremely high concentrations of zinc chloride smoke when
several smoke generators exploded in a tunnel during World War II (Evans 1945). Two of the
exposed persons had cornea1 burns and four had small vesicular burns on the forehead or wrist.
Zinc chloride was the major component of the smoke. However, other components such as zinc
oxide, hexachloroethane, calcium silicide, the igniter, or the heat of the explosion may have
contributed to the injuries that were observed.
The dermal irritancy of several zinc compounds was compared in mice, rabbits, and guinea pigs
(Lansdown 1991). Of the six zinc compounds tested, zinc chloride had the greatest irritancy
potential, followed by zinc acetate and zinc sulfate; no signs of irritation were observed following
exposure to zinc oxide. Although zinc chloride is clearly the most irritating, the relative irritancy
of zinc sulfate and zinc acetate was not determined because only one dose was tested and a
different dose was used for each compound. The severe skin irritancy observed following
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application of zinc chloride was characterized by parakeratosis, hyperkeratosis, inflammatory
changes in the epidermis and superficial dermis, and acanthosis of the follicular epithelia
(Lansdown 1991).







Genotoxicity studies are discussed in Section 2.4.
2.2.3.8 Cancer
No studies were located regarding carcinogenic effects in humans or animals after dermal
exposure to zinc.
2.3 TOXICOKINETICS
There is limited information on the toxicokinetic properties of zinc following inhalation or dermal
exposure. Increased zinc levels in the blood and urine of humans and in the tissue of animals
after inhalation and dermal exposure to zinc, respectively, indicate that zinc is absorbed by these
routes. The toxicokinetic properties of ingested zinc have been extensively studied. The
absorption of zinc from the gastrointestinal tract is homeostatically regulated; under normal
physiological conditions, 20-30% of ingested zinc is absorbed. Zinc uptake from the intestinal
lumen involves passive diffusion and a carrier-mediated process. A number of factors influence
the absorption of zinc; these include inhibitors, such as calcium, phosphorus, and dietary fiber and
phytates (components of dietary fiber that may coprecipitate with zinc in the intestines), and
enhancers, such as amino acids? picolinic acid, and prostaglandin E2,. Once absorbed, zinc is
widely distributed throughout the body. Zinc content is highest in muscle, bone, gastrointestinal
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tract, kidney, brain, skin, lung, heart, and pancreas. In plasma, two-thirds of the zinc is bound to
albumin which represents the metabolically active pool of zinc. This pool of plasma zinc is
frequently referred to as loosely bound zinc because albumin has the ability to give up bound zinc
to tissues. Zinc is excreted in both urine and feces.
Metal fume fever, a critical end point, was observed in workers who inhaled high levels of zinc
oxide fumes or dust. The mechanism of metal fume fever has been reported to be an immune
response to zinc oxide in the respiratory tract. The anemia observed in humans and animals after
oral exposure to high levels of zinc could result from a zinc-induced copper deficiency. Excess
levels of dietary zinc inhibit the transport of copper to the blood from either the intestinal lumen
or the intestinal mucosal cell.
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
Quantitative studies regarding absorption of zinc and zinc compounds after inhalation exposure in
humans are limited. The absorption of inhaled zinc depends on the particle size and solubility.
Elevated levels of zinc have been found in the blood and urine of workers exposed to zinc oxide
fumes (Hamdi 1969).
The rates or percentages of absorption of inhaled zinc in animals are not available; however,
studies provide data on zinc retention in the lungs. Zinc retention values were 19.8%, 11.5%, and
4.7% in the lungs of guinea pigs, rats, and rabbits, respectively, after inhalation exposure (noseonly)
to 3.5-9.1 mg zinc/m3 as zinc oxide aerosol for 2-3 hours (Gordon et al. 1992). The aerosol had a
mass median diameter of 0.17 l µm. The retention of zinc in lungs was dose related in male Wistar
rats administered a single intratracheal instillation of 0-07-3.7 mg zinc/m3 as zinc oxide (Hirano et al.
1989). A half-life of 14 hours was calculated for this experiment.
The absorption of zinc oxide fumes lead to increased levels of zinc measured in the liver, kidney,
and pancreas of cats exposed to zinc oxide fumes for durations ranging from 15 minutes to
3.25 hours (Drinker and Drinker 1928). The usefulness of the study is limited because reporting
was inadequate and particle size of the zinc oxide aerosol was not determined. Some inhaled
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particles of zinc oxide are subject to ciliary clearance and swallowing. Thus, a portion of the
inhaled zinc may ultimately be absorbed from the gastrointestinal tract.
2.3.1.2 Oral Exposure
Several studies have measured oral absorption rates of zinc in humans. Absorption ranged from
8% to 81% following short-term exposures to zinc supplements in the diet; differences in
absorption are probably due to the type of diet (amount of zinc ingested, amount and kind of
food eaten) (Aamodt et al. 1983; Hunt et al. 1991; Istfan et al. 1983; Reinhold et al. 1991;
Sandstrom and Abrahamson 1989; Sandstrom and Cederblad 1980; Sandstrom and Sandberg
1992). For example, dietary protein facilitates zinc absorption; fractional zinc absorption ranged
from 8% for low-protein rolls to 26% for high-protein rolls 3 days after individuals ingested
0.05 mg zinc/kg (Hunt et al. 1991).
Absorption of labeled zinc was 40.0-48.4% in male Wistar rats fed a diet containing
0.81 mg zinc/kg as zinc chloride or zinc carbonate (Galvez-Morros et al. 1992). Fractional
absorption in immature organisms generally exceeds that in adults. In growing rats, on the basis
of indirect calculation from isotope experiments, Weigand and Kirchgessner (1992) suggested
surprisingly high absorption values of as much as 94.7%. It is likely that all these results were
influenced by isotope exchange and do not provide estimates of net absorption.
The body’s natural homeostatic mechanisms control zinc absorption from the gastrointestinal tract
(Davies 1980). Persons with adequate nutritional levels of zinc absorb approximately 20-30% of
all ingested zinc. Those who are zinc-deficient absorb greater proportions of administered zinc
(Johnson et al. 1988; Spencer et al. 1985).
Absorption of zinc occurs from all segments of the intestine, although the largest proportion of
zinc absorption occurs from the duodenum (Methfessel and Spencer 1973). The zinc absorption
process includes both passive diffusion and a carrier-mediated process (Tacnet et al. 1990). The
intestinal absorption of zinc appears to be a saturable carrier-mediated process at low zinc dose
levels involving a cysteine-rich intestinal protein (CRIP) (Davies 1980; Gunshin et al. 1991;
Hempe and Cousins 1992; Sturniolo et al. 1991). This protein binds zinc entering the intestinal
cells from the lumen (Hempe and Cousins 1991). CRIP has a limited binding capacity for zinc
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and becomes saturated when zinc concentration in the intestine is high. Metallothionein, a metal
binding protein may contribute to zinc homeostasis at higher zinc absorption. Like several other
metals, zinc can induce metallothionein production in intestinal mucosal cells (Richards and
Cousins 1975). Zinc binds to metallothionein, which remains in the mucosal cells lining the
gastrointestinal tract, and the bound metal is excreted from the body upon sloughing off of these
cells. Although the affinity of zinc for metallothionein is relatively low, the protein may thus
serve to prevent absorption of excess zinc in the body (Foulkes and McMullen 1987). Thus,
absorption of zinc in rats is increased when metallothionein levels are lower (Flanagan et al.
1983). It is hypothesized that zinc entering luminal cells is associated with CRIP, and a small
amount is bound to metallothionein; however, as the luminal zinc concentration increases, the
proportion of cytosolic zinc associated with CRIP is decreased with a concomitant increase in zinc
binding to metallothionein (Hempe and Cousins 1992). Further details on the influence of CRIP
and metallothionein on zinc absorption are provided in Section 2.3.5, Mechanisms of Action.
Phytate and high phosphorus intakes in animals decrease zinc absorption. In humans, dairy
products that contain both calcium and phosphorus decrease zinc absorption and plasma zinc
concentration (Pecoud et al. 1975). Zinc binds to phosphate which results in coprecipitation of
zinc with calcium phosphate in the intestines (Nelson et al. 1985). Dietary phytate also reduces
zinc absorption. The addition of 400 pmol phytate to the diet decreased zinc absorption from
43.3±17.9% in females fed bread containing 0.02 mg zinc/kg (zinc-65 isotope) to 14.3±3.2%
(Sandstrom and Sandberg 1992). Rats given diets supplemented with radiolabeled zinc and
phytate excreted significantly more zinc in the feces than rats given diets supplemented with
radiolabeled zinc but without phytate (Davies and Nightingale 1975). The study authors
suggested that the decrease in absorption was due to the formation of zinc-phytate complexes in
the intestines. Phytate also reduced reabsorption of zinc secreted into the gastrointestinal tract of
humans (Sandstrom and Sandberg 1992).
Endogenous substances, such as amino acids, can influence the absorption of zinc. Complexing of
zinc with amino acids generally enhances its absorption in all segments of the intestine (Wapnir
and Stiel 1986). Although neither zinc nor the amino acid proline are readily absorbed in the
colon, complexing of zinc with proline during an in vivo intestinal perfusion in rats resulted in
increased zinc absorption.
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Acrodermatitis enteropathica is a metabolic disorder that results in the malabsorption of zinc.
However, when patients afflicted with this disorder were treated with human milk, zinc absorption
was enhanced (Lombeck et al. 1975). It was reported by Evans (1980) that patients with
acrodermatitis enteropathica have an impaired tryptophan metabolic pathway. Picolinic acid, a
chief metabolite of tryptophan, is also a constituent of human milk. Picolinic acid is secreted by
the pancreas into the intestinal lumen. A study by Boosalis et al. (1983) demonstrated that
patients with pancreatic insufficiency had difficulty absorbing zinc administered as zinc sulfate.
However, when these pancreatic-insufficient patients were given zinc as zinc picolinate, the extent
of zinc absorption was similar to that of healthy controls. Zinc absorption may depend on the
bioavailability of picolinic acid. Such a mandatory role of picolinic acid in absorption has not
been confirmed (Bonewitz et al. 1982).
The addition of prostaglandin E, (PGE,) to the mucosal media of everted jejunal sacs from rats
significantly increased zinc transport (Song and Adham 1979). In contrast, similar addition of
prostaglandin F2 (PGF2) significantly decreased zinc transport. Addition of PGF2 to the serosal
side of the jejunal sacs increased the transport of zinc to the mucosal side; PGE2 decreased the
serosal to mucosal transport of zinc. The mechanism by which prostaglandins regulate zinc
transport has not been established (Song et al. 1992). The limitation of the in vitro study is the
absence of vascular perfusion and consequent trapping of metals in the submucosal tissue.
Hence, studies of absorption of heavy metals, including zinc, in everted sacs have limited
physiological relevance (Foulkes 1984) but may provide information useful for the design of
future in vivo experiments.
The presence of other trace metals (e.g., mercury, cadmium, copper) may also diminish zinc
transport. Section 2.6 provides detailed information on the interaction of zinc with other metals.
2.3.1.3 Dermal Exposure
Dermal absorption of zinc occurs, but its mechanism is not clearly defined. Studies are very
limited regarding the absorption of zinc through the skin. Historically, zinc oxide has been used
clinically to promote the healing of burns and wounds (Gordon et al. 1981). Absorption has been
observed in burn patients treated with gauze dressings containing zinc oxide (Hallmans 1977)
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The pH of the skin, the amount of zinc applied, and the vehicle administered with zinc all affect
the absorption of zinc (Agren 1990, 1991).
Zinc chloride was also absorbed through the intact skin of the rat (Keen and Hurley 1977).
Absorption of zinc sulfate was greater than zinc oxide following 4-48-hour dermal application to
open wounds in Sprague-Dawley rats (Agren et al. 1991). About 12% of zinc oxide
(0.25 mg zinc/cm2) from the dressing reached the wound while 65% of zinc sulfate
(0.066 mg zinc/cm2) reached the wound. The data suggest that zinc oxide applied to wounds
resulted in sustained delivery of zinc ions causing constant wound-tissue zinc levels. In contrast,
zinc sulfate, being more water soluble than zinc oxide, is rapidly transferred into the blood and,
therefore, caused decreased wound-tissue zinc levels (Agren et al. 1991).
2.3.2 Distribution
Zinc is one of the most abundant trace metals in humans. It is found normally in all tissues and
tissue fluids and is a cofactor in over 200 enzyme systems. Together, muscle and bone contain
approximately 90% of the total amount of zinc in the body (≈60% and 30%, respectively)
(Wastney et al. 1986). Organs containing sizable concentrations of zinc are the liver,
gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas (Bentley and Gribb 1991;
Drinker and Drinker 1928; He et al. 1991; Llobet et al. 1988a). High concentrations of zinc were
also detected in the prostate (Forssen 1972) retina, and sperm (Bentley and Grubb 1991). Zinc
levels may vary considerably from one individual to another (Forssen 1972).
To some degree, the distribution of zinc in some tissues appears to be regulated by age
(Schroeder et al. 1967). Zinc concentrations increase in the liver, pancreas, and prostate and
decrease in the uterus and aorta with age. Levels in the kidneys and heart peak at approximately
40-50 years of age and then decline.
Zinc is present in blood plasma, erythrocytes, leukocytes, and platelets, but is chiefly localized
within erythrocytes (of which 87% is in carbonic anhydrase, the major binding site) (Ohno et al.
1985). Zinc deficiency has been demonstrated to decrease the ability of erythrocytes to resist
hemolysis in vitro. This finding suggests that zinc stabilizes the erythrocyte membrane. In plasma,
two-thirds of the zinc is bound to albumin; the remainder is bound primarily to α2-macroglobulin
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(Bentley and Grubb 1991; Giroux et al. 1976; Wastney et al. 1986). It appears that the limited
number of binding sites for zinc in plasma albumin and macroglobulin regulates the amount of
zinc retained by the body (Andermann and Dietz 1982). Albumin-bound zinc has been correlated
with plasma zinc levels, whereas α2-macroglobulin shows no correlation with plasma zinc levels.
Hormones, such as the adrenocorticotrophic hormone (ACTH), appear to regulate the
concentration of zinc in the liver. ACTH, secreted by the anterior pituitary gland, stimulates the
secretion of glucocorticoids. Glucocorticoids, or hormones with glucocorticoid activity, have been
shown in vitro to stimulate the net zinc uptake in cultured liver cells and at the same time activate
the gene that regulates metallothionein synthesis (Failla and Cousins 1978). However, there are
no in vivo data to support these in vitro findings. Metallothionein in the cells of the intestinal
mucosa binds zinc, thus regulating its release into the blood.
The transfer of zinc across perfused placentas is slow; only ≈3% of maternal zinc reached the
fetal compartment in 2 hours (Beer et al. 1992). The in vitro transfer of zinc between mother and
fetus is bidirectional, with binding in the placenta (Beer et al. 1992). It is proposed that zinc
uptake in the placenta involves a potassium/zinc transport system (Aslam and McArdle 1992).
Newborns may also be exposed to zinc from their mothers by milk transfer of zinc during lactation
(Rossowska and Nakamoto 1992).
2.3.2.1 Inhalation Exposure
No studies were located regarding distribution in humans after inhalation exposure to zinc.
However, occupational studies provided indirect evidence that zinc may distribute to tissues to
produce systemic effects (Brown 1988; Drinker et al. 1927a; Malo et al. 1990; McCord et al. 1926;
Rohrs 1957; Sturgis et al. 1972).
Zinc levels in the lungs of cats peaked immediately after acute exposure to 12-61 mg zinc/kg/day
as zinc oxide for approximately 3 hours and remained high for 2 days postexposure, then dropped
significantly thereafter (Drinker and Drinker 1928). Levels in pancreas, liver, and kidneys
increased slowly.
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2.3.2.2 Oral Exposure
A single oral dose of 0.7 mg zinc/kg as zinc sulfate given to I1 individuals resulted in peak zinc
levels in the plasma at 2-3 hours (Statter et al. l988; Sturniolo et al. 1991). Similarly, Neve et al.
(1991) reported peak serum zinc concentration at 2.3 hours with 0.7 mg zinc/kg as zinc sulfate.
Following feeding of 191 mg zinc/kg/day as zinc acetate to rats for 3 months, increased zinc levels
were significant in the heart, spleen, kidneys, liver, bone, and blood (Llobet et al. 1988a). The
greatest increases were in bone (258%) and blood (520%). Elevated zinc levels were found in
the kidneys and liver of mice fed 76.9 mg zinc/kg/day as zinc sulfate (Schiffer et al, 1991) or
38 mg zinc/kg/day as zinc nitrate (Cooke et al. 1990) for approximately 1 month. The kidneys and
pancreas had higher zinc levels than the liver and carcass of rats fed diets containing
1.1 mg/kg/day for an unspecified duration (Weigand and Kirchgessner 1992). Newborn, young,
and adult mice receiving a single oral dose of 4.6 mg zinc/kg as zinc chloride generally had the
highest levels of zinc in the liver, kidneys, lungs, bone, muscle, and carcass 1 day after dosing (He
et al. 1991). However, the amount of zinc in the lungs, muscle, and femur decreased with age.
2.3.2.3 Dermal Exposure
No studies were located regarding distribution in humans after dermal exposure to zinc.
Animal data on the distribution of zinc following dermal exposure are limited. Elevated serum
zinc levels occurred with the application of zinc oxide or zinc sulfate to skin wounds of Sprague-
Dawley rats for 4-48 hours (Agren et al. 1991). Serum zinc level peaked at 4 hours in rats
treated with zinc sulfate, while levels were slightly elevated for 48 hours in rats administered zinc
oxide. The differences may be attributed to the absorbability of the zinc compounds.
2.3.3 Metabolism
Plasma provides a metabolically active transport compartment for zinc (Cousins 198.5). Zinc is
most often complexed to organic ligands (existing in loosely or firmly bound fractions) rather than
free in solution as metallic ion (Gordon et al. 1981). Zinc is found in diffusible or nondiffusible
forms in the blood (NAS/NRC 1979). In the diffusible form, approximately two-thirds of plasma
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zinc is freely exchangeable and loosely bound to albumin (Cousins 1985); the zinc-albumin
complex has an association constant of about 106 (NAS/NRC 1979). The diffusible form of zinc
also includes zinc bound to amino acids (primarily histidine and cysteine). The zinc-albumin
complex is in equilibrium with the zinc-amino acid complex (Henkin 1974). The zinc-amino acid
complex can be transported passively across tissue membranes to bind to proteins. An important
binding protein in the kidney and liver is metallothionein, although other tissue-binding proteins
may be present.
In the nondiffusible form, a small amount of circulating zinc is tightly bound to α2-macroglobulin
in the plasma (Cousins 1985). Zinc is incorporated into and dissociated from α2-macroglobulin
only in the liver (Henkin 1974). This zinc-protein complex has an association constant of >1010
(Henkin 1974; NAS/NRC 1979). Th e zinc bound to α2-macroglobulin is not freely exchangeable
with other zinc ligands (i.e., zinc-albumin and zinc-amino acid complexes) in serum.
2.3.4 Excretion
2.3.4.1 Inhalation Exposure
Information was limited regarding zinc excretion following inhalation exposure in humans.
Workers exposed to zinc oxide fumes had elevated levels of zinc in the urine (Hamdi 1969)
indicating that this is a route of excretion.
No studies were located regarding excretion in animals after inhalation exposure to zinc.
2.3.4.2 Oral Exposure
The principal route of excretion of ingested zinc in humans is through the intestine (Davies and
Nightingale 1975; Reinhold et al. 1991; Wastney et al. 1986). Zinc loss in the body is by secretion
via the gut, and the remainder occurs in the urine (Wastney et al. 1986). Fecal excretion of zinc
increases as intake increases (Spencer et al. 1985). Excretion of zinc in the urine also reflects
zinc intake (Wastney et al. 1986). Minor routes of elimination are saliva secretion, hair loss, and
sweat (Greger and Sickles 1979; Hambidge et al. 1972; Henkin et al. 1975a; Prasad et al. 1963a;
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There was a linear increase in fecal excretion of zinc in proportion to dietary intake in rats fed
supplementations of 32 mg zinc/kg/day as zinc oxide for 7-42 days (Ansari et al. 1975) or
50-339 mg/kg/day for 21 days (Ansari et al. 1976). No differences in fecal excretion, total
excretion, or retention of zinc were found among rats given diets containing different forms of
zinc (Seal and Heaton 1983). Rats receiving 2.65 mg zinc/kg/day as zinc chloride, zinc sulfate,
zinc phosphate, or zinc citrate, over a 4-day period excreted 87-98% of intake.
A study by Alexander et al. (1981) demonstrated that zinc is excreted in the bile of rats. Analysis
of the bile indicated that the zinc is primarily complexed with reduced glutathione. Treatment of
these rats with diethylmaleate, which conjugates with reduced glutathione and restricts its
availability, depressed the biliary excretion of zinc. This depression confirms a relationship
between zinc and glutathione and suggests that zinc is transferred from liver to bile by a
glutathione-dependent process.
Other factors may affect zinc excretion. For example, low dietary intake of zinc or malnutrition
can increase the urinary excretion of zinc. This release of zinc is a result of tissue breakdown and
catabolism during starvation; and elevated urinary excretion of zinc may persist after intake levels
return to normal (Spencer et al. 1976). Administration of histidine or high-protein diet may
increase urinary zinc excretion; however, a corresponding increase in zinc absorption may
maintain zinc balance in the body (Henkin et al. 1975b; Hunt et al. 1991).
2.3.4.3 Dermal Exposure
No studies were located regarding excretion in humans or animals after dermal exposure to zinc.
2.3.5 Mechanisms of Action
The absorption of zinc from the intestine is homeostatically controlled. A study by Hempe and
Cousins (1992) found that CRIP, a diffusible intracellular zinc carrier, binds zinc in the mucosa
during absorption; this process appears to be saturable (Gunshin et al. 1991; Hempe and Cousins
1992; Sturniolo et al. 1991). Zinc transport in the intestinal lumen is also influenced by
metallothionein which can inhibit zinc absorption by competing with CRIP for zinc (Hempe and
Cousins 1992). CRIP binds about 40% of radiolabeled zinc entering the intestinal cells from the
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lumen in ligated loops of the small intestine of anesthetized rats when the zinc concentration is
low (5 µM), but only 14% of the radiolabel when the concentration is high (300 µM) (Hempe
and Cousins 1991). These findings suggest that CRIP has a limited binding capacity for zinc and
becomes saturated when zinc concentration in the intestine is high (Hempe and Cousins 1992).
High luminal zinc concentrations may damage the brush border membrane, allowing zinc to enter
the cell and bind nonspecifically to cell proteins and other ligands (Cousins 1985; Hempe and
Cousins 1992). Within the intestinal lumen, a number of factors appears to influence the
availability of zinc for absorption. Methionine, histidine, cysteine, reduced glutathione, citrate,
and prostaglandin E2 increase the intestinal uptake of zinc (Song et al. 1992) whereas inorganic
inhibitors of zinc absorption include cadmium, copper, calcium, and ferrous iron (Hamilton et al.
1978; Harford and Sarkar 1991; Ogiso et al. 1979; Spencer et al. 1992; Yoshida et al. 1993). The
mechanism of inhibition has not been clearly elucidated, but it is believed to involve competition
for zinc binding sites in the intestinal mucosal cells; an effect on charge distribution on the
mucosal membrane has also been suggested (Foulkes 1985). The organic inhibitors, including
phytate and some components of dietary fiber, are believed to complex with zinc and decrease its
availability. In the mucosal cell, zinc is associated with metalloproteins, including metallothionein.
The release of zinc from the intracellular protein ligands and its transfer to the blood may involve
diffusion of complexes with glutathione and similar compounds (Foulkes 1993).
In the plasma, albumin is the primary carrier for zinc, with smaller amounts of zinc bound to
α2-macroglobulin and amino acids (Giroux et al. 1976). The albumin-bound zinc represents the
metabolically active pool of zinc. Zinc is loosely bound in plasma, and albumin-bound zinc can
readily be given up to tissues; however, the mechanisms are not fully elucidated. Zinc is initially
concentrated in the liver after ingestion, and is subsequently distributed throughout the body.
The liver, pancreas, bone, kidney, and muscle are the major tissue storage sites. When plasma
zinc levels are high, liver metallothionein synthesis is stimulated, which facilitates the retention of
zinc by hepatocytes (Richards and Cousins 1975). A storage form of zinc has not been identified
in soft tissues, with the possible exception of zinc metallothionein. Zinc in bone is relatively
unavailable for use by other tissues.
Metal fume fever is the primary effect observed in workers exposed to zinc oxide fumes or dust
(Blanc et al. 1991; Brown 1988; Drinker et al. 1927b; Vogelmeier et al. 1987). Metal fume fever
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usually occurs 3-10 hours after exposure, and the symptoms persist for 24-48 hours. The exact
pathogenesis of metal fume fever is not known It is believed to be an immune response to the
inhaled zinc oxide (Mueller and Seger 1985). It has been suggested that the zinc oxide causes
inflammation of the respiratory tract and the release of histamine or histamine-like substances. In
response, an allergen-antibody complex is formed that may elicit an allergic reaction upon
subsequent exposure to the allergen. In response to the allergen-antibody complex, an antiantibody
is formed. The anti-antibody dominates with continued exposure to the zinc oxide,
thereby producing a tolerance. When the exposure is interrupted and re-exposure occurs, the
allergen-antibody complex dominates, producing an allergic reaction and symptoms of metal fume
fever (McCord 1960).
Oral exposure to high levels of zinc has caused anemia, decreased levels of HDL cholesterol, and
pancreatic damage in humans (Black et al. 1988; Chandra 1984; Chobanian 1981; Hooper et al.
1980; Murphy 1970) and animals (Allen et al. 1983; Aughey et al. 1977; Drinker et al. 1927d;
Katya-Katya et al. 1984; Klevay and Hyg 1973; Maita et al. 1981; Straube et al. 1980). The
mechanisms involved in the pancreatic damage have not been elucidated. The anemia and
possibly the decreased HDL cholesterol levels are thought to be caused by a zinc-induced copper
deficiency. Although it is generally accepted that the anemia is the result of copper deficiency,
the relationship between zinc and copper levels and HDL cholesterol levels has been extensively
debated (Fischer et al. 1980; Katya-Katya et al. 1984; Klevay and Hyg 1973; Murthy and Petering
1976) and is beyond the scope of this profile.
2.4 RELEVANCE TO PUBLIC HEALTH
Zinc is required for normal growth, bone formation, brain development, behavioral response,
reproduction, fetal development, sensory function (taste and smell), immune function, membrane
stability, and wound healing. The recommended dietary allowance for zinc is 5 mg/day for infants
(0-l year), 10 mg/day for children (l-10 years), 15 mg/day for males (11-15 + years), 12 mg/day
for females (11-15 + years), 15 mg/day for pregnant women, 19 mg/day during the first 6 months
of lactation, and 16 mg/day during the next 6 months of lactation (NAS/NRC 1989b). There are
over 100 enzymes that require zinc for maximum catalytic activity (Cousins 1985). Zinc provides
structural integrity to the enzyme and/or participates directly in catalysis. Not all of the zinc
enzymes are responsive to changes in zinc intake (Kirchgessner et al. 1976). Decreases in plasma
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alkaline phosphatase, alcohol dehydrogenase, connective tissue thymidine kinase, pancreatic
carboxypeptidase A, and liver nuclear DNA-dependent RNA polymerase have been observed
during deficiency. No changes in carbonic anhydrase, lactate dehydrogenase, or malate
dehydrogenase activities were observed.
Zinc deficiency has been observed in the inhabitants of Middle Eastern countries who have diets
rich in cereals that provide little readily available zinc and who have a high incidence of parasitic
infections, geophagia, and chronic infectious diseases (Prasad et al. 1963a, 1963b). The primary
effects observed in males were growth failure, delayed sexual maturation, and iron-deficiency
anemia (Prasad et al. 1963b). Marginal zinc deficiency has been observed in the United States
(Hambidge et al. 1972; Henkin et al. 1976). Signs of deficiency include poor growth, anorexia,
hypogeusia, and dysgeusia. Supplementation with zinc reversed these signs. Impaired fetal
development, delayed wound healing, oligospermia, decreased serum testosterone concentration,
hyperammonemia, impaired immune function, psoriasis, and decreased lean body mass have been
observed in humans with experimentally induced marginal zinc deficiency (Prasad 1991) or with
secondary zinc deficiency due to malabsorption, sickle cell anemia (Cunningham-Rundles et al.
1990) or cirrhosis of the liver (Parodi et al. 1991).
Metal fume fever has been observed in humans who inhaled high concentrations of zinc oxide
fumes. Metal fume fever is believed to be an immune response characterized by increased body
temperature, impaired lung function, increased number of leukocytes in the blood, and
bronchoalveolar lavage fluid. Similar effects were observed in animals. Metal fume fever has
been observed after acute, intermediate, and chronic inhalation exposures to zinc oxide.
The principal effects observed in humans after oral acute doses of zinc oxide include abdominal
pain, vomiting, anemia, and pancreatic damage. The dose associated with these effects is
>10-fold higher than the RDA for zinc. Similar effects are observed in animals. Kidney damage
has also been observed in animals following intermediate exposure, but not in humans.
There is limited information on the dermal toxicity of zinc. Dermal application of zinc acetate,
zinc chloride, or zinc sulfate caused slight-to-severe skin irritation in rabbits, guinea pigs, and
mice. These compounds would also be irritating to human skin. In contrast, dermal exposure to
zinc oxide did not usually cause skin irritation to humans and animals. However, a few workers
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who routinely became covered with zinc oxide dust have had pustules on the axilla and inner
thighs possibly formed in response to plugging of glands by sweat, bacteria, and zinc oxide dust.
Four cases of premature deliveries and stillborns were reported following supplemental oral doses
of 0.6 mg zinc/kg/day during the last trimester of pregnancy in humans. Increased fetal
resorptions and stillbirths were observed in rats fed diets containing ≥200 mg zinc/kg/day. Rats
failed to reproduce after being fed 250 mg zinc/kg/day for 5 months. It is not known if this would
also occur in humans. Positive genotoxic results have been observed in vivo and in vitro in
mammalian cells. There are limited human and animal data suggesting that zinc is not
carcinogenic, but more information is needed to further assess this inference.
Following ingestion of large amounts of zinc, increased levels are found in the heart, spleen,
kidneys, liver, bone, and blood. It is not known if there is a relationship between the toxic effects
observed in humans and tissue storage levels of zinc. Zinc stored in bone is not readily available
to the general metabolic pool. During decreased calcium intake or bone resorption, zinc is
released from the bone. It is not known if there are any toxic effects associated with this release
of zinc.
The general population is primarily exposed to zinc by ingestion. Several factors influence the
potential for adverse health effects after oral exposure to zinc, including age, gender, and diet. It
is possible that people living near a hazardous waste site would be exposed to increased levels of
zinc in the drinking water. This, in addition to the zinc naturally occurring in food, may result in
toxic effects. Inhalation exposure to the general population is less likely because ambient air
levels of zinc are generally very low; however, near a smelter, levels can be as high as 5 µg/m3.
Zinc dust from contaminated soil may also be inhaled. It is not likely that exposure to this level
of airborne zinc would result in toxic effects. Dermal exposure may occur from skin contact with
contaminated soil containing zinc.
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Minimal Risk Levels for Zinc
Inhalation MRL’s
No inhalation MRLs have been derived for zinc (see Table 2-l and Figure 2-l). A number of
acute-duration human studies have identified metal fume fever as an end point of concern.
Animal studies corroborate the effects observed in humans; however, other possible targets of
toxicity were not examined. Only one intermediate-duration inhalation study in humans was
located. In this study, no exposure levels were reported; thus, the study could not be used as the
basis for the derivation of an intermediate-duration MRL. No exposure-related effects on lung
function were observed in a group of welders chronically exposed to zinc; however, the exposure
level was not reported. Thus, no chronic-duration inhalation MRL could be derived.
Oral MRLs
• An MRL of 0.3 mg zinc/kg/day has been derived for intermediate oral exposure to zinc.
The MRL was based on hematological effects, specifically decreased hematocrit, serum
ferritin, and erythrocyte superoxide dismutase activity, in women given daily supplements of
50 mg zinc as zinc gluconate for 10 weeks (Yadrick et al. 1989). The LOAEL of
1 mg/kg/day was derived from 9.72 mg zinc/day, the estimation of dietary zinc for females
(20-30 years old) from the FDA Total Diet study for 1982-1986 (Pennington et al. 1989)
plus 50 mg zinc/day, the reported supplemental zinc dose. A reduction in erythrocyte
superoxide dismutase activity was also seen in males receiving daily zinc supplements of
50 mg for 6 weeks (Fisher et al. 1984). Zinc supplementation has been shown to decrease
HDL levels with daily doses of at least 50 mg zinc for 12 weeks (Black et al. 1988; Chandra
et al. 1984; Hooper et al. 1980). These studies suggest that there is a dose-response trend and
that 50 mg/day is the threshold LOAEL for zinc. In animals, decreased hematocrit has been
observed at higher doses (Jenkins and Hidiroglou 1991; Maita et al. 1981; Smith and Larson
1946).
• The intermediate oral MRL of 0.3 mg zinc/kg/day has been adopted as the chronic oral
MRL. The chronic oral MRL is expected to be without adverse effects when consumed on
a daily basis over a long period of time; neither inducing nutritional deficiency in healthy,
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non-pregnant, adult humans ingesting the average American diet nor causing undesirable
inhibition of normal lipid transport. The MRL was not based on a chronic-duration oral study
due to a lack of adequate long-term studies in humans and animals. The chronic human study
by Hale et al. (1988) provides support for the Yadrick et al. (1989) study and suggests that
hematological effects may occur at higher zinc doses. A significant decrease in red blood cells
in females receiving daily supplements of 2 mg zinc/kg/day for an average of 8 years was
reported by Hale et al. (1988). Furthermore, decreases in serum creatinine, total protein, and
uric acid and an increase in mean MCH were observed in the treated male and female subjects
(mean age of 78 years) compared to controls.
In general, the MRL is an estimate of the daily human exposure to a substance that is likely to
be without an appreciable risk of adverse effects (noncarcinogenic) over a specified duration
of exposure. The intermediate and chronic oral MRLs for zinc do not provide levels of
concern for zinc in infants, children, or lactating women. Also, the MRLs are based on soluble
zinc salts, and it is less likely that nonsoluble zinc compounds would have these effects at this
level.
No oral acute MRL was derived for zinc (see Table 2-2 and Figure 2-2). A number of case reports
involving acute exposure were located. These reports suggest that the gastrointestinal tract and the
pancreas are end points of concern, and that the adrenal cortex may also be affected. A great deal of
uncertainty exists regarding the exposure levels for these studies. An oral exposure study in sheep
was also identified. Because sheep are ruminants, it is doubtful that they are a good model for human
toxicity.
Death. Death from respiratory failure has occurred in humans after acute inhalation exposure to zinc
chloride smoke (Evans 1945; Hjortso et al. 1988; Milliken et al. 1963). However, the level of
airborne zinc was not determined. Furthermore, exposure to zinc was accompanied by exposure to
other chemicals. Hence, death could not be attributed exclusively to zinc exposure.
Only limited information was located regarding death in animals from inhalation exposure to zinc.
The LCT50 of zinc chloride was reported as 11,800 mg-min/m3 (Schenker et al. 1981), but the basis
for this value was not provided. Exposure to 119.3-121.7 mg zinc/m3 as zinc chloride smoke for 3-20
weeks decreased the survival of guinea pigs and mice (Man-s et al. 1988). Death was
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reported in ferrets orally exposed to 390 mg zinc/kg/day as zinc oxide (Straube et al. 1980) and
mice exposed to 1,110 mg zinc/kg/day as zinc sulfate (Maita et al. 1981) following acute and
intermediate oral exposures, respectively. Adverse systemic effects were observed in these
animals, but the specific cause of death could not be determined. Acute oral LD50 values in rats
depend on the specific zinc compound and range from 237 mg zinc/kg as zinc acetate to
623 mg zinc/kg as zinc sulfate. In mice, the range of LD50 values is 86 mg zinc/kg as zinc acetate
to 605 mg zinc/kg as zinc chloride (Domingo et al. 1988a). Death from exposure to
environmental levels of zinc is improbable.
Systemic Effects
Respiratory Effects. Respiratory disorders have been observed in humans and animals after acute
inhalation exposure to zinc and its compounds. No adverse respiratory effects have been
observed following ingestion or dermal application of zinc or its compounds.
Acute exposure to high concentrations of airborne zinc oxide in humans causes metal fume fever.
Zinc oxide penetrates the alveoli, damages the lung tissue, and transiently impairs pulmonary
function (Blanc et al. 1991; Brown 1988; Drinker et al. 1927b; Vogelmeier et al. 1987). Lung
volumes are decreased, as is the carbon monoxide diffusion capacity (Drinker et al. 1927b;
Mueller and Seger 1985; Sturgis et al. 1927). Metal fume fever is believed to be the result of an
immune reaction to inhaled metal oxide particles (Mueller and Seger 1985).
Respiratory tract irritation occurs in both humans and animals (Drinker and Drinker 1928; Sturgis
et al. 1927) after exposure to zinc oxide. Most laboratory animals, except guinea pigs, begin to
present respiratory abnormalities (e.g., pulmonary congestion, peribronchial leukocytic infiltration) at
exposure levels similar to those that cause effects in humans (Drinker and Drinker 1928). Cats
exhibited more severe effects, including bronchopneumonia, than other animals (Drinker and Drinker
1928).
In humans, inhalation of zinc chloride causes greater damage to respiratory tissue than inhalation
of zinc oxide. Reported lesions included acute pneumonitis, ulceration of mucous membranes,
subpleural hemorrhage, and pulmonary fibrosis. Exposed individuals have died from respiratory
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distress syndrome (Evans 1945; Hjortso et al. 1988; Johnson and Stonehill 1961; Matarese and
Matthews 1966; Milliken et al. 1963; Schenker et al. 1981).
The studies in humans and animals reveal that inhalation of zinc as particulate or fume can result
in respiratory ailments (Drinker and Drinker 1928; Sturgis et al. 1927). These zinc fumes or
particles are a particular problem for industrial workers. It is possible that inhalation exposure to
zinc compounds could result in respiratory effects in people living near a hazardous waste site.
Cardiovascular Effects. In humans, oral exposure of intermediate duration to zinc has decreased
serum HDL cholesterol levels (Chandra 1984; Hooper et al. 1980). Although this is not a direct
effect on the cardiovascular system, the decrease in HDL levels may be associated with an
increased risk of coronary artery disease. However, another study showed no effect on HDL
levels and a decrease in LDL levels (Samman and Roberts 19&S), which would be associated with
a decreased risk of coronary artery disease. More information on this effect is presented later in
this section under Other Systemic Effects. It is not known if exposure to zinc in air, water, or soil
would result in cardiovascular effects in people living near hazardous waste sites.
Gastrointestinal Effects. Gastrointestinal irritation (abdominal pain, vomiting, nausea, esophageal
erosions, and gastric hemorrhagic erosion) has been observed in humans after acute ingestion of
zinc compounds. In most cases, the actual exposure levels associated with these effects are not
known (Anonymous 1983; Chobanian 1981; Potter 1981). In a 15year-old girl, epigastric
discomfort, gastritis, and hemorrhagic erosion were observed after exposure to 2.6 mg zinc/kg/day
as zinc sulfate for 1 week (Moore 1978). Longer-term human oral studies found no signs of
gastrointestinal irritation at dose levels of ≤4.3 mg zinc/kg/day (Chandra 1984; Hallbook and
Lanner 1972; Hoffman et al. 1988; Hooper et al. 1980; Shah et al. 1988). Gastrointestinal effects
were not investigated in human inhalation studies. One mechanism for clearing particles (≥3 pm
in diameter) from the respiratory tract is swallowing. It is possible, therefore, that exposure to
airborne zinc would result in gastrointestinal effects. Ulceration of the forestomach and intestinal
hemorrhages have been observed in mice ingesting 1,110 mg zinc/kg/day as zinc sulfate and ferrets
consuming 390 mg zinc/kg/day as zinc oxide, respectively (Maita et al. 1981; Straube et al. 1980).
Gastrointestinal irritation could occur in humans exposed to zinc in air, water, or soil near
hazardous waste sites.
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Hematological Effect. In humans, oral chronic exposure to high levels of zinc caused decreased
levels of hemoglobin and hematocrit, and/or microcytic anemia (Broun et al. 1990; Hale et al.
1988; Hoffman et al. 1988; Patterson et al. 1985; Porter et al. 1977; Prasad et al. 1978).
Reduction in serum ferritin and erythrocyte superoxide dismutase activity in humans have also
been reported in intermediate-duration studies (Fischer et al. 1984; Yadrick et al. 1989). Similar
effects have been observed in rats (Maita et al. 1981), mice (Maita et al. 1981; Walters and Roe
1965), rabbits (Bentley and Grubb 1991), dogs (Drinker et al. 1927d), ferrets (Straube et al.
1980), and preruminant calves (Jenkins and Hidiroglou 1991). The anemia is believed to be the
result of zinc-induced copper deficiency. De novo synthesis of metallothionein in the intestinal
mucosal cells is induced by high levels of dietary zinc (Cousins 1985). Copper has a higher
binding affinity than zinc to metallothionein and will replace the zinc. Metallothionein-bound
copper is not transferred to the portal blood and is excreted in the feces when the intestinal
mucosal cell is sloughed off (Fischer et al. 1981; L’Abbe and Fischer 1984a). Decreases in
hemoglobin and hematocrit levels were larger in animals fed diets low in copper and high in zinc,
compared to those fed a diet with adequate levels of zinc but low levels of copper, or those fed a
diet with excess zinc but adequate levels of copper (Johnson and Flagg 1986). Although the
interaction between copper and zinc has been well established in animals, conflicting results have
been observed in human studies. Copper deficiency has been diagnosed in individuals chronically
(14-24 months) taking zinc sulfate for the treatment of sickle-cell anemia or celiac disease (Porter
et al. 1977; Prasad et al. 1978). Studies have also reported increases in fecal excretion of copper
and decreased copper retention in healthy subjects consuming high levels of zinc (Burke et al.
1981; Festa et al. 1985; Greger et al. 1978a). Other studies in humans have not reported altered
copper metabolism (Colin et al. 1983; Greger et al. 1978b; Henkin et al. 1976; Samman and
Roberts 1987; Taper et al. 1980). Anemia might occur in humans if exposed orally to zinc found
near hazardous waste sites.
Leukocytosis has been reported in a number of studies of acute human exposure to zinc oxide
fumes (Brown 1988; Drinker et al. 1927a; Malo et al. 1990; Mueller and Seger 1985; Rohrs 1957;
Sturgis et al. 1927). Data are contradictory regarding whether inhalation exposure of humans to
zinc oxide can result in anemia (Hamdi 1969; McCord et al. 1926), and very limited human data
suggest that dermal exposure to zinc chloride perhaps could cause anemia (DuBray 1937). None
of the animal inhalation or dermal exposure studies examined hematological parameters. Altered
copper metabolism has not been observed following subcutaneous administration of zinc in rats
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(Hill et al. 1984). The limited data suggest that anemia might occur in humans exposed to zinc by
inhalation or dermally near hazardous waste sites.
Musculoskeletal Effects. Musculoskeletal effects have not been observed in humans or animals
after inhalation, oral, or dermal exposure to zinc or its compounds. Muscles and bones contain
the highest levels of zinc, and bones are believed to serve as storage depots for zinc. It is not
known whether high levels of zinc in bone might be a problem because of replacement of other
minerals in the bone.
Hepatic Effects. Hepatic effects have not been observed in humans after inhalation, oral, or
dermal exposure to zinc. Hepatic necrosis was observed in sheep after acute and intermediate
exposures to zinc compounds (Allen et al. 1983). Intermediate oral exposure of rats to zinc
compounds induced liver enzymes at a dose similar to that administered to sheep (Kadiiska et al.
1985). No histopathological alterations have been observed in the livers of rats (Drinker et al.
1927c; Kadiiska et al. 1985; Llobet et al. 1988a) or mink (Aulerich et al. 1991) after
intermediateduration ral exposure to zinc. The weight of evidence suggests that the liver is not
a primary target organ in humans or animals for zinc toxicity.
Renal Effects. No adverse renal effects have been observed in humans after inhalation or oral
exposure to zinc compounds. Following intermediate oral exposure to zinc compounds, cellular
damage in the glomerulus and proximal convoluted tubules and regressive lesions were observed
in rats and mice (Llobet et al. 1988a; Maita et al. 1981). It is not known whether renal effects
may be found in humans living near a hazardous waste site where zinc is present in the air, water,
or soil.
Dermal/Ocular Effects. Adverse dermal or ocular effects have not been observed in humans after
inhalation or oral exposure to zinc. When applied to the skin, zinc’s effects differ with respect to
the particular zinc salt. Zinc oxide creams are widely used to promote wound healing. No signs
of skin irritation were observed in humans after dermal exposure to zinc oxide (Agren 1990).
Intermediate to chronic exposure to high concentrations of zinc oxide dust has resulted in
plugging and infection of the sebaceous glands on the axilla and inner thighs and in the pubic
region (Batchelor et al. 1926; Turner 1921). It was reported that this effect was probably due to
poor hygiene rather than the irritancy of the zinc oxide dust. In contrast, zinc chloride was
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reported to be irritating to the eyes and skin at very high concentrations. Exposure to extremely
high concentrations of zinc chloride-containing smoke resulted in reddened conjunctiva and
running eyes in 34 persons, cornea1 burns in 2 persons, and small burns on the forehead or wrists
of 4 persons (Evans 1945). In rabbits, guinea pigs, and mice, moderate-to-severe skin irritation
was observed following dermal exposure to zinc acetate or zinc chloride. Slight irritation in mice,
but no irritation in rabbits or guinea pigs, was observed after exposure to zinc sulfate; no signs of
skin irritation were observed in rabbits, guinea pigs, or mice following application of zinc oxide
(Lansdown 1991). Exposure to air or water at or near a hazardous waste site containing a
sufficiently high concentration of one of the more caustic zinc salts could result in skin or eye
irritation.
Other Systemic Effects. Elevated body temperature, a symptom of metal fume fever syndrome, was
reported by workers inhaling zinc fumes and dust (Malo et al. 1990).
Systemic effects observed in humans and animals after oral exposure to zinc compounds include
damage to the pancreas and adrenal gland, alterations in the serum lipid profile, and pituitary
hyperactivity. An increase in serum amylase and lipase levels was observed in individuals ingesting
single high-level doses of zinc (Chobanian 1981; Murphy 1970). These changes are indicative of
pancreatic damage. Pancreatic lesions have been observed in rats (Maita et al. 1981) mice (Aughey et
al. 1977; Maita et al. 1981) cats (Drinker et al. 1927d), ferrets (Straube et al. 1980) and sheep (Allen
et al. 1983) after intermediate or chronic oral exposure to high levels of zinc compounds. Several of
the intermediate-duration studies reported that the lesions were located in the acinar cells. Acinar cell
necrosis and metaplasia in pancreas were reported in rats exposed to 565 mg/kg/day and mice
exposed to 1110 mg/kg/day in an intermediate-duration study (Maita et al. 1981). The pancreatic
acinar cells are responsible for the secretion of pancreatic lipase, pancreatic amylase, trypsinogen,
chymotrypsinogen, and procarboxypeptidase. A chronic mouse study reported marked cellular
alterations in the pancreatic islets during 12 months of oral exposure to 70 mg/kg/day (Aughey et al.
1977). The islets are involved in the secretion of insulin and glucagon. No changes in blood glucose
or insulin levels and no change in the response to a glucose load were observed in humans after a
single dose of 0.5 mg zinc/kg/day as zinc sulfate (Brandao-Neto et al. 1990b).
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Decreases in serum cortisol levels in humans after a single oral dose of zinc sulfate may indicate
adrenal cortical damage (Brandao-Neto et al. 1990a). A chronic-duration drinking water study in
rats exposed to 70 mg/kg/day revealed hypertrophy and vacuolation of the zona fasciculata cells of
the adrenal cortex (Aughey et al. 1977). Glucocorticoids (cortisol, cortisone, corticosterone,
deoxycorticosterone) are secreted by cells in the zona fasciculata. It is not known if there is a
relationship between the damage to the pancreatic islets and the hypertrophy of the zona
fasciculata cells in the adrenal cortex.
Decreased levels of serum HDL cholesterol were observed in humans after oral exposure to high
levels of zinc for an intermediate duration (Black et al. 1988; Chandra 1984; Hooper et al. 1980).
No other consistent changes in the serum lipid profile (total cholesterol, LDL cholesterol, and
triglyceride levels) were observed. Changes in HDL cholesterol were not observed in young
subjects (mean age of 22 years) (Samman and Robetts 1988) or in elderly subjects (60-89-years
old) who also received copper supplements for 3-12 months (Bogden et al. 1988). Increases in
serum cholesterol have been observed in rats in some oral exposure studies (Katya-Katya et al.
1984; Klevay and Hyg 1973). However, other studies using similar zinc compounds, doses, and
durations of exposure have not found alterations in the serum lipid profile of rats (Fischer et al.
1980; Woo et al. 1983). It is possible that inhalation, oral, or dermal exposure to zinc compounds
at hazardous waste sites could cause pancreatic damage, adrenal gland damage, and an alteration
in the serum lipid profile.
Immunological Effects. Although the pathogenesis of metal fume fever is uncertain, it is
believed to be an immune response to submicron-sized particles of zinc oxide. In addition,
increased levels of lymphocytes, polymorphonuclear leukocytes, and macrophages were observed
in the bronchoalveolar lavage fluid of welders. Significant correlations between the concentration
of airborne zinc and the levels of T cells were reported by Blanc et al. (1991). Impaired immune
function was also observed in humans taking high-dose (4.3 mg zinc/kg/day) zinc sulfate
supplements for 6 weeks (Chandra 1984). Immunotoxicity was not observed in mice after oral
exposure to 76.9 mg zinc/kg/day as zinc sulfate for 4 weeks (Schiffer et al. 1991). Immune
suppression was observed in rats given a single injection of zinc chloride (82 mg zinc/kg)
(Yatsuyanagi et al. 1987). Because zinc particles flocculate in the atmosphere, it is unlikely that
persons near hazardous waste sites would be exposed to zinc particles fine enough (≤1 µm in
diameter) to enter the alveolar region of the lung and elicit an immune response. However,
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ingestion of zinc in drinking water at concentrations found at hazardous waste sites could result in
immune suppression.
Neurological Effects. Zinc appears to be necessary for normal brain function. Nonspecific
signs and symptoms of neurotoxicity (headache, dizziness, lethargy, staggering gait) have been
observed in humans after acute ingestion of large amounts of zinc compounds (Anonymous 1983;
Murphy 1970; Potter 1981). Neurotoxicity has not been observed in animals after inhalation, oral,
or dermal exposure to zinc or its compounds although minor neuron degeneration was observed
in rats after a 10-day oral exposure (Kozik et al. 1988). In vitro investigations on the effects of
zinc on neurological tissue indicate that zinc competitively inhibits the entry of calcium into nerve
terminals, thereby influencing the release of neurotransmitters (Nishimura 1987). Zinc (at
concentrations that may occur in vivo) is toxic to neurons and glial cells of the central nervous
system in vitro cultures (Choi et al. 1988; Yokoyama et al. 1986). It is not known if neurological
effects would occur in humans exposed to zinc in air, water, or soil at or near a hazardous waste
site.
Reproductive Effects. Daily oral exposure to zinc sulfide to women during the last two
trimesters did not cause any complications in pregnancies (Mahomed et al. 1989). No studies
were located regarding reproductive toxicity in humans after inhalation or dermal exposure to
high levels of zinc. Zinc deficiency in humans has been shown to result in abnormalities of labor,
atonic bleeding, pre-term labor, and post-term pregnancies.
Oral exposure to high levels of zinc increased the incidence of pre-implantation loss in rats when
exposure began on gestational day 0 and continued throughout the gestational period (Pal and Pal
1987). Failure to reproduce was observed in multiparous rats fed 250 mg zinc/kg/day as zinc
carbonate for 150 days. In rats fed zinc for 21 days prior to mating, no reproductive effects were
observed (Pal and Pal 1987). No histological alterations of the testes or ovaries were observed in
rats and mice fed high levels of zinc in their diet (Maita et al. 1981). There are very limited data
to suggest that reproductive effects might occur in humans exposed to zinc in air, water, or soil at
or near a hazardous waste site.
Developmental Effects. There is only one report of developmental effects occurring in humans
exposed to high levels of zinc compounds. In this brief report, three cases of stillbirths and one
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case of premature delivery were observed in a group of women taking 0.6 mg zinc/kg/day as zinc
sulfate supplements during the third trimester of pregnancy (Kumar 1976). Extreme caution must
be taken in interpreting the results of this study. The number of subjects taking the supplements,
demographic information on the women, and comparison of the exposed individuals to a
unexposed control group were not reported. A number of other human studies found no
developmental effects in the children of mothers taking zinc supplements (highest NOAEL is
0.3 g zinc/kg/day) (Kynast and Saling 1986; Mahomed et al. 1989; Simmer et al. 1991). Zinc
deficiency in humans is associated with pregnancy complications, particularly growth retardation.
An increase in the incidence of fetal resorptions and decreased fetal weights were observed in rats
after oral exposure to 200 mg zinc/kg/day prior to and during mating and throughout gestation
(Schlicker and Cox 1968). Alopecia and hair discoloration were observed in the offspring of mice
exposed to 260 mg zinc/kg/day (Mulhern et al. 1986). These effects are believed to be the result
of zinc-induced copper deficiency. No developmental effects were observed in rats exposed to up
to 100 mg zinc/kg/day (Schlicker and Cox 1968; Uriu-Hare et al. 1989).
Congenital malformations, such as exencephaly and rib fusions, have been observed in the
offspring of pregnant golden hamsters injected intravenously with a single dose of
2 mg zinc sulfate/kg on day 8 of gestation (Ferm and Carpenter 1968). Similarly, single
intraperitoneal injections of 12.5, 20.5, or 25 mg/kg zinc chloride on days 8, 9, 10, or 11 of
gestation produced skeletal anomalies, including delayed ossification and rippled ribs without
accompanying soft tissue defects in mice. Rippled ribs, an unusual anomaly, appeared when zinc
salt was given on day 9 of gestation at a dose of 20.5 mg/kg, becoming more prevalent when
25 mg/kg of the salt was administered on day 11 of gestation (Chang et al. 1977). It is not known
whether exposure to air, waker, or soil at or near a hazardous waste site could cause
developmental effects in humans.
Genotoxic Effects. Genotoxicity studies conducted in a variety of test systems have failed to
provide evidence for mutagenicity of zinc. However, there are indications of weak clastogenic
effects following zinc exposure.
Results of in vivo studies are shown in Table 2-4. A dominant lethal study in mice failed to show
a mutagenic potential for zinc. However, chromosomal aberrations have been observed in bone
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marrow cells following in vivo exposure to zinc (Vilkina et al. 1978). This effect was observed in
rats exposed to 14.8 mg zinc/kg/day as zinc chlorate in drinking water (Kowalska-Wochna et al.
19&Q mice given intraperitoneal injections of 3.6 mg zinc/kg/day as zinc chloride (Gupta et al.
1991), and mice exposed to zinc oxide by inhalation (Voroshilin et al. .1978). Chromosomal
aberrations caused by zinc were observed in the bone marrow cells of mice maintained on a
low-calcium diet (Deknudt and Gerber 1979). Calcium may be displaced by zinc in calcium-depleted
conditions, leading to chromosome breaks and/or interfering in the repair process (Deknudt and
Gerber 1979). An increased incidence of sister chromatid exchange was observed in bone marrow
cells of rats exposed to 17.5 mg zinc/kg/day as zinc chlorate in drinking water (Kowalska-Wochna et
al. 1988).
Results of in vitro studies are shown in Table 2-5. Exposure to zinc as zinc sulfate or zinc
chloride does not increase mutation frequencies in bacterial or mammalian cell culture test
systems (Amacher and Paillet 1980; Gocke et al. 1981; Marzin and Vo Phi 1985; Nishioka 1975;
Thompson et al. 1989; Venitt and Levy 1974; Wong 19&S). Similarly, there was no convincing
evidence of a clastogenic effect in human lymphocytes exposed to 0.0003-0.00003 M zinc chloride
(Deknudt and Deminatti 1978).
Cancer. No reliable human carcinogenicity data were located. The carcinogenicity of zinc
following oral exposure has been evaluated in a study with mice (Walters and Roe 1965). In this
study, mice were given 0, 190, or 951 mg zinc/kg/day as zinc sulfate in drinking water for 1 year.
Relative to controls, no increase in tumor incidence was observed in treated mice. The
investigation was not adequate for evaluating the carcinogenicity of zinc because of several study
limitations (inadequate or lack of details of protocol, age, sex, number of animals tested, and
purity of test material). Lung adenomas were not found in mice injected intraperitoneally with
doses up to 5.3 mg/kg/day, three times a week, for 8 weeks (Stoner et al. 1976), but there was no
indication that a sufficiently high dose was tested. Teratomas of the testes were observed in fowl
given testicular injections of 2 mL of a 10% zinc sulfate solution (Falin and Gromzewa 1939) but
they were not observed in rats given testicular injections of 23 mg zinc/kg/day as zinc sulfate
(Guthrie 1956). The relevance of this study to public health is not known. EPA has determined
that zinc is not classifiable as to its human carcinogenicity (IRIS 1993).
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2.5 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They
have been classified as markers of exposure, markers of effect, and markers of susceptibility
(NAWNRC 1989a).
A biomarker of exposure is a xenobiotic substance or its metabolite(s), or the product of an
interaction between a xenobiotic agent and some target molecule(s) or cell(s) that is measured
within a compartment of an organism (NAS/NRC 1989a). The preferred biomarkers of exposure
are generally the substance itself or substance-specific metabolites in readily obtainable body
fluid(s) or excreta. However, several factors can confound the use and interpretation of
biomarkers of exposure. The body burden of a substance may be the result of exposures from
more than one source. The substance being measured may be a metabolite of another xenobiotic
substance (e.g., high urinary levels of phenol can result from exposure to several different
aromatic compounds). Depending on the properties of the substance (e.g., biologic half-life) and
environmental conditions (e.g., duration and route of exposure), the substance and all of its
metabolites may have left the body by the time samples can be taken. It may be difficult to
identify individuals exposed to hazardous substances that are commonly found in body tissues and
fluids (e.g., essential mineral nutrients such as copper, zinc, and selenium). Biomarkers of
exposure to zinc are discussed in Section 2.5.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration
within an organism that, depending on magnitude, can be recognized as an established or
potential health impairment or disease (NAS/NRC 1989a). This definition encompasses
biochemical or cellular signals of tissue dysfunction (e.g., increased liver enzyme activity or
pathologic changes in female genital epithelial cells), as well as physiologic signs of dysfunction
such as increased blood pressure or decreased lung capacity. Note that these markers are not
often substance specific. They also may not be directly adverse, but can indicate potential health
impairment (e.g., DNA adducts). Biomarkers of effects caused by zinc are discussed in
Section 2.5.2.
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s
ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an
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intrinsic genetic or other characteristic or a preexisting disease that results in an increase in
absorbed dose, a decrease in the biologically effective dose, or a target tissue response. If
biomarkers of susceptibility exist, they are discussed in Section 2.7, Populations That Are
Unusually Susceptible.
2.5.1 Biomarkers Used to Identify or Quantify Exposure to Zinc
There is no simple measure of zinc body burden. Under normal physiological conditions, the
plasma/serum zinc level is ≈1 µg/mL (NAS/NRC 1979) and the urinary level is 0.5 mg/g creatinine
(Elinder 1986). S everal studies have reported increased levels of zinc in the serum and urine of
humans and animals after inhalation, oral, or dermal exposure to zinc (Agren et al. 1991; Bentley and
Grubb 1991; Brandao-Neto et al. 1990a; Hallmans 1977; Hamdi 1969; Keen and Hurley 1977; Neve
et al. 1991; Statter et al. 19818; Sturniolo et al. 1991). However, relationships between serum and/or
urine levels and zinc exposure levels have not been established.
Hair and nail samples provide a lasting record of long-term metal intake possibly over weeks or
months (Hayashi et al. 1993; Wilhelm et al. 1991). Mean zinc concentrations of 129-179 µg/g
have been estimated for nails (Hayashi et al. 1993; Wilhelm et al. 1991) and 102-258 µg/g for hair
(Folin et al. 1991; McBean et al. 1971; Provost et al. 1993; Wilhelm et al. 1991). Most
investigators have found a poor correlation between hair and plasma zinc levels since the zinc in
hair does not exchange with the body zinc pool (McBean et al. 1971; Rivlin 1983). Furthermore,
measurements of zinc in hair can be affected by extraneous contamination of hair, contamination
by sweat, location of hair sample (distance from scalp), hair coloring, and rate of hair growth
(McBean et al. 1971; Rivlin 1983). Although the nail is considered more resistant to washing
procedures than hair, external contamination and uncertainties regarding the length and period of
exposure reflected by the observed zinc concentration limit this measurement as a biomarker of
exposure for zinc (Wilhelm et al. 1991).
2.5.2 Biomarkers Used to Characterize Effects Caused by Zinc
The respiratory tract is the most sensitive target organ for zinc following inhalation exposure.
Inhalation of zinc oxide results in a syndrome referred to as metal fume fever. Symptoms include
fevers, chills, cough, listlessness, and metallic taste. Although oxides of several heavy metals
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(antimony, aluminum, arsenic, cadmium, cobalt, copper, iron, lead, magnesium, manganese,
mercury, nickel, selenium, silver, and tin) and pyrolysis products of fluorocarbon polymers
(polytetrafluoroethylene [Teflon] and fluorinated polyethylene propylene) also produce metal
fume fever (Ellenhorn and Barceloux 1988), this group of symptoms may be used as a nonspecific
biomarker to identify inhalation exposure to zinc oxide.
The target organs associated with oral zinc exposure include the gastrointestinal tract, blood,
immune system, and pancreas. The toxic effects observed after oral exposure to zinc include
nausea, vomiting, diarrhea, decreased hemoglobin and hematocrit levels, immune suppression,
increased serum amylase and lipase, and decreased HDL cholesterol levels. (A more detailed
discussion of effects associated with exposure to zinc is presented in Section 2.2.) However,
nausea, vomiting, and diarrhea may be observed following exposure to any gastrointestinal irritant.
Increases in serum amylase and lipase are also markers for pancreatic damage; therefore, any
condition resulting in pancreatitis (i.e., biliary tract disease [gallstones], alcoholism, trauma,
inflammation, blood-borne bacterial infections, viral infections, ischemia, and drugs such as
azathioprine, thiazides, sulfonamides, and oral contraceptives) would result in similar increases in
these enzymes (Cotran et al. 1989). A hypochromic microcytic anemia that is not responsive to
iron supplements may indicate exposure to zinc; however, such anemia may also retlect copper,
pyridoxine, or cobalt deficiency, lead intoxication, poor diet, or chronic blood loss (Suber 19S9).
Thus, none of the above-mentioned effects observed after exposure to zinc is specific to zinc
exposure. However, the combination of these toxic effects may be indicative of zinc
overexposure. Additional information on the health effects of zinc may be found in Section 2.2.2.
Additional information on biomarkers for renal, hepatobiliary, immune, and nervous system effects
may be found in the CDC/ATSDR (1990) and OTA (1990) reports listed in Chapter 8.
Increased erythrocyte metallothionein may be an index of zinc exposure in humans (Grider et’al.
1990). Daily supplementation of 50 mg zinc/day to subjects for at least 7 days caused a seven-fold
increase in metallothionein concentration in erythrocytes. At least 3-4 days were required before
an increase in metallothionein is observed. This biomarker of exposure is only useful for recent
zinc exposure because the metallothionein levels decreased approximately a week after
discontinuation of a 63-week supplementation of zinc (Grider et al. 1990). Fourteen days after
discontinuation of zinc supplements, metallothionein levels were reduced by 61%.
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2.6 INTERACTIONS WITH OTHER CHEMICALS
Zinc is an essential element obtained from the diet. Many different metals and nutrients interact
with the absorption, distribution, and excretion of zinc. However, information was not found
concerning interactions that increase the toxicity of zinc or other substances in the presence of
zinc. Zinc administration may increase the toxicity of lead; however, the data are conflicting
(Cerklewski and Forbes 1976; Hsu et al. 1975).
Metallothionein, a sulfhydryl-rich protein inducible by certain divalent cations and a variety of
other agonists, is involved in the interaction between zinc and other metals such as copper
(Wapnir and Balkman 1991). Inhibition of intestinal copper absorption by zinc may demonstrate
competition between the two metals at the brush border of the lumen (Wapnir and Balkman
1991). Dietary intake of copper (1, 6, and 36 mg/kg) or zinc (5, 30, and 180 mg/kg) do not
significantly alter the absorption of the other (Oestreicher and Cousins 1988), but when zinc
levels are much higher than copper levels, copper absorption is depressed (Fischer et al. 1981).
High levels of dietary zinc are known to induce de novo synthesis of metallothionein in the
intestinal mucosal cell. Both copper and zinc appear to bind to the same metallothionein protein;
however, copper has a higher affinity for metallothionein than zinc and displaces the zinc that is
attached to the metallothionein (Ogiso et al. 1979). Copper complexed with metallothionein is
retained in the mucosal cell, relatively unavailable for transfer to plasma, and is excreted in the
feces when the mucosal cells are sloughed off (Fischer et al. 1981; L’Abbe and Fischer 1984b). A
number of factors influence the effect of dietary zinc on copper metabolism, including the amount
of copper and zinc in the diet, the zinc-to-copper ratio, age of the individual, and the duration of
exposure to high zinc levels (Johnson and Flagg 1986).
Physiological interactions of zinc and cadmium have been discussed in a number of reviews (EPA
1980c; NAS 1980; Underwood 1977). Exposure to cadmium may cause changes in the distribution of
zinc, with accumulation of zinc in the liver and kidney. This accumulation in the liver and kidney
may result in a deficiency in other organs, particularly if the dietary intake of zinc is
marginal. In vitro data demonstrate that zinc and cadmium enter renal proximal cells by a
saturable, carrier-mediated process and a non-saturable pathway (Gachot and Poujeol 1992). At
low cadmium doses, cadmium and zinc compete for a common transport carrier system in renal
proximal cells. It is hypothesized that, at high doses, the subcellular microtubule system is
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disrupted by cadmium, which may interfere with changes in carrier configuration that are
necessary for transport of the metals (modification of the cytoskeleton), and thereby lead to
noncompetitive inhibition between cadmium and zinc (Gachot and Poujeol 1992). Combined
treatment with cadmium and zinc in primary cultures of kidney cells resulted in enhanced toxicity
of cadmium (Yoshida et al. 1993); however, pretreatment with a nontoxic concentration of zinc
caused increased induction of metallothionein synthesis and partial protection against cadmium
(Yoshida et al. 1993).
Cadmium is 10 times more efficient than zinc in metallothionein induction in vitro (Harford and
Sarkar 1991). Induction by either cadmium or zinc alone is saturable; however, simultaneous
administration of cadmium and zinc results in induction of metallothionein in an additive manner.
The additive effect on metallothionein induction may involve binding of the metals either to two
or more metallothionein promoter binding proteins or separate sites on the same promoter
binding protein (Harford and Sarkar 1991).
Zinc acetate pretreatment in the mouse TRL-1215 cell line reduced single-strand DNA damage
associated with cadmium exposure (Coogan et al. 1992). Diminished cadmium-induced DNA
damage was not due to decreased cadmium burden in the zinc-pretreated cells. Instead, cadmium
levels were actually greater than those in non-pretreated cells (Coogan et al. 1992).
Metallothionein levels were elevated in these cells, suggesting that zinc pretreatment affects
cadmium genotoxicity by inducing metallothionein which may sequester cadmium from genetic
material. In contrast, simultaneous exposure to cadmium and zinc decreased cadmium
accumulation in the cells, perhaps because of direct competition for a common transport
mechanism (Coogan et al. 1992).
Zinc acetate reduced or prevented cadmium carcinogenesis in the prostate, in the testes, or at the
injection site in rats (Gunn et al. 1963a, 1964; Waalkes et al. 1989). The effect of zinc on the
cadmium-induced carcinogenesis appeared to be dependent on dose, route, and target site.
Sustained levels of zinc inhibited cadmium-induced injection sarcomas but had no effect on the
incidence of testicular Leydig cell tumors (Waalkes et al. 1989).
Excessive dietary zinc has been shown to induce a reversible copper deficiency and anemia in
experimental animals (Magee and Matrone 1960; Murthy and Petering 1976; O’Dell 1969;
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Underwood 1977; Wapnir and Balkman 1991). Similar effects have been seen in humans
receiving long-term treatment with zinc (Porter et al. 1977; Prasad et al. 1978). However, no
significant decreases in plasma copper levels were observed in humans receiving zinc for 6 weeks
or 6 months (Henkin et al. 1976; Samman and Roberts 1987) or in mice administered zinc for
l-12 weeks (Sutomo et al. 1992). A reduction in erythrocyte superoxide dismutase (an index of
metabolically available copper), without a decrease in plasma copper levels, was exhibited
following exposure to high amounts of ingested zinc (Fischer et al. 1984). These findings suggest
that superoxide dismutase may be a sensitive indicator of zinc-copper interaction.
Cobalt has been demonstrated to induce seminiferous tubule damage and degeneration (vacuole
formation, sloughing of cells, giant cell formation) in the testes of mice following exposure for
13 weeks (Anderson et al. 1993). Coadministration of cobalt and zinc chloride in the drinking
water resulted in complete or partial protection in 90% of the animals. The sites of competitive
interaction between zinc an cobalt were not established in the study; however, the authors
postulated that the mechanism(s) may be similar to those involved in prevention of cadmium
toxicity by zinc.
The effect of tin on heme biosynthesis appears to be dependent on the concentration of zinc
(Chmielnicka et al. 1992). Oral administration of tin can affect the heme synthesis by inhibiting
δ-aminolevulinic acid dehydratase (ALAD) activity in blood, Zinc is required for ALAD activity
and provides a protective role in heme synthesis by increasing the activity of ALAD. It is
postulated that when the tin and zinc are coadministered, these metals are probably attaching to
similar binding sites in the ALAD enzyme (Chmielnicka et al. 1992).
Calcium decreases the bioavailability of zinc; the converse is also true (Heth and Hoekstra 1965;
Spencer et al. 1992). Oral zinc administration is associated with decreased calcium levels in the
serum and in the bone of rats (Yamaguchi et al. 1983). Zinc inhibited calcium uptake in rat
brush border membrane vesicles, possibly by competing directly at high-affinity calcium binding
sites (Roth-Bassell and Clydesdale 1991). The interaction of calcium and zinc is apparently dose
related; intestinal absorption of calcium at a low calcium intake (230 mg/day) was inhibited at a
high zinc intake of 140 mg/day but not at a lower zinc intake of 100 mg/day (Spencer et al. 1992).
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Pretreatment with zinc has been shown to reduce hepatotoxicity induced by xenobiotics such as
acetaminophen, bromobenzene, carbon tetrachloride, D-galactosamine, gentamicin, and salicylate
(Cagen and Klaassen 1979; Gunther et al. 1991; Hu et al. 1992; Szymanska et al. 1991; Yang et
al. 1991). The protective effect of zinc against carbon tetrachloride toxicity is dose dependent at
high dose levels of zinc, probably because of sequestering of toxic metabolites of carbon
tetrachloride by metallothionein (Cagen and Klaassen 1979). Similarly, the protective action of
zinc against bromobenzene and acetaminophen appears to be associated with elevated
metallothionein levels (Szymanska et al. 1991). Inhibition of lipid peroxidation may be the basis
for the protective effect of zinc against hepatic damage induced by D-galactosamine in rats (Hu et
al. 1992). Zinc may be elevating NADPH (nicotinamide adenine dinucleotide phosphate) content
in the cell, resulting in regeneration of glutathione, which increases the antioxidative ability of
hepatic cells. Salicylate-induced hepatic alterations (increased lipid droplets and iron, reduced
glycogen) (Gunther et al. 1991) and gentamicin-induced proximal tubular necrosis (Yang et al.
1991) were diminished in rats pretreated with injections of zinc chloride and zinc sulfate,
respectively. This finding corresponded to a dramatic increase in metallothionein content with
combined treatment of salicylate and zinc compared to a less significant increase with salicylate
alone.
Animal studies suggest that the administration of zinc may also inhibit tumor growth. Forty weeks
after exposure, the incidence of injection site sarcomas was 40-60% in rats receiving simultaneous
intramuscular administration of nickel subsulfide and zinc oxide compared to an incidence of
100% following administration of nickel subsulfide alone (Kasprzak et al. 1988). Supplementing
drinking water with zinc sulfate reduced the incidence of 9,10-dimethyl-1,2-benzanthraceneinduced
tumors in the cheek pouches of mice (Poswillo and Cohen 1971). Zinc decreased DNA
synthesis in hepatomas induced by 3’-methyl-4-dimethylaminoazobenzene (Duncan and Dreosti
1975). The investigators speculated that the changes were due to inhibited cell division cycle at
the level of DNA replication.
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to zinc than will most
persons exposed to the same level of zinc in the environment. Reasons include genetic make-up,
developmental stage, age, health and nutritional status (including dietary habits that may increase
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susceptibility, such as inconsistent diets or nutritional deficiencies), and substance exposure history
(including smoking). These parameters result in decreased function of the detoxification and
excretory processes (mainly hepatic, renal, and respiratory) or the pre-existing compromised
function of target organs (including effects on clearance rates and any resulting end-product
metabolites). For these reasons we expect the elderly with declining organ function and the
youngest of the population with immature and developing organs will generally be more
vulnerable to toxic substances than healthy adults. Populations who are at greater risk due to
their unusually high exposure are discussed in Section 5.6, Populations With Potentially High
Exposure.
No specific data regarding human subpopulations that are unusually susceptible to the toxic
effects of zinc were located. Healthy elderly people have been shown to have greater daily zinc
intake than housebound elderly people (Bunker et al. 1987; Prasad 1988). Data from animal
studies indicate that certain human subpopulations may be more susceptible to excess zinc
because of zinc’s depleting effect on copper (Underwood 1977). People who are malnourished or
have a marginal copper status may be more susceptible to the effects of excessive zinc than
people who are adequately nourished (Underwood 1977).
Hepatic zinc levels are elevated in patients with hemochromatosis, a genetic disease associated
with increased iron absorption from the intestine (Adams et al. 1991). The chronic iron loading
that occurs could result in hepatic metallothionein induction leading to the accumulation of zinc
because metallothionein has a greater affinity for zinc than iron. These individuals may,
therefore, have a greater likelihood of developing toxicity with zinc exposure levels that do not
normally result in any symptoms in the general population.
2.8 METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic
effects of exposure to zinc. However, because some of the treatment discussed may be
experimental and unproven, this section should not be used as a guide for treatment of exposures
to zinc. When specific exposures have occurred, poison control centers and medical toxicologists
should be consulted for medical advice.
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2.8.1 Reducing Peak Absorption Following Exposure
General recommendations for the management and treatment of patients following acute
exposure to zinc include removal of the victim from the contaminated area and removal and
isolation of contaminated clothing, jewelry, and shoes (Bronstein and Currance 19818; Stutz and
Janusz 1988). Excess contaminant is gently brushed away and excess liquids blotted with
absorbent material. Measures that are appropriate to the route of exposure are taken to remove
zinc from the body. Exposed eyes are flushed immediately with water, followed as soon as
possible with irrigation of each eye with normal saline. Exposed skin is washed immediately with
soapy water. Administration of ipecac to induce emesis, gastric lavage, ingestion of activated
charcoal, and cathartics have been recommended to decrease the gastrointestinal absorption of
zinc (Burkhart et al. 1990; Ellenhorn and Barceloux 19%). Because zinc causes nausea and
vomiting following exposure by the oral route, use of emetic agents may be unnecessary. Ipecac
administration may be contraindicated following ingestion of caustic zinc compounds such as zinc
chloride. The large amounts of phosphorus and calcium in milk and cheese, and phytate in brown
bread, may reduce absorption of zinc from the gastrointestinal tract (Pecoud et al. 1975).
Therefore, if vomiting and diarrhea are not prohibitive, ingestion of dairy products or brown
bread may also reduce gastrointestinal absorption of zinc. In a study of intestinal absorption of
zinc in iron-deficient mice, the uptake of zinc from the gut was inhibited by adding iron to the
duodenal loop system. The proposed mechanism was that iron and zinc shared a common gut
mucosal binding site (Hamilton et al. 1978). However, it is unknown whether ingestion of iron
supplements would be effective in reducing absorption of zinc overdoses.
2.8.2 Reducing Body Burden
Zinc is an essential trace element that is normally found in tissues and fluids throughout the body
and is under homeostatic control (NAS/NRC 1989b). Increased levels have been observed in the
heart, spleen, kidneys, liver, bone, and blood of animals following subchronic oral exposure to zinc
(Llobet et al. 1988a) indicating that some zinc accumulation occurs during excess intakes. The
greatest increases were observed in bone and blood.
Administration of the chelating agent, calcium disodium ethylene diaminetetraacetate
(CaNa2EDTA), is the treatment of choice for reducing the body burden of zinc in humans
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following exposure to high levels (Ellenhorn and Barceloux 19%). Ethylenediaminetetraacetic
acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), and dimercaprol (BAL) are the most
common antidotes used in the treatment of human zinc intoxications (Murphy 1970; Spencer and
Rosoff 1966). Markedly elevated serum zinc levels in a young child who ingested a zinc chloride
solution were normalized by intravenously administering a single small dose of CaNa2EDTA
(11.5 mg/kg) (Potter 1981). Use of chelation therapy (administration of BAL) was reported in a
case study of a 16-year-old boy who ingested 12 g of metallic zinc (Murphy 1970). The boy
exhibited lethargy and elevated blood zinc levels that were both reversed following intramuscular
administration of BAL. Chelation therapy has been demonstrated to increase the urinary
excretion of zinc 22-fold (Spencer and Rosoff 1966). Intravenous and nebulized N-acetylcysteine
(another metal chelating agent) have also been observed to increase urinary zinc excretion and
decrease plasma levels following inhalation of zinc chloride smoke (Hjortso et al. 1988).
The efficacy of 16 different chelating agents as possible antidotes for acute oral zinc exposure has
been determined in mice (Llobet et al. 1988b). The most efficient chelators were DTPA,
cyclohexanediamine-tetraacetic acid (CDTA), and EDTA. Increased urinary levels of zinc and
decreased bone and liver zinc levels were observed following administration of the chelators. The
maximum efficiency of the chelators was observed when they were administered 0-.167-12 hours
after zinc exposure (Domingo et al. 1988a, 1988b).
2.8.3 Interfering with the Mechanism of Action for Toxic Effects
Anemia has been observed in humans and animals after oral exposure to zinc. It has been
postulated that excess zinc intake may result in copper deficiency (mechanisms of action are
discussed in Section 23.5). The anemia observed following zinc intake is believed to be caused by
the copper deficiency. Administration of copper has been shown to be effective in increasing the
hemoglobin levels (Porter et al. 1977; Smith and Larson 1946).
The exact mechanism of metal fume fever (a syndrome consisting of a leukocytosis with chills,
fever, cough, myalgias, headache, weakness, and dyspnea) is unknown (Ellenhorn and Barceloux
1988), but respiratory tract inflammation and the development of an immune complex reaction
have been proposed (McCord 1960).
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In severe cases, inhalation of zinc chloride has resulted in advanced pulmonary fibrosis and fatal
respiratory distress syndrome (Evans 1945; Hjortso et al. 1988; Milliken et al. 1963).
L-3,4-Dehydroproline was given to two soldiers after inhaling a high concentration of zinc chloride
smoke (also contained other chemicals) in an attempt to inhibit collagen deposition in the lungs
(Hjortso et al. 1988). This therapy did not prevent respiratory failure.
2.9 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation
with the Administrator of EPA and agencies and programs of the Public Health Service) to assess
whether adequate information on the health effects of zinc is available. Where adequate
information is not available, ATSDR, in conjunction with the National Toxicology Program
(NTP), is required to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health effects) of zinc.
The following categories of possible data needs have been identified by a joint team of scientists
from ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if
met would reduce the uncertainties of human health assessment. This definition should not be
interpreted to mean that all data needs discussed in this section must be filled. In the future, the
identified data needs will be evaluated and prioritized, and a substance-specific research agenda
will be proposed.
2.9.1 Existing Information on Health Effects of Zinc
The existing data on health effects of inhalation, oral, and dermal exposure of humans and
animals to zinc are summarized in Figure 2-3. The purpose of this figure is to illustrate the
existing information concerning the health effects of zinc. Each dot in the figure indicates that
one or more studies provide information associated with that particular effect. The dot does not
imply anything about the quality of the study or studies. Gaps in this figure should not be
interpreted as “data needs.” A data need, as defined in ATSDR’s Decision Guide for Identifying
Substance-Specific Data Needs Related to Toxicological Profiles (ATSDR 1989) is
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ATSDR defines a data gap more broadly as any substance-specific information missing from the
scientific literature.
Figure 2-3 indicates whether a particular health effect end point has been studied for a specific
route and duration of exposure. There is little information concerning death in humans after
inhalation, oral, or dermal exposure to zinc. Several case studies report death after exposure to
extremely high levels of zinc chloride and other components of zinc chloride smoke (Evans 1945;
Hjortso et al. 1988; Milliken et al. 1963).
Systemic effects of acute inhalation exposure to generally unspecified levels of various zinc
compounds in humans have been reported in several clinical case studies (Blanc et al. 1991;
Brown 1988; Hjortso et al. 1988; Matarese and Matthews 1966; Vogelmeier et al. 1987). Case
studies and experimental studies of systemic effects in humans following acute, intermediate, and
chronic oral exposures are available (Anonymous 1983; Black et al. 1988; Brandao-Neto et al.
1990a; Chandra 1984; Chobanian 1981; Hale et al. 1988; Hallbook and Lanner 1972; Hoffman et
al. 1988; Hooper et al. 1980; Malo et al. 1990; Moore 1978; Patterson et al. 1985; Porter et al.
1977; Potter 1981; Prasad et al. 1978). Experimental studies in humans following acute,
intermediate, and chronic dermal exposures were located for hematological, dermal, and ocular
effects (Agren 1990; Evans 1945; Fischer et al. 1984; Turner 1921; Yadrick et al. 1989).
Information concerning respiratory effects of acute inhalation exposure to zinc in animals is
available (Amdur et al. 1982; Drinker and Drinker 1928; Lam et al. 1982, 1988). One study
(Marrs et al. 1988) was located regarding other systemic effects in animals following inhalation
exposure to zinc for an intermediate exposure duration. Information regarding systemic effects of
zinc following oral exposure in animals is available for acute, intermediate, and chronic exposure
durations (Allen et al. 1983; Anderson and Danylchuk 1979; Aughey et al. 1977; Bentley and
Grubb 1991; Domingo et al. 1988a; Drinker et al. 1927; Jenkins and Hidiroglou 1991; Katya-
Katya et al. 1984; Klevay and Hyg 1973; Llobet et al. 198Sa; Maita et al. 1981; Straube et al.
1980; Walters and Roe 1965). One acute dermal study evaluated dermal irritancy in animals
(Lansdown 1991).
Immunological effects were reported in humans following inhalation exposure to zinc oxide (Blanc
et al. 1991; Farrell 1987). Another study reported potential adverse immunological effects
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following oral exposure of humans (Chandra 1984). Clinical symptoms suggestive of neurological
effects have been reported by humans following inhalation exposure (Rohrs 1957; Sturgis et al.
1927; Wilde 1975) or oral exposure (Anonymous 1983; Murphy 1970; Potter 1981) to zinc. There
were studies that examined reproductive and developmental effects in women orally exposed to
zinc during their pregnancies (Kynast and Saling 1986; Mahomed et al. 1989; Simmer et al. 1991).
One study examined immunological and reproductive effects in animals following inhalation
exposure to zinc chloride (Marrs et al. 1988). Immunological and neurological end points were
evaluated in animals following oral exposure to zinc (Bleavins et al. 1983; Kozik et al. 1980, 1981;
Schiffer et al. 1991). Information regarding developmental and reproductive effects in animals
after oral exposure to zinc is available (Cox et al. 1969; Ketcheson et al. 1969; Kinnamon 1963;
Mulhern et al. 1986; Pal and Pal 1987; Schlicker and Cox 1968; Sutton and Nelson 1937). Studies
regarding genotoxicity in animals after inhalation and oral exposures to zinc are limited (Gupta et
al. 1991; Kowalska-Wochna et al. 1988; Voroshilin et al. 1978).
Epidemiological studies regarding carcinogenicity after inhalation and oral exposure to zinc are
available (Logue et al. 1982; Neuberger and Hollowell 1982; Philipp et al. 1982; Stocks and
Davies 1964); however, they were not well controlled and the data are of little significance.
Studies are available regarding carcinogenicity in animals after inhalation and oral exposure to
zinc (Marrs et al. 1988; Walters and Roe 1965). However, the studies have several deficiencies
that limit their usefulness.
2.9.2 Identification of Data Needs
Acute-Duration Exposure. Symptoms of metal fume fever (headache, fever, leukocytosis,
myalgias) have been observed in humans acutely exposed to airborne zinc oxide (Blanc et al.
1991; Brown 1988; Drinker et al. 1927b; Sturgis et al. 1927). Acute oral exposure to zinc has
resulted in gastrointestinal disturbances (abdominal pain, nausea, vomiting, esophageal erosion),
evidence of pancreatic damage (increased serum amylase and lipase levels), and decreased levels
of serum cortisol in humans (Anonymous 1983; Brandao-Neto et al. 1990a; Chobanian 1981;
Murphy 1970; Potter 1981). Acute dermal exposure to zinc oxide has not been shown to be
irritating to human skin (Agren 1990). Toxic effects similar to those observed for metal fume
fever have been observed in guinea pigs (Amdur et al. 1982; Lam et al. 1985). In addition to
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LD50 data, only one reliable study assessed the acute oral toxicity of zinc compounds in animals.
Pancreatic, gastrointestinal, and liver damage were observed in sheep (Allen et al. 1983). It is
doubtful that sheep (ruminant animals) are an appropriate model for toxicity of orally
administered zinc in humans. The dermal toxicity of several zinc compounds has been tested in
rabbits, guinea pigs, and mice (Lansdown 1991). Zinc acetate, zinc chloride, and zinc sulfate have
irritating properties. Skin irritation was not observed in rabbits, guinea pigs, or mice after zinc
oxide paste application (Lansdown 1991).
The animal data (Amdur et al. 1982; Drinker and Drinker 1928; Lam et al. 1982, 1988)
corroborate occupational exposure studies that indicate metal fume fever is an end point of
concern. However, other possible targets of toxicity have not been examined. Thus, an acute
inhalation MRL cannot be derived. A large amount of the human oral exposure data is in the
form of case reports, and a great deal of uncertainty exists regarding the dose levels. The
uncertainty about whether sheep are a good model for humans precludes using these data to
derive an oral MRL for acute-duration exposure. Additional studies involving acute exposure to
zinc compounds by all routes of exposure would be helpful to identify target organ and doseresponse
relationships. There are groups who may be exposed to zinc at hazardous waste sites for
brief periods; therefore, this information is important.
Intermediate-Duration Exposure. Metal fume fever was observed in an individual exposed to
zinc fumes and zinc powder for approximately 1 month (Malo et al. 1990). Anemia and decreased
levels of HDL cholesterol have been observed in humans taking high doses of zinc supplements
(Chandra 1984; Hoffman et al. 1988; Hooper et al. 1980). Intermediate-duration dermal exposure
to zinc oxide dust has resulted in pustuIar lesions, but these lesions were attributed to clogging of
the sebaceous glands resulting from poor hygiene (Turner 1921). Rats, mice, and guinea pigs
exposed to smoke containing zinc chloride and other compounds had evidence of lung irritation
(Marrs et al. 1988). No intermediate-duration animal dermal studies were located. In animals
that ingested zinc for an intermediate duration, anemia and kidney and pancreas damage were
observed (Bentley and Grubb 1991; Drinker et al. 1927d; Jenkins and Hidiroglou 1991; Llobet et
al. 1988a; Maita et al. 1981; Straube et al. 1980).
Only one case report regarding human intermediate-duration inhalation exposure was located, and
this study did not report the exposure level (Malo et al. 1990). Thus, an intermediate-duration
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inhalation MRL could not be derived. The less serious LOAELs (decreased serum HDL
cholesterol) identified in the Hooper et al. (1980) and Chandra (1984) human oral exposure
studies could be used as the basis of an intermediate-duration oral MRL; however, evidence
regarding this effect is inconsistent (Bogden et al. 1988; Hale et al. 1988; Samman and Roberts
1988). In addition, the resulting MRL would be ≈l0-fold lower than the RDA of 15 mg/day
(0.21 mg zinc/kg/day). An intermediate-duration oral MRL was derived for zinc based on
hematological effects (decreased hematocrit, serum ferritin, and erythrocyte superoxide dismutase)
in women given zinc gluconate supplements for 10 weeks (Yadrick et al. 1989). The toxic effects
of intermediate-duration exposure to zinc compounds are relatively well characterized for the oral
route. There are insufficient toxicokinetic data to determine if the toxic effects observed
following oral exposure would occur following inhalation or dermal exposure. Inhalation and
dermal studies would be useful to determine possible target organs and dose-response
relationships. There are populations surrounding hazardous waste sites that might be exposed to
zinc compounds for similar durations.
Chronic-Duration Exposure and Cancer. No exposure-related effects on lung function were
observed in a group of welders chronically exposed to zinc (Marquart et al. 1989). Anemia has
been observed in humans following ingestion of high doses of zinc supplements (Broun et al.
1990; Hale et al. 1988; Porter et al. 1977; Prasad et al. 1978). Chronic-duration dermal exposure
to zinc oxide dust has resulted in pustular lesions, but these were attributed to clogging of the
sebaceous glands resulting from poor hygiene (Batchelor et al. 1926). No chronic-duration
inhalation or dermal studies in animals were located. Pancreatic damage was observed in mice
after chronic exposure to zinc sulfate in drinking water (Aughey et al. 1977).
A chronic-duration inhalation MRL could not be derived for zinc because neither of the
inhalation studies reported the levels of airborne zinc. Due to a lack of adequate chronicduration
oral studies, the intermediate-duration oral MRL was adopted as the chronic-duration
oral MRL, based on hematological effects (decreased hematocrit, serum ferritin, and erythrocyte
dismutase) in women given zinc gluconate supplements for 10 weeks (Yadrick et al. 1989).
Additional studies involving chronic exposure to zinc compounds by all routes of exposure would
be helpful to identify dose-response relationships.
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Although there are several human and animal carcinogenicity studies, the limitations of these
studies preclude their use in assessing the carcinogenicity of zinc (Logue et al. 1982; Neuberger
and Hollowell 1982; Walters and Roe 1965). Carcinogenicity studies by all routes of exposure
would be useful.
Genotoxicity. Several in vitro microbial gene mutation assays were negative (Marzin and Vo Phi
1985; Nishioka 1975; Thompson et al. 1989; Venitt and Levy 1974; Wong 19&S), but evidence
from gene mutation assays in mammalian cells is mixed (Amacher and Paillet 1980; Thompson et
al. 1989). An increase in the occurrence of chromosomal aberrations was observed in vitro in
human lymphocytes (Deknudt and Deminatti 1978) and in vivo in rats and mice (Deknudt and
Gerber 1979; Gupta et al. 1991; Kowalska-Wochna et al. 1988; Voroshilin et al. 1978). Increased
sister chromatid exchange was observed in vivo in rat bone marrow (Kowalska-Wochna et al.
1988). However, while there are sufficient in vivo data establishing the clastogenicity of zinc, data
regarding the mutagenicity of zinc are conflicting. Studies designed to assay different types of
genotoxicity (i.e., mutagenicity in mammalian cells, effect of excess zinc on DNA replication)
would be useful for determ.ining the genotoxic potential of zinc.
Reproductive Toxicity. No complications occurred in the pregnancies of women exposed to
daily doses of zinc sulfide during the last two trimesters (Mahomed et al. 1989). No studies were
located regarding the reproductive toxicity of zinc in humans after inhalation or dermal exposure.
Increased pre-implantation loss and reproductive dysfunction in rats were observed in oral
exposure studies (Pal and Pal 1987; Sutton and Nelson 1937). No histological changes in
reproductive organs were observed in rats, mice, or guinea pigs following inhalation exposure to
zinc chloride smoke, but reproductive function was not assessed (Marrs et al. I988). No dermal
reproductive toxicity studies in animals were located. Inhalation and dermal studies assessing
reproductive function would be useful to determine whether zinc has the potential to cause
reproductive effects by these routes. An oral reproductive toxicity study in a different animal
strain as well as a multigeneration study, including reproductive organ pathology, would be useful
Developmental Toxicity. No studies were located regarding the potential of zinc to cause
developmental effects in humans after inhalation or dermal exposure. In a very brief report of a
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Sandberg 1992; Spencer et al. 1985). However, quantitative evidence of zinc absorption in
humans after inhalation or dermal exposure is very limited. It is known that workers exposed to
zinc oxide fumes who experience toxic effects have elevated levels of zinc in plasma and urine
(Hamdi 1969). However, it remains to be established whether the elevated levels are the result of
the pulmonary absorption or of the swallowing of particles leading to gastrointestinal absorption.
Toxic effects have also been observed in humans after dermal exposure (DuBray 1937) indicating
dermal absorption.
Information regarding the absorption of zinc in animals following inhalation exposure was limited
to lung retention data (Gordon et al. 1992; Hirano et al. 1989). However, there was information
to assess the extent of absorption following oral exposure (Davies 1980; Galvez-Morros et al.
1992; Johnson et al. 1988; Weigand and Kirchgessner 1992). Evidence is limited regarding dermal
absorption in animals, but it indicates that zinc sulfate and zinc oxide can penetrate the skin
(Agren 1990; Agren et al. 1991; Gordon et al. 1981; Hallmans 1977). Mechanistic data on the
oral absorption is reported by Hempe and Cousins (1992); however, there is a lack of information
regarding the mechanism of action of inhalation and dermal exposures.
Information on physiological levels and zinc distribution following subtoxic short-term exposures
to zinc in humans and animals is abundant (NAS/NRC 1979; Wastney et al. 1986). Blood levels
of zinc have been determined in humans following oral exposure to zinc sulfate (Neve et al. 1991;
Statter et al. 1988; Sturniolo et al. 1991). Increased zinc tissue content has been seen after shortterm
oral exposure in humans (Cooke et al. 1990; He et al. 1991; Llobet et al. 198Sa; Schiffer et
al. 1991; Weigand and Kirchgessner 1992). Studies on tissue distribution in humans following
high exposure to zinc for inhalation, oral, and dermal would be useful. There were no studies
regarding blood or tissue distribution after acute, high-level exposures to zinc in animals following
inhalation or dermal exposure. Additional mechanistic data on the transfer of zinc from
respiratory and dermal absorption sites to the blood would be useful.
The principal excretion route of ingested zinc is through the intestines (Davies and Nightingale
1975; Reinhold et al. 1991; Wastney et al. 1986). There is a lack of information regarding the
excretion of zinc in both animals and humans following inhalation and dermal exposure.
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Therefore, additional studies designed to assess the toxicokinetic properties of zinc following
inhalation and dermal exposures would be useful.
Comparative Toxicokinetics. Data suggest that humans and animals have similar target organs
of zinc toxicity (Allen et al. 1983; Aughey et al. 1977; Black et al. 1988; Blanc et al. 1991; Brown
1988; Chandra 1984; Chobanian 1981; Drinker et al. 1927b, 1927d; Hoffman et al. 1988; Hooper
et al. 1980; Katya-Katya et al. 1984; Kievay and Hyg 1973; Lam et al. 1982, 1985, 1988; Maita et
al. 1981; Moore 1978; Murphy 1970; Smith and Larson 1946; Straube et al. 1980; Sturgis et al.
1927). Toxicokinetic studies have been performed in both humans and animals following oral
exposure; however, data are limited for inhalation and dermal exposures. The animal model used
most often to evaluate the toxicokinetics of zinc are rats (Agren et al. 1991; Alexander et al.
1981; Galvez-Morros et al. 1992; Hirano et al. 1989; Llobet et al. 1988a; Weigand and
Kirchgessner 1992) and may be a good model for assessing the kinetics of zinc in humans.
Methods for Reducing Toxic Effects. No established methods or treatments for reducing the
absorption of zinc were located. Studies that examined the effectiveness of emetics and cathartics
in the prevention of zinc absorption would be useful. Once absorbed from the gastrointestinal
tract, zinc bound to plasma albumin is distributed to the rest of the body. Zinc has a high affinity
for proteins, and a number of chelating agents are effective in increasing urinary excretion of zinc
following acute- and intermediate-duration administrations (Domingo et al. 1988a, 1988b; Llobet
et al. 1989). Studies designed to examine the effectiveness of chelating agents following chronic
zinc exposure would be useful in determining treatments to reduce the zinc body burden. Very
little information is known about the absorption and distribution of zinc following inhalation or
dermal exposure. Studies to determine the mechanisms of absorption and distribution would be
useful for developing treatments or methods for reducing the toxic effects of zinc after inhalation
or dermal exposure.
Although the exact mechanisms of many of the toxic actions of zinc are not known, the
pathogenesis of metal fume fever following inhalation exposure (McCord 1960; Mueller and Seger
1985) and anemia following oral exposure (Prasad et al. 1978) are known. Studies to more clearly
elucidate the mechanisms involved in metal fume fever and anemia and to determine the
mechanisms involved in pancreatic damage and decreased HDL cholesterol levels would be useful.
Therapy for metal fume fever is mainly supportive (Mueller and Seger 1985). Administration of
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copper has been shown to be effective in alleviating zinc-induced anemia (Porter et al. 1977).
Research into methods useful for mitigating metal fume fever and other adverse effects of zinc
would be helpful.
2.9.3 On-going Studies
Currently, D.W. Christianson (University of Pennsylvania, Philadelphia, Pennsylvania) and
C.A. Fierke (Duke University, Durham, North Carolina) are looking at redesigning the zinc
binding site of the human carbonic anhydrase II enzyme and E. Kimura’s group (Hiroshima
University, Hiroshima, Japan) is examining the roles of zinc(I1) ion in zinc enzymes.
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3.  CHEMICAL AND PHYSICAL INFORMATION
3.1 CHEMICAL IDENTITY
The chemical identities of zinc and selected zinc compounds are provided in Table 3-1.
3.2 PHYSICAL AND CHEMICAL PROPERTIES








4  PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
4.1 PRODUCTION
Zinc is widely distributed in nature, constituting 0.027% (by weight) of the earth’s crust (Merck
1983), but it is usually not found as elemental zinc in nature (Lloyd and Showak 1984). The
procedure used to mine zinc varies with the composition of the ore. The zinc is mined using both
underground mining and open pit mining (Stokinger 1981).
The mined zinc ores retrieved from the mines are too low in zinc content for direct reduction to
refined metal; thus, they are first concentrated. Production of concentrates requires crushing and
grinding followed by gravity or magnetic methods of separation or flotation. These processes may
be combined, depending on the complexity of the ore. A caustic-leach process is used to decrease
the extent of metal loss during the concentration process. In this process, the metal is leached by
caustic soda, the resulting electrolyte is purified with zinc dust and lime, and the zinc is
electrodeposited. The crude zinc may be dissolved in sulfuric acid and purified by
electrodeposition. Two processes are used to produce metallic zinc from the ore concentrates
that are not subjected to caustic soda leaching. In one process, the ore concentrate containing
zinc sulfide is roasted in the presence of air to produce zinc oxide, which is combined with coke
or coal and retorted to approximately 1,100°C to produce metallic zinc. In the other process, the
roasted zinc oxide is leached with sulfuric acid, and the solution is electrolyzed to produce zinc of
>99.9% purity. The electrolytic processing of zinc is replacing smelting as the most commonly
used process (Lloyd and Showak 1984; Stokinger 1981).
The 20 leading U.S. zinc-producing mines accounted for more than 97% of production, with the
5 leading mines accounting for 47%. Tennessee is the largest zinc-producing state, followed by
Missouri, New York, Colorado, Alaska, Montana, and Idaho (DO1 1991). In 1989, three
companies operated four primary zinc refineries (Zinc Corporation of America, Monaco,
Pennsylvania; Zinc Corporation of America, Bartlesville, Oklahoma; Big River Zinc Corporation,
Sauget, Illinois; and Jersey Miniere Zinc Co., Clarksville, Tennessee). Secondary zinc metal was
produced at nine plants from scrap materials, with the Zinc Corporation of America’s plant in
Monaco, Pennsylvania, being the largest producer of secondary zinc (DOI 1991). Table 4-l
summarizes the facilities that manufacture or process zinc in the United States. The information
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in this table was obtained from the Toxics Release Inventory (TRI), and it summarizes the
reported release data for 1991 (TR191 1993). However, this list does not include all facilities that
manufacture or process zinc. Table 4-l also lists the maximum amounts of zinc that are present
at these sites and the end uses of zinc. In 1989, approximately 278,900 metric tons were produced
from domestic ores in the United States, valued at roughly $499,100,000. The estimated world
production from mines in 1989 was 7,062,000 metric tons. The production of zinc decreased from
1985 to 1987, but increased from 1987 to 1989 (DOI 1991).
Zinc is available in many commercial forms, including ingots, lumps, sheets, wire, shot, strips,
sticks, granules, granulated zinc (obtained when molten metal is poured into cold water), and
powder (Merck 1983).
4.2 IMPORT/EXPORT
In 1989, approximately 712,000 metric tons of zinc were imported to the United States in slab,
block, and bar forms, approximately 388,600 metric tons were imported as ores and concentrates,
and 72,000 metric tons were imported as pigments and compounds. In 1989, the United States
imported less ore and concentrate than in the previous 2 years; more blocks, bars, and slabs than
in 1987; and less blocks, bars, and slabs than in 1988 (DO1 1991).
In 1989, an estimated 78,880 metric tons of ores and concentrates, 17,120 metric tons of zinc and
zinc alloys, and 108,090 metric tons of waste and scrap were exported from the United States. In
contrast, exports of ores and concentrates reached approximately 23,000 metric tons in 1985. In
1989, the United States exported the largest amount of zinc ores and concentrates to Canada,
Belgium, and Japan (DOI 1988, 1991).
4.3 USE
Zinc is used most commonly as a protective coating of other metals. In addition, it is used in
alloys such as bronze and brass, for the electrical apparatus in many common goods, and in
organic chemical extractions and reductions. Alloys containing zinc and copper are used to make
U.S. one-cent coins. Zinc salts have numerous applications and are used in wood preservation,
catalysts, photographic paper, vulcanization acceleration for rubber, ceramics, textiles, fertilizers,
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pigments, and batteries. Zinc chloride is a primary ingredient in smoke bombs used for crowd
dispersal, in fire-fighting exercises (by both military and civilian communities), and by the military
for screening purposes. Zinc chloride, zinc sulfate, zinc oxide, and zinc sulfide have dental,
medical, and household applications. Zinc chloride and zinc sulfate are also used as herbicides
(HSDB 1993). In pharmaceuticals, zinc salts are used as solubilizing agents in many drugs,
including insulin (Lloyd 1984; Lloyd and Showak 1984; Merck 1983). Zinc is also utilized
therapeutically in human medicine in the treatment of zinc deficiency (Elinder 1986).
4.4 DISPOSAL
Criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant
revision (HSDB 1993). Zinc processing plants have attempted to limit releases to the
environment by using techniques such as water re-use, control of particulate emissions, and
filtration thickener overflow. In addition, liquid effluents are limed and allowed to settle so that
zinc can precipitate out as the hydroxide (Lloyd and Showak 1984). Waste products containing
zinc are also being used as a source of zinc for electrogalvanizing (Jolly 1988). Disposal
procedures for spills include ferric hydroxide precipitation and cement-based fixation processes;
the latter method is very effective in rendering zinc contaminants insoluble (Dawson and Mercer
1986). Unsalvageable zinc waste may be buried in an approved landfill. The maximum allowable
concentration in effluent to sewers or streams is 1.0 ppm (HSDB 1993).
In 1989, EPA applied its revised interpretation of the Bevill Amendment (exclusion) to solid
waste from the extraction, beneficiation, and processing of ores and minerals. The slag from the
primary zinc processing is the only zinc-related waste remaining in the Bevill exclusion (DOI
1991).
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5.1 OVERVIEW
Zinc is an element commonly found in the earth’s crust. It is released to the environment both
from natural and anthropogenic sources; however, releases from anthropogenic sources are
greater than those from natural sources. The primary anthropogenic sources of zinc in the
environment (air, water, soil) are related to mining and metallurgic operations involving zinc and
use of commercial products containing zinc. Worldwide, releases to soil are probably the greatest
source of zinc in the environment. The most important sources of zinc in soil are discharges of
smelter slags and wastes, mine tailings, coal and bottom fly ash, and the use of commercial
products such as fertilizers and wood preservatives that contain zinc. Zinc does not volatilize
from soil. Although zinc usually remains adsorbed to soil, leaching has been reported at waste
disposal sites. Zinc does not volatilize from water but is deposited primarily in sediments through
adsorption and precipitation. Severe zinc contamination tends to be confined to areas near
emission sources.
Zinc is capable of forming complexes with a variety of organic and inorganic groups (ligands).
Biological activity can affect the mobility of zinc in the aquatic environment, although the biota
contains relatively little zinc compared to the sediments. Zinc bioconcentrates moderately in
aquatic organisms; bioconcentration is higher in crustaceans and bivalve species than in fish. Zinc
does not concentrate in plants, and it does not biomagnify through terrestrial food chains.
There are few data regarding the speciation of zinc released to the atmosphere. Zinc is removed
from the air by dry and wet deposition, but zinc particles with small diameters and low densities
suspended in the atmosphere travel long distances from emission sources.
Zinc has been detected in air, surface water, groundwater, and soil; the frequency of detection
and the concentrations are greatest near source areas (e.g., hazardous waste sites and industrial
areas such as lead smelters). In a survey by the National Air Surveillance Network, the mean
concentration of zinc in the air in the United States in 1977-1979 was 0.02-0.16 µg/m3 for urban
air compared to 0.01-0.05 µg/m3 for rural air. The concentrations of zinc in the air of remote
areas range from <0.003 to 0.027 µg/m3. The mean concentrations of zinc in ambient water and
drinking water range from 0.02 to 0.05 mg/L and from 0.01 to 0.1 mg/L, respectively. The
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concentration of zinc in drinking water can often be higher than the concentration in the raw
water from which the drinking water was obtained because zinc may leach from transmission and
distribution pipes. The concentration of zinc in standing water from galvanized household water
pipes was ≤1.3 mg/L (Sharrett et al. 1982a). The concentration of zinc in cultivated soils in the
United States ranged from <5 to 400 mg/kg, with a mean of 36 mg/kg, compared to a range of
<l0-2,000 mg/kg, with a mean of 51 mg/kg, in uncultivated soils; this probably results from the
differences in soils used for farming rather than the use of zinc in agriculture. Concentrations of
zinc can be high in soils from contaminated sites, such as waste dumps. Zinc has been identified
in at least 776 of the 1,350 NPL hazardous waste sites (HAZDAT 1993). However, the number
of sites evaluated for zinc is not known. The frequency of these sites can be seen in Figure 5-l.
Seven sites are located in the Commonwealth of Puerto Rico (not shown).
The concentrations of zinc in various foods and human tissues have also been determined. In a
1980-1982 survey of total diet samples, the Food and Drug Administration (FDA) estimated that
the average intake of zinc from food (including water) for an adult was 0.23 mg/kg/day. The FDA
concluded that the daily intake of zinc from the inhalation of ambient air is negligible compared
to the daily intake from food. Certain population groups may be exposed to higher
concentrations of zinc than the general population. People who work in coal mines, people who
work with the refining and smelting of nonferrous metals, and people who live near waste sites
and metal smelting operations may be exposed to high levels of zinc. People who consume large
amounts of foods high in zinc content, such as oysters and mussels, may also be exposed to high
levels of zinc. The higher exposure may not always be manifested as increased body burden in
the exposed individuals.
5.2 RELEASES TO THE ENVIRONMENT
Zinc is commonly found in the earth’s crust, and natural releases to the environment can be
significant. In addition, zinc is one of the most widely used metals in the world. The major industrial
sources of zinc include electroplating, smelting and ore processing, and drainage from both active
and inactive mining operations (Mirenda 1986). Furthermore, zinc is an important component of
brass, bronze, die casting metal, other alloys, rubber, and paints. The environmental releases of zinc
from anthropogenic sources far exceed the releases from natural sources (Fishbein 1981).
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5.2.1 Air
Zinc is released to the atmosphere as dust and fumes from zinc production facilities, lead
smelters, brass works, automobile emissions, fuel combustion, incineration, and soil erosion.
Refuse incineration, coal combustion, smelter operations, and some metal-working industries
constitute the major sources of zinc in air (EPA 1980d; Ragaini et al. 1977). Estimated
atmospheric zinc loss is 100 g/ton of zinc mined, and most of the loss comes from handling raw
and concentrated ore and wind erosion of tailing piles (Lloyd and Showak 1984). Average zinc
emissions to the atmosphere from stationary sources in the United States were 151,000 tons/year
for 1969-1971 (Fishbein 1981). An estimated projection of zinc emission for 1983, based on
production estimates and assuming no changes in processes or control technology, was
273,000 tons/year. The estimated worldwide emission of zinc to the atmosphere in 1983 was
70,250-193,500 metric tons. Emissions from zinc-cadmium production, steel and iron
manufacture, and copper-nickel production were estimated to be the principal atmospheric
sources of zinc (Nriagu and Pacyna 1988). According to the TRI, an estimated total of
1,933,687 pounds of zinc, amounting to about 17% of the total environmental release, was
discharged into the atmosphere in the United States in 1991 from the manufacturing and
processing facilities listed in Table 5-l (TR191 1993). The TRI data should be used with caution
since only certain facilities are required to report. Table 5-l is not an exhaustive list.
5.2.2 Water
Zinc and its compounds are found in the earth’s crust and are present in most rocks, certain
minerals, and some carbonate sediments. As a result of the weathering of these materials, soluble
compounds of zinc are formed and may be released to water (NAS 1977). The largest input of
zinc to water results from erosion of soil particles containing natural traces of zinc (45,400 metric
tons/year) (EPA 1980d). Erosion resulting from human activities accounts for 70% of this soil
loss; geologic or natural erosion constitutes the other 30% (EPA 1980d). However, this source of
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Urban runoff, mine drainage, and municipal and industrial effluents are smaller but more
concentrated sources of zinc in water. Industries that discharge large quantities of zinc directly to
water include iron and steel, zinc smelting, plastics, and electroplating (EPA 1980d). The
arithmetic mean concentration of zinc in influents of 239 waste-water treatment plants in the
United States was 0.7 mg/L, with minimum and maximum concentrations of 0.0001 and 28.7 mg/L,
respectively (Minear et al. 1981). Accidental zinc discharges to water are most often associated
with smelting and refining operations. Zinc is present with cadmium and lead in these processes
(NAS 1977). Urban runoff and drainage from inactive mines account for approximately 5,250 and
4,060 metric tons/year, respectively, of the total releases of zinc to water (EPA 1980d). Drainage
from active mining areas is considerably less than from inactive areas because of the disposal
methods currently employed. Hazardous waste sites, in which zinc has been improperly disposed
of, are additional sources of the element.
Metals, such as zinc, also enter estuaries from many natural and man-made sources. Three
important sources of zinc input into surface water are metal manufacturing, domestic waste water,
and atmospheric fallout. On an annual worldwide basis, an estimated 77,000-375,000 metric tons
of zinc are discharged into water from anthropogenic sources (Nriagu and Pacyna 1988). Publicly
owned treatment works are the largest total point source for zinc discharges. Publicly owned
treatment works receive zinc contributions from the water supply and distribution system
corrosion, combined sewer area runoff, industrial wastes, and human excrement (EPA 1980d).
According to the TRI, publicly owned treatment works discharged 30,466 pounds of zinc into the
environment, whereas manufacturing and processing facilities listed in Table 5-l discharged an
estimated 28,080 pounds of zinc (amounting to much less than 1% of the total environmental
release) into surface waters in the United States in 1991 (TR191 1993). The TRI data should be
used with caution since only certain types of facilities are required to report output. Table 5-l is
not an exhaustive list.
The concentration of zinc in drinking water may increase as a result of the distribution system and
household plumbing (EPA 1987~). Common piping materials used in distribution systems often
contain zinc, as well as other metals and alloys. Trace metals may enter the water through
corrosion products or simply by the dissolution of small amounts of metals with which the water
comes in contact. Reactions with materials of the distribution system, particularly in soft low-pH
waters, very often have produced concentrations of zinc in tap water much greater than those in
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the raw or treated waters at the plant of origin (NAS 1977). The total quantity of annual releases
of zinc from these sources has not been estimated.
5.2.3 Soil
Limited information is available on total releases of zinc to soil. Zinc is often present in soils and
grasses as a result of atmospheric deposition. Furthermore, approximately 22,000 tons of zinc are
used in fertilizers each year in the United States (NAS 1977). The extent to which zinc may run
off into soil, rivers, and streams has not been evaluated. Hazardous waste sites are additional
sources of zinc in soil. Municipal sludges applied to cropland soils can also be an important
source of trace metals, including zinc (Chang et al. 1987).
On a worldwide basis, an estimated 1,193,000-3,294,000 metric tons of zinc per year are released
to soil from anthropogenic sources (Nriagu and Pacyna 1988). The four most important sources
of zinc in soil were estimated to be smelter slugs and wastes, mine tailings, coal and bottom fly
ash, and the discharge of commercial products such as fertilizers. According to the TRI, an
estimated total of 9,216,574 pounds of zinc, amounting to about 82% of the total environmental
release in the United States, was released to soil in the United States in 1991 from the
manufacturing and processing facilities listed in Table 5-l (TR191 1993). An estimated total of
115 pounds was released through underground injection, and another 73,000,000 pounds were
transferred to off-site treatment, storage, and disposal facilities. The TRI data should be used
with caution since only certain types of facilities are required to report. Table 5-l is not an
exhaustive list.
5.3 ENVIRONMENTAL FATE
Zinc occurs in the environment mainly in the +2 oxidation state (Lindsay 1979). Sorption is the
dominant reaction, resulting in the enrichment of zinc in suspended and bed sediments (Callahan
et al. 1979). Zinc in aerobic waters is partitioned into sediments through sorption onto hydrous
iron and manganese oxides, clay minerals, and organic material. The efficiency of these materials
in removing zinc from solution varies according to their concentrations, pH, redox potential (Eh),
salinity, nature and concentrations of complexing ligands, cation exchange capacity, and the
concentration of zinc. Precipitation of soluble zinc compounds appears to be significant only
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under reducing conditions in highly polluted water. Generally, at lower pH values, zinc remains
as the free ion. The free ion (Zn+2) tends to be adsorbed and transported by suspended solids in
unpolluted waters. In polluted waters in which the concentration of zinc is high, removal of zinc
by precipitation of the hydroxide is possible, particularly when the pH is greater than 8.0
(Callahan et al. 1979). In anaerobic environments and in the presence of sulfide ions,
precipitation of zinc sulfide limits the mobility of zinc. The relative mobility of zinc in soil is
determined by the same factors that affect its transport in aquatic systems (i.e., solubility of the
compound, pH, and salinity) (Clement 1985).
Zinc is an essential nutrient that is present in all organisms. Although biota appears to be a
minor reservoir of zinc relative to soils and sediments, microbial decomposition of biota in water
can produce ligands, such as humic acids, that can affect the mobility of zinc in the aquatic
environment through zinc precipitation and adsorption (Callahan et al. 1979).
Zinc concentrations in the air are relatively low, except near industrial sources such as smelters.
No estimate for the atmospheric lifetime of zinc is available at this time, but the fact that zinc is
transported long distances in air indicates that its lifetime in air is at least on the order of days.
5.3.1 Transport and Partitioning
The tendency of a chemical to partition between soil, water, sediment, air, and biota can be
inferred from its physical and/or chemical properties. Zinc occurs in the environment primarily in
the +2 oxidation state. It dissolves in acids to form hydrated Zn+2 cations and in strong bases to
form zincate anions (probably Zn[OH]4-2). I n most unpolluted waters, zinc exists primarily as the
hydrated form of the divalent cation. In polluted waters, the metal often forms complexes with a
variety of organic and inorganic ligands (Callahan et al. 1979; EPA 1984b, 1987c).
Zinc can occur in both suspended and dissolved forms in surface water. Dissolved zinc may occur
as the free (hydrated) zinc ion or as dissolved complexes and compounds with varying degrees of
stability. Suspended (undissolved) zinc may be dissolved following minor changes in water
chemistry or may be sorbed to suspended matter.
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In the aquatic environment, zinc partitions to sediments or suspended solids in surface waters
through sorption onto hydrous iron and manganese oxides, clay minerals, and organic material.
Reservoirs located downstream from lead-zinc mining and milling areas were found to contain
higher concentrations of zinc than reservoirs in other areas, and the zinc was more highly
concentrated in reservoir bottom sediments than in the surrounding soils (Pita and Hyne 1975).
In addition, the zinc content in sediment closely correlated with the depth, organic content, and
clay content of the sediments. Phosphates and iron hydroxides play an important role in the
transfer of heavy metals (and presumably zinc) from river water to the sediments, according to a
study by Houba et al. (1983). In this study, zinc was bound predominantly to carbonate and
amorphous matter (iron, aluminum, and manganese hydroxides). In addition, mobile components
of naturally occurring organic matter contributed to the increase in the metal hydroxide-bound
fraction.
The transport of zinc in the aquatic environment is controlled by anion species. In natural waters,
complexing agents, such as humic acid, can bind zinc. The stability of the zinc complex depends
on the pH of the water and the nature of the complex. The dissociation of the complex may
determine the amount of zinc in solution. Zinc in humic acid complex may be 50% dissociated at
pH 5.5, and the dissociation rate may be higher as the pH decreases (Guy and Chakrabarti 1976).
Therefore, as the pH of the water decreases, the concentration of zinc ions in the water phase
increases at the same rate as that of the release of zinc from the sediment. The magnesium
found in the silicate minerals of igneous rocks is often replaced with the divalent zinc ion;
consequently, weathering of this zinc-containing bedrock gives rise to Zn+2 in solution. The
hydrated cation is the dominant form when the pH is ≤9 (Callahan et al. 1979).
The tendency of zinc to be sorbed is affected not only by the nature and concentration of the
sorbent but also by pH and salinity (Callahan et al. 1979). Zinc tends to sorb more readily at a
high pH (pH >7) than at a low pH (Callahan et al. 1979). Desorption of zinc from sediments
occurs as salinity increases (Helz et al. 1975), apparently because of displacement of the adsorbed
zinc ions by alkali and alkaline earth cations, which are abundant in brackish and saline waters
(Callahan et al. 1979). In column leaching tests with sediment collected from the banks of the
Rhone River, the presence of dissolved organic matter and pH was found to be the factors
controlling the adsorption and mobility of zinc (Bourg and Darmendrail 1992).
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A small fraction of the zinc initially exists in the aquatic phase as soluble inorganic zinc compounds.
Zinc chloride and zinc sulfate are very soluble in water but hydrolyze in solution to form a zinc
hydroxide precipitate. Hydrolysis may lower pH, but the buffering action present in most natural
water prevents a significant alteration in pH. The precipitation of zinc hydroxide and zinc carbonate
was studied by Patterson et al. (1977) who found that zinc hydroxide precipitates faster than zinc
carbonate. Zinc carbonate is soluble in pure water at 25°C at concentrations of ≤107 mg zinc/L. The
hydroxide is soluble only at concentrations of ≤0.2 mg zinc/L. As a result, some of the inorganic
forms of zinc that are expected to be present in water are basic carbonate (Zn2[OH]2CO3), hydroxide
(Zn[OH]2) and silicate (Zn2SiO4) (Florence 1980; NAS 1977). When the pH is ≥8, most of these
compounds will precipitate; however, as the pH decreases, more and more of these compounds will
dissolve and remain in the water phase (Callahan et al. 1979).
The effect of pH on the mobilization of zinc in a few highly acidic clean lakes has been studied
(Sprenger et al. 1987; White and Driscoll 1987). In these lakes, in which the pH was ≤3.6,
concentrations of zinc were elevated in the water column, and the concentration of zinc in the
upper layer of sediment was substantially lower than values reported for other lakes at higher pH
values. The relatively higher concentration of zinc in the water column compared to the sediment
may be the result of lower adsorption of zinc on oxide surfaces due to low pH, solubilization of
inorganic zinc from the sediment layer, and the dissociation of bound organic complexes of zinc
present in the sediment and their subsequent release into the water phase.
The precipitation of zinc sulfide is an important control on the mobility of zinc in reducing
environments where hydrogen sulfide is formed. The precipitation of the hydroxide, carbonate, or
basic sulfate may become more significant at high concentrations in highly polluted water. The
hydroxides and hydrous oxides of iron and manganese are often components of the clay fraction
of sediments and often exist as coatings on the surfaces of other minerals (NAS 1977). Zinc may
coprecipitate with hydrous oxides when reduced iron or manganese oxides are oxidized. As the
new solids are formed, they can trap various ions in their crystal lattice (Callahan et al. 1979).
Zinc sorbs strongly onto soil particulates. Little water-soluble and exchangeable heavy metals
were found in soil irrigated with raw waste water (Schalscha et al. 1982). Although considerable
amounts of metals were added to the soil in soluble and exchangeable forms during waste-water
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irrigation, they were converted into the less chemically active forms (i.e., organically bonded and
inorganic precipitates). Further examination showed that zinc accumulation in soil resulting from
waste disposal occurred primarily in inorganic precipitates.
The mobility of zinc in soil depends on the solubility of the speciated forms of the element and
on soil properties such as cation exchange capacity, pH, redox potential, and chemical species
present in soil; under anaerobic conditions, zinc sulfide is the controlling species (EPA 1980d;
Kalbasi et al. 1978). Since zinc sulfide is insoluble, the mobility of zinc in anaerobic soil is low.
In a study of the effect of pH on zinc solubility, Saeed and Fox (1977) showed that, when the pH
is <7, an inverse relationship exists between the pH and the amount of zinc in solution. As
negative charges on soil surfaces increase with increasing pH, additional sites for zinc adsorption
are activated and the amount of zinc in solution decreases. The active zinc species in the
adsorbed state is the singly charged zinc hydroxide species (i.e., Zn[OH]+) (Sanders and
Kherbawy 1987). Other investigators have also shown that the mobility of zinc in soil increases at
lower soil pH under oxidizing conditions and at a lower cation exchange capacity of soil (Bergkvist
et al. 1989; Hermann and Neumann-Mahlkau 1985; Tyler and McBride 1982). On the other
hand, the amount of zinc in solution generally increases when the pH is >7 in soils high in
organic matter. This is probably a result of either the release of organically complexed zinc,
reduced zinc adsorption at higher pH, or an increase in the concentration of chelating agents in
soil (Saeed and Fox 1977). For calcareous soils, the relationship between zinc solubility and pH is
nonlinear. At a high pH, zinc in solution is precipitated as Zn(OH)2, zinc carbonate (ZnCO3), or
calcium zincate (Saeed and Fox 1977). Clay and metal oxides are capable of sorbing zinc and
tend to retard its mobility in soil. Soil distribution constants (Kd) of 100±770 mL/g for sandy
loam soil and 0.2±4 mL/g for sandy soils were reported by Gerritse et al. (1982). A Kd of
0.1±8,000 mL/g was reported by Baes and Sharp (1983), but an average Kd of 40 mL/g was
reported by Baes et al. (1984).
Zinc in a soluble form, such as zinc sulfate, is fairly mobile in most soils. However, relatively little
land-disposed zinc is in the soluble form, and mobility is, therefore, limited by a slow rate of
dissolution. Consequently, movement towards groundwater is expected to be slow unless zinc is
applied to soil in soluble form (such as in agricultural applications) or accompanied by corrosive
substances (such as in mine tailings) (EPA 1980d). Yet, soil conditions not suitable for zinc
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sorption may lead to leaching. Low pH (pH <7) and high ionic strength of the leaching solution
favor desorption (EPA 1987c; Saeed and Fox 1977).
Zinc is an essential nutrient and occurs in the tissues of organisms, even at normal ambient water
and soil concentrations. Zinc can accumulate in freshwater animals at 51-1,130 times the
concentration present in the water (EPA 1987c). Microcosm studies indicate, in general, that zinc
does not biomagnify through food chains (Biddinger and Gloss 1984; Callahan et al. 1979; Hegstrom
and West 1989). Furthermore, although zinc actively bioaccumulates in aquatic systems, biota
appears to represent a relatively minor sink compared to sediments. Steady-state zinc
bioconcentration factors (BCFs) for 12 aquatic species range from ≈4 to 24,000 (EPA 1987c).
Crustaceans and fish can accumulate zinc from both water and food. A BCF of 1,000 was reported
for both aquatic plants and fish, and a value of 10,000 was reported for aquatic invertebrates
(Fishbein 1981). The order of enrichment of zinc in different aquatic organisms was as follows (zinc
concentrations in µg/g dry weight appear in parentheses): fish (23, shrimp (50), mussel (60),
periphyton (260), zooplankton (330), oyster (3,300) (Ramelow et al. 1989). The high enrichment in
oysters may be due to their ingestion of particulate matter containing higher concentrations of zinc
than does ambient water. Other investigators have also indicated that organisms associated with
sediments have higher zinc concentrations than organisms living in the aqueous layer (Biddinger and
Gloss 1984). With respect to bioconcentration from soil by terrestrial plants, invertebrates, and
mammals, BCFs of 0.4, 8, and 0.6, respectively, have been reported. The concentration of zinc in
plants depends on the plant species, soil pH, and the composition of the soil (Dudka and Chlopecka
1990; Rudd et al. 1988). Plant species do not concentrate zinc above the levels present in soil (Levine
et al. 1989).
Wind-blown dust transports zinc bound to soil particulates into the atmosphere (EPA 1980d). The
particulates may also contain other materials (Pacyna et al. 1989; Saltzman et al. 1985). Zinc-bearing
particles in the atmosphere are transported to soil and water by wet deposition (rain and snow) and
dry deposition (gravitational settling and deposition on water and soil surfaces). The detection of zinc
in rainwaters (at concentrations higher than atmospheric particles) confirms the importance of wet
precipitation in the removal of zinc particles from the atmosphere (Aten et al. 1983; Colin et al. 1990;
Dasch and Wolff 1989; Heaton et al. 1990). Zinc particles with low dry deposition velocities (i.e.,
particles with small diameters and low densities) can be transported from their emission source to
distant regions (Pacyna et al. 1989).
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5.3.2 Transformation and Degradation
The transformation of zinc compounds can occur as a result of changes in chemical speciation,
such as the formation of zinc oxide in the atmosphere, the hydrolysis of hydrated zinc cations, or
the oxidation/reduction of organic and inorganic zinc complexes.
5.3.2.1 Air
The chemical interaction of zinc compounds in the atmosphere may change the anionic speciation
of the compound. Atmospheric interactions are greatest for particles with small aerodynamic
diameters (Fishbein 1981). Zinc is found in the atmosphere at the highest concentrations in the
smallest particles (Fishbein 1981). Atmospheric emissions of zinc, consisting primarily of zinc
sorbed to submicron particulate matter in the form of zinc oxide, are expected to dissipate quickly
as a result of deposition to soil and surface waters (EPA 1980d).
In the atmosphere, zinc-bearing particles may undergo chemical transformation before deposition.
The association of zinc particles in aerosols in Arizona was studied, and five zinc-bearing particles
were identified with an automated scanning electron microscope (Anderson et al. 1988). These
particles, in decreasing order of concentration in the aerosol, were zinc sulfide, ferrous zinc, zinc
phosphides, zinc chloride, and metallic zinc. The presence of zinc sulfide in an area adjacent to
mining and smelting activities is not surprising, but no conclusion regarding the speciation of zinc
in the atmosphere can be drawn from this investigation. However, the relative concentration of
zinc ions in rainwater from a rural area was one order of magnitude higher than in airborne
particulates (Aten et al. 1983). This finding suggests that zinc sulfide in the atmosphere is
oxidized to a more water-soluble form, zinc sulfate.
5.3.2.2 Water
Zinc is in the +2 form in aqueous solution and exhibits amphoteric properties; it dissolves in acids
to form hydrated Zn+2 cations and in strong bases to form zincate anions (probably Zn[OH]4-2)
(Callahan et al. 1979). However, at the pH of most natural waters, the formation of anionic zinc
species is not likely.
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A small part of the available zinc may partition into the aquatic phase through the formation of
soluble zinc chloride and sulfate compounds. These compounds hydrolyze in solution to form the
hydroxide or hydrated zinc oxide precipitate with the resultant decrease in pH. The decrease in
pH may increase the solubility of zinc hydroxide and increase the zinc concentration in water.
However, the buffering action of most natural waters prevents any significant change of pH due
to the hydrolysis reactions. As a result, in the water phase, the solubility of its carbonate and
hydroxide is likely to control the availability of zinc. It was reported by Patterson et al. (1977)
that Zn(OH)2 precipitates faster than ZnCO3. Zinc is not directly affected by changes in Eh;
however, the valences and reactivity of ligands reacting with zinc are affected by Eh. Zinc is an
active reducing agent for many ions such as iron (Fe+3) and permanganate (MnO4-2) ions
(Stokinger 1981). As a result of the reducing reactions, the manganese oxides and ferric salts may
precipitate out and, in the process, may entrap soluble zinc in the precipitate, thereby reducing
the zinc concentration in the water phase.
Because alkyl zinc compounds are unstable in water and oxygen, biomethylation of zinc
compounds in aquatic ecosystems probably does not occur (Callahan et al. 1979). No evidence
was found that photolysis in the aquatic environment significantly affects the fate of zinc
compounds.
5.3.2.3 Sediment and Soil
No information specifically related to transformation and degradation in sediment and soil was
identified in the available literature. However, chemical speciation of zinc in sediment and soil is
probably affected by the same factors affecting its fate in water. The sediment and soil chemistry
of zinc are governed primarily by the pH and the physical properties of sediment and soil. In
acidic sediments and soils, more zinc is available in ionic forms, and cation exchange processes
influence its fate. Depending on the nature and concentrations of other mobile metals in
sediments and soils, competition for the binding sites probably occurs. In the absence of suitable
binding sites, zinc may be mobilized (ICF 1986). In alkaline soils, the chemistry of zinc is
dominated by interactions with organic ligands.
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5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1 Air
Zinc concentrations in air are relatively low and fairly constant except near sources such as smelters.
Average atmospheric concentrations of zinc resulting from releases from automobiles, fuel
combustion, incineration, soil erosion, and industrial, commercial, and construction activity
throughout the United States generally are less than 1 µg/m3 (EPA 1980d; Lloyd and Showak 1984).
Data on zinc concentrations in New York City during 1972-1975 show that the average atmospheric
zinc concentration ranged from 0.293 to 0.380 pg/m3 annually (Lioy et al. 1978). An average ambient
zinc concentration of 0.127 µg/m3 (concentration range, 0.027-0.500 µg/m3) was determined from
analyses of particulate samples collected at nine air monitoring sites in the San Francisco Bay area
(John et al. 1973). The concentrations of zinc in atmospheric samples collected from seven cities in
the United States during 1968-1971 ranged from 0.17 to 0.67 µg/m3, whereas the concentrations at
two rural sites ranged from 0.02 to 0.16 µg/m3 (Saltzman et al. 1985). The concentrations of zinc
during 1977-1979 from the National Air Surveillance Networks were reported by Evans et al. (1984).
The arithmetic mean zinc concentrations in urban areas in the United States ranged from 0.02 to 0.16
µg/m3, whereas the concentrations in non-urban areas ranged from 0.01 to 0.05  µg/m3. The
geometric mean concentrations of zinc from three urban areas in New Jersey monitored more
recently (1981-1982) ranged from 0.07 to 0.59 µg/m3, whereas the concentrations at a rural site
ranged from 0.02 to 0.06 µg/m3 (Daisey 1987). The reported concentration range of zinc in air at
remote sites (arctic) was <0.003-0.027 µg/m3 (Barrie and Hoff 1985; Duce et al. 1975; Zoller et al.
1974). In aerosol samples of the lower troposphere collected over the Southern Bight of the North
Sea between September 1988 and October 1989, the average zinc concentration was 67 ng/m3
(standard deviation, 54 ng/m3; range, 3-220 ng/m3; n = 108 samples) (Injuk et al. 1992). The
concentration of atmospheric zinc is usually lower in winter than in summer (Barrie and Hoff 1985;
Daisey 1987).
Although data are sparse, higher-than-background concentrations have been reported near ironand
steel-producing factories and zinc, lead, and copper smelters. During zinc smelting
operations, concentrated zinc ore goes through a roasting procedure to convert zinc sulfide to
zinc oxide. This process accounts for a large portion of the total atmospheric zinc emission during
primary production (EPA 1980d). About 1.5 miles from a smelter in Kellogg, Idaho, Ragaini
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al. (1977) detected high annual mean concentrations of zinc in ambient air of 5 µg/m3. The 24-hour
values for zinc ranged from 0.27 to 15.7 µg/m3; the average lead and cadmium concentrations at this
smelter site were 11 and 0.8 µg/m3, respectively, indicating severe environmental pollution. Higher
concentrations of zinc in the vicinity of a copper smelter than in reference areas were also reported by
Patterson et al. (1977).
5.4.2 Water
In general, zinc is more concentrated in the sediments of streams and rivers than in the water column.
It is reported by NAS (1977) that zinc will probably be detected in 75% of all water samples
examined for zinc from various locations.
The zinc background concentrations in surface waters are usually less than 50 µg/L (EPA 1980d), but
concentrations in different surface waters and groundwater can range from 0.002 to 50 mg/L (NAS
1977). In many locations (e.g., New England, the southeast, the Missouri River basin, the Rio Grande
River basin, and the Upper Colorado River basin), higher-than-background concentrations of zinc are
common and appear to be correlated with mining activities in these areas and/or geological areas rich
in zinc (EPA 1980d). However, in all river basins there are some locations with zinc concentrations
of 0.1-1.0 mg/L (EPA 1980d).
The concentrations of zinc in water samples from Whitewood Creek, South Dakota, were measured
by Hale (1977). The samples were collected upstream from the discharge of a local mining company.
In 42 analyses, zinc concentrations ranged from <.004 to 0.048 mg/L with a mean concentration of
0.018 mg/L. The level of dissolved zinc in water from Lakes Erie and Ontario ranged from 3x10-6 to
1.1x10-4 mg/L (Coale and Flegal 1989).
Concentrations of zinc in surface water often correlate with the introduction of urban and industrial
runoff. The Nationwide Urban Runoff Program (NURP), initiated to evaluate the significance of
priority pollutants in urban storm water runoff, reports a frequency of detection for zinc of 95%, with
a concentration range of 0.01-2.4 mg/L (Cole et al. 1984).
The concentrations of zinc in drinking water can be higher than concentrations in surface waters.
Concentrations of 0.002-1.2 mg/L were detected in 77% of 1,577 surface water samples; levels of
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0.003-2.0 mg/L were found in 380 drinking water samples (NAS 1977). The higher
concentrations in drinking waters are due to water treatment and to the distribution systems used
for the water. Zinc in drinking water at levels as great as several mg/L was due to galvanized
pipes and tanks in alkaline-water distribution systems. For example, drinking water samples from
galvanized pipe plumbing systems in Seattle, Washington, contained zinc concentrations of
0.128-1.279 mg/L; these levels were >l0 times higher than those in homes with copper pipe
plumbing systems (Sharrett et al. 1982a). The results of analyzing 43 tap-water samples, collected
in homes in Dallas, Texas, for trace metals reported maximum, minimum, median, and average
concentrations of 0.049, 0.005, 0.011, and 0.0124 mg zinc/L, respectively (NAS 1977). The high
zinc concentrations in these water samples were believed to be due to the household plumbing.
In a study investigating associations between inorganic constituents of drinking water and
cardiovascular diseases, Greathouse and Osborne (1980) collected and analyzed tap water samples
in 35 geographic areas in the United States. From 100 to 110 tap-water samples were collected
from each area. The maximum, minimum, and mean concentrations were 1.447, 0.025, and
0.144 mg zinc/L, respectively. Seventy-five percent of the zinc values were below 0.236 mg/L.
Other investigators have also attributed the higher concentrations of zinc in household tap waters,
compared to the raw originating water, to distribution and transmission lines (Maessen et al. 1985;
Ohanian 1986; Schock and Neff 1988).
The available data suggest that zinc concentrations in drinking water are far less than the levels
required to meet a daily intake level of 15 mg/day (assuming an adult water consumption of
2 L/day) (NAS 1977).
5.4.3 Sediment and Soil
Data on ambient concentrations of zinc in soil are limited. Zinc is generally found in soils at
concentrations between 10 and 300 mg/kg, with a mean of ≈50 mg/kg (EPA 1980d). Zinc
concentrations measured across the United Stated ranged from <5 to 400 mg/kg and from <10 to
2,000 mg/kg, with corresponding means of 36 and 51 mg/kg in cultivated and uncultivated
subsurface soils, respectively (Connor and Shacklette 1975); however, these differences in zinc
concentration may be attributed to differences in the soils prior to use (and not to cultivation).
The sampling survey was designed to determine zinc concentrations of surficial materials unaltered
from their natural condition. Soils near highways and smelters contained high zinc concentrations
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as a result of deposition of zinc released in tire abrasion and stack emissions (EPA 198Od). A
study was designed by Hutchinson and Wai (1979) to investigate the distribution of cadmium,
lead, and zinc in the soil and vegetation grown on it at two reclaimed waste dumps from
phosphate ore mines in southeastern Idaho. Zinc concentrations in the soil of the waste dumps
averaged from 443±210 to 1,112±124 mg/kg. These values were high compared with those found
in the control plot (54216 mg/kg). Zinc concentrations in vegetation from the reclaimed waste
dumps were also high compared to the control plot. Moderate-to-high levels of zinc
contamination were found in leafy vegetables (lettuce) and their supporting soil in a zone with a
0-5-km radius around a copper smelter (Beavington 1975). The mean concentrations of zinc in
17 soil samples and 12 lettuce samples collected in this zone were 229±17 and 316±64 mg/kg dry
weight, respectively. Significant relationships were found between the distance from the smelter
and the levels of easily extractable zinc in the soil, and between the distance from the smelter and
the content of zinc in herbage. Concentrations of zinc in soil irrigated with waste water or river
water were measured by Schalscha et al. (1982). The total concentration of zinc in waste-watertreated
soils was 228 mg/kg. The total concentration of zinc in soils irrigated with river water
ranged from 103 to 136 mg/kg.
Municipal sludge and municipal incineration ash contain considerably higher levels of zinc than
uncontaminated soils (Mumma et al. 1984, 1990, 1991). Therefore, application of sludge and
municipal ash to soil will elevate the levels of zinc in these soils. The mean concentrations
(mg/kg) of zinc according to four land use types were as follows: agricultural, 25; suburban
residential, 75; mixed industrial/residential, 157; and industrial inner urban area, 360 (Haines
1984).
Since zinc in water is transported to the sediment in the adsorbed or precipitated state, the
concentration of zinc in sediments of most waters is higher than the zinc concentration in aqueous
phase. The concentration of zinc in Hamilton Harbor sediments ranged from 1,050 to
2,900 mg/kg, compared to zinc concentrations of 6-48 µg/L in the aqueous phase (Mayer and
Manning 1990). The concentrations of zinc in sediments of upper Columbia River, British
Columbia, ranged from 45 to 51 mg/kg, while zinc concentrations in sediments from Lake
Roosevelt, Washington, were 60-26,840 mg/kg (Johnson et al. 1990). The higher zinc
concentrations in lake sediments were due to discharges from a lead-zinc smelter and a refinery.
In the sediments of eight remote lakes in the Adirondack region of the northeastern United
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States, zinc concentrations in sediment cores ranged from 550±140 mg/m2 to 5620±2680 mg/m2
(Kada and Heit 1992).
5.4.4 Other Environmental Media
Bivalves and other sessile estuarine organisms are often used as a measure of contamination of
estuarine water because they usually contain higher levels of metals than fish. The arithmetic
mean concentration of zinc in oysters (Crassostrea virginica) from the Mississippi Sound collected
in 1988 was 640 mg/kg (wet weight) (Lytle and Lytle 1990). In a nationwide mussel watch
program, the mean concentrations of zinc in molluscs (Mytilus edulis) around the coast of the
United States during 1976-1988 ranged from 67 to 3,700 mg/kg (dry weight) (Lauenstein et al.
1990). Although the concentration on a nationwide basis varied depending on sampling sites, the
level of zinc showed little evidence of statistically significant change during 1976-1988. The mean
concentration of zinc in oysters (Crassostrea virginica) collected from the U.S. coastline of the
Gulf of Mexico during 1986-1988 was 2,150 mg/kg (dry weight) (Presley et al. 1990). In the
National Contaminant Biomonitoring Program, the geometric mean concentration of zinc in
various whole fish was 21.7 mg/kg (wet weight) (Schmitt and Brumbaugh 1990). Of all fish tested
(e.g., bloater, sucker, white perch, bass, catfish, etc.), common carp showed the highest level of
zinc. No significant trend in the level of zinc in whole fish was observed during 1978-1984. The
concentration of zinc in yellow perch (Perca flavescens) from six acidic lakes in northwestern New
Jersey ranged from 26.1 to 66.2 mg/kg (dry weight) (Sprenger et al. 1988). Although the
concentrations of mercury and lead in fish from acidic lakes were higher compared to fish
collected from non-acidic lakes, the concentrations of zinc showed no significant difference.
Similarly, high concentrations of zinc were not found in white suckers (Catostomus commersoni)
and brown bullheads (Ictalurus nebulosus) collected from two acidic Adirondack lakes in New
York (Heit and Klusek 1985).
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
Zinc is ubiquitous in living organisms and ranks as one of the most abundant trace metals in
humans. Humans are primarily exposed to zinc through ingestion. Sources of exposure include
drinking water, food, air that is polluted, tobacco products, and occupational exposure. An
average intake in humans is on the order of 0.14-0.21 mg zinc/kg/day (NAS 1977). The dietary
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intake of an average teenage male has been estimated to be so ≈0.27 mg zinc/kg/day, and dietary
supplements may provide up to an additional 1 mg zinc/kg/day (EPA 1980d). In an extensive
survey of foods in the total diets of individuals in the United States, conducted by the FDA
during 1982-1984, the following values for daily zinc intakes (mg/day) were estimated in eight age
and sex groups: 6-ll-month-old infants, 5.24; 2-year-old children, 7.37; 14-16-year-old girls, 9.90;
14-16-year-old boys, 15.61; 25-30-year-old women, 9.56; 25-30-year-old men, 16.15; 60-65-yearold
women, 8.51; and 60-85-year-old men, 12.64 (Pennington et al. 1986). Based on a body
weight of 70 kg for a 25-30-year-old man, the intake corresponds to 0.23 mg/kg/day. The FDA
included drinking water in the total diet. In a review of the literature, the National Research
Council concluded that zinc concentrations in drinking water are generally well below 5 mg/L
(NAS 1977). Assuming a daily intake of 2 L of water and an average body weight of 70 kg, a
daily intake of less than 0.14 mg zinc/kg/day from drinking water can be estimated. Based on a
body weight of 70 kg, the mean daily intakes of zinc in drinking water for residents of homes with
galvanized and copper pipe plumbing systems in Seattle, Washington, were estimated to be
0.017-0.028 and 0.002-0.006 mg/kg/day, respectively (Sharrett et al. 1982b).
The NAS established the RDAs for zinc at 15 mg/day for men and 12 mg/day for women
(NAS/NRC 1989b). The major source of zinc for the general population is food (EPA 1987~).
Zinc is widespread in commonly consumed foods but tends to be higher in those of animal origin,
particularly some seafoods (e.g., one serving of oysters will more than meet the daily dietary
requirements of zinc) (NAS/NRC 1979). Meat products contain relatively high concentrations of
zinc, whereas fruits and vegetables have relatively low concentrations. Generally, a person must
eat a fairly high-protein diet to meet the RDA for zinc. Meats, fish, and poultry contained an
average of 24.5 mg zinc/kg, whereas grains (or cereal products) and potatoes contained 8 and
6 mg/kg, respectively (Mahaffey et al. 1975). Zinc was present in all of the examined food classes.
A diet of dairy products, meat, fish, poultry, grains, and cereals provides approximately 77% of the
daily zinc intake. More recent data reported by the Food Safety and Inspection Service of the
U.S. Department of Agriculture indicate that zinc was detected in 99.4-100% of the samples of
healthy livestock and poultry randomly selected from among the specimens presented for
slaughter in 1985-1986. Zinc concentrations in muscle tissue ranged from 0.20 ppm in young
turkeys (n=61) to 1.92 ppm in heifers/steer (n=287) (Coleman et al. 1992). In a review of zinc
levels in vegetables and other foods and beverages of plant origin, Weigert (1991) reported the
following average concentrations (mg/kg): wheat - 41; rye - 13; rice - 8-20; potatoes - 3.51;
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vegetables - 4.31; fruit - 1.66; mushrooms - 9.7; cocoa - 35; tea - 35; and coffee - 6.7. Zinc has
also been detected in wines from Seville, Spain, at concentrations of 0.3-5.40 pg/mL (Lopez-
Artiquez et al. 1990). The FDA collected samples of foods representative of adult diets in
27 cities between October 1980 and March 1982 as part of its Total Diet Studies program
(Gartrell et al. 1986a). Individual food items were separated into a number of food groups, and
each was analyzed as a composite sample. The results for each food group were as follows:
Food Group Average Concentration (ppm) Average Intake (mg/day)
Dairy products 4.57 3.47
Meat, fish, and 29.20 7.67
poultry
Grain and cereal 8.68 3.64
products
Potatoes 4.82 0.77
Leafy vegetables 2.26 0.12
Legume vegetables 8.27 0.60
Federal regulations permit the use of zinc acetate, zinc oxide, and zinc sulfide as components of
adhesives, coatings, or rubber packaging materials intended for food contact (FDA 1987b, 1987c,
1987d). Federal regulations also permit the use of zinc chloride, zinc oxide, zinc stearate, and
zinc sulfate as GRAS (Generally Recognized As Safe) food additives when they are used “in
accordance with good manufacturing practices” (FDA 1987e, 1987f, 1987g, 1987h, 1987i, 1987j).
In addition, the use of zinc oxide as a color additive in drugs and cosmetics is also permitted with
certain restrictions (FDA 1987a).
Negligible quantities of zinc are inhaled in ambient air. Exposure to airborne zinc is largely
occupational through the inhalation of industrial dusts or fumes. Individuals occupationally
exposed to metallic zinc and zinc compounds are those involved in galvanizing, smelting, welding,
or brass foundry operations. In such operations, zinc as ore or metal and its alloys are often
exposed in an oxidizing atmosphere to temperatures near the metal’s boiling point of 907°C. This
heating results in the formation of fresh zinc oxide particles (0.2-1.0 µm), which may subsequently
be inhaled. Inhalation of zinc oxide particles and fumes by workers can result in metal fume
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fever. Inhalation was reported to be the most probable route of exposure to zinc for 26 lead
smelter workers found to have significantly (p<0.01) elevated blood plasma levels of zinc. Mean
plasma zinc concentrations were 12.9 mmol/L (range, 9.8-16.7) for the workers versus
10.9 mmol/L (range, 8.1-14.6) for a non-lead-exposed control group (Vasikaran et al. 1992).
Data from the National Occupational Exposure Survey (NOES), conducted by NIOSH from 1980
to 1983, indicate that 269 workers (including 22 women) in 22 plants were potentially exposed to
pure zinc, and 133,608 workers (including 17,586 women) in 6,157 plants were potentially exposed
to other forms of zinc (unknown composition) in the workplace in 1980 (NIOSH 1984b). All of
the workers exposed to pure zinc were employed in the fabricated metal products industry as
millwrights or assemblers. The largest numbers of workers exposed to other forms (unknown
composition) of zinc worked in the primary metal industries, with fabricated metal products, with
transportation equipment, with stone, clay, and glass products, and in special trade contractors
industries. The occupational groups with the largest numbers of exposed workers were
miscellaneous machine operators (not elsewhere classified or not specified), molding and casting
machine operators, janitors and cleaners, and machinists. Exposure estimates were derived from
observations of the actual use of the compound and the use of trade name products known to
contain the compound.
The mean concentration of zinc in the fingernails and toenails of populations from the United
States, Canada, and Japan were 105, 109, and 94 mg/kg, respectively (Takagi et al. 1988). The
geometric mean concentrations of zinc in toenails (129 mg/kg) and scalp hair (108 mg/kg) of
preschool
children in Germany were about the same (Wilhelm et al. 1991). The total concentrations
of zinc in 29 body tissues of 55 human cadavers were measured (Saltzman et al. 1990). The
lowest concentration (mean of 1.5±2.2 mg/kg [wet weight]) of zinc in both males and females was
found in adipose tissues, while the highest concentrations were detected in the skull of males
(mean of 54.3 mgkg [wet weight]) and in the skeletal muscle of females (mean of 59.0 mg/kg [wet
weight]). The mean concentrations of zinc in the feces of low-income urban Hispanics and rural
Blacks in the United States were 75 and 94 mg/kg (wet weight), respectively (Prevost et al. 1985).
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5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
Certain populations receive greater-than-average exposures to zinc from environmental sources.
For example, higher levels of zinc have been reported in soil and water near waste sites, metal
smelters, and areas exposed to untreated waste water (Hutchinson and Wai 1979; Ragaini et al.
1977; Schalscha et al. 1982). Other populations at risk of high exposure are those that have
galvanized plumbing in their residences, and those that intentionally consume large doses of zinc
as a dietary supplement. Patients who receive chronic treatment with drugs containing zinc salts
(such as injectable insulin) are exposed to higher zinc levels than the general population. Allergic
reactions to the zinc in insulin have been reported (Bruni et al. 1986). People in certain
occupations are likely to be exposed to higher concentrations of zinc than the general population
(see Section 5.5). However, the higher exposure may not be indicative of a long-term increase in
body burden. For example, the median zinc concentration in the lung tissues of 21 Swedish
workers previously employed in the refining and smelting of nonferrous metals was about the
same as in a control group (11.0 versus 10.7 mg/kg [wet weight]) (Hewitt 1988). On the other
hand, the median concentration of zinc in lung tissues of eight deceased coal miners from
England was 72 mg/kg (wet weight) compared to a median value of 54 mg/kg (wet weight) for a
control group (Hewitt 1988); however, the study author did not provide any evidence that the
difference in zinc concentrations in the lungs of unexposed controls is statistically significant.
5.7 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation
with the Administrator of EPA and agencies and programs of the Public Health Service) to assess
whether adequate information on the health effects of zinc is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required to assure the
initiation of a program of research designed to determine the health effects (and techniques for
developing methods to determine such health effects) of zinc.
The following categories of possible data needs have been identified by a joint team of scientists
from ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if
met would reduce the uncertainties of human health assessment. This definition should not be
interpreted to mean that all data needs discussed in this section must be filled. In the future, the
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identified data needs will be evaluated and prioritized, and a substance-specific research agenda
will be proposed.
5.7.1 Identification of Data Needs
Physical and Chemical Properties. The available data adequately characterize the physical and
chemical properties of the various forms of zinc to permit estimation of their environmental fate
(ACGIH 1991; Baes and Sharp 1983; Baes et al. 1984; Gerritse et al. 1982; HSDB 1986, 1990;
Merck 1983; NIOSH 1990; Weast 1988; Weiss 1986).
Production, Import/Export, Use, and Disposal. Zinc is a metallic element commonly found in
ores in the earth’s crust, and natural releases to the environment can be significant. Zinc is also
one of the most widely used metals in the world (Mirenda 1986). In 1989, approximately 278,900
metric tons were produced from domestic ores in the United States (DOI 1991). The estimated
world production from mines in 1989 was 7,062,000 metric tons. The production of zinc
decreased from 1985 to 1987 but increased from 1987 to 1989 (DO1 1991). No estimates were
located regarding current production. Zinc is most commonly used as a protective coating for
other metals. It is also used in alloys such as bronze and brass, for electrical apparatus, and in
organic chemical extractions. Zinc salts have numerous applications, including wood preservation.
Zinc chloride is a primary ingredient in smoke bombs. In pharmaceuticals, zinc salts are used as
solubilizing agents in drugs, including insulin (Lloyd 1984; Lloyd and Showak 1984; Merck 1983).
Zinc oxide is found in ointments used to treat burns and infectious and skin diseases (EPA
1987d). Zinc is also utilized therapeutically in human medicine in the treatment of zinc deficiency
(Elinder 1986). Zinc is also a food contaminant (EPA 1987~). The primary anthropogenic
sources of zinc in the environment (air, water, soil) are related to mining and metallurgic
operations involving zinc and use of commercial products containing zinc (EPA 198Od; NAS 1977;
Nriagu and Pacyna 1988; Ragaini et al. 1977; TRI91 1993). Zinc has been detected in air, surface
water, groundwater, and soil, with the frequency of detection and the concentrations greatest near
source areas (e.g., hazardous waste sites and industrial areas such as lead smelters) (EPA 1980d;
HAZDAT 1993; Lioy et al. 1978; Lloyd and Showak 1984; Mumma et al. 1984, 1990, 1991; NAS
1977). Current disposal methods are efficient (Dawson and Mercer 1986; Lloyd and Showak
1984). No data were located regarding the amount of zinc being disposed. There are rules and
regulations regarding the disposal of zinc (Dawson and Mercer 1986; DO1 1991).
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According to the Emergency Planning and Community Right-to-Know Act of 1986, 42 USC.
Section 11023, industries are required to submit chemical release and off-site transfer information
to the EPA. The Toxics Release Inventory (TRI), which contains this information for 1991,
became available in May of 1993. Environmental releases of zinc from manufacturing and
processing facilities required to report their releases are listed in Table 5-1. This database is
updated yearly and should provide a list of industrial production facilities and emissions.
Environmental Fate. Zinc partitions to the air, water, and soil (Callahan et al. 1979; Guy and
Chakrabarti 1976; Houba et al. 1983; Pita and Hyne 1975). Zinc occurs in the environment
mainly in the +2 oxidation state (Lindsey 1979). Adsorption is the dominant fate of zinc,
resulting in enrichment of zinc in suspended and bed sediments (Callahan et al. 1979). The
mobility of zinc in soil has been characterized (Baes and Sharp 1983; Bergkvist et al. 1989; EPA
1980d; Hermann and Neumann-Mahlkau 1985; Kalbasi et al. 1978; Saeed and Fox 1977; Tyler and
McBride 1982). No estimate for the atmospheric lifetime of zinc is available. Development of
pertinent data on the atmospheric processes important for zinc speciation in the atmosphere
would be helpful. Development of this information would permit construction of a
comprehensive model for the transport and interaction of zinc not only in air but in other media
as well. Transformation in air and water can occur as a result of changes in chemical speciation
(Anderson et al. 1988; Callahan et al. 1979; EPA 1980d; Stokinger 1981). Data that describe the
transformation processes for zinc in soil or the fate of zinc in soil are needed. A model of zinc
flux from all environmental compartments would be useful for providing information on the
overall environmental fate of zinc.
Bioavailability. Zinc can be absorbed following inhalation (Drinker and Drinker 1928; Hamdi
1969), ingestion (Aamodt et al. 1983; Davies 1980; Johnson et al. 1988; Methfessel and Spencer
1973; NAWNRC 1979; Spencer et al. 1985) or dermal contact (Agren 1990; Gordon et al. 1981;
Hallmans 1977; Keen and Hurley 1977). No estimates of the bioavailability of zinc after
inhalation of zinc particles in air, ingestion from water and soil, or skin contact with bath water or
soil were located. The bioavailability of zinc is higher in media with a low pH, as a result of
increased zinc solubility and ionization. If zinc is partly present in an irreversibly adsorbed state
in soil, this part is not available for skin absorption. It would be useful to develop quantitative
data on the bioavailability of zinc from various environmental media.
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Food Chain Bioaccumulation. Zinc bioconcentrates moderately in aquatic organisms, and this
bioconcentration is higher in crustaceans and bivalve species than in fish (EPA 1987~; Ramelow
et al. 1989). Zinc does not concentrate in plants, and it does not biomagnify through the
terrestrial food chain (Biddinger and Gloss 1984; Callahan et al. 1979; Hegstrom and West 1989;
Levine et al. 1989).
Exposure Levels in Environmental Media. Zinc has been detected in air (Barrie and Hoff
1985; Duce et al. 1975; EPA 1980d; Evans et al. 1984; John et al. 1973; Lioy et al. 1978; Lloyd
and Showak 1984; Patterson et al. 1977; Ragaini et al. 1977; Saltzman et al. 1985; Zoller et al.
1974) water (Coale and Flegal 1989; Cole et al. 1984; EPA 1980d; Hale 1977; HAZDAT 1993;
Maessen et al. 1985; Minear et al. 1981; NAS 1977; Ohanian 1986; Schock and Neff 1988; Shiller
and Boyle 1985; Windom et al. 1991), soil (Beavington 1975; Connor and Shacklette 1975; EPA
1980d; Haines 1984; HAZDAT 1993; Johnson et al. 1990; Mayer and Manning 1990; Mumma et
al. 1984, 1990, 1991; Schalscha et al. 1982), and food (Coleman et al. 1992; Gartrell et al. 1986a;
Mahaffey et al. 1975; Weigert 1991). However, since most of the data are not current, i.e., within
the last 3 years, additional data would be useful to provide a more complete characterization of
human exposure and the trend in zinc concentrations in various environmental media. Estimates
have been made for human intake of zinc from food and drinking water (EPA 1980d; Gartrell et
al. 1986a; NAS 1977; NAS/NRC 1989b; Pennington et al. 1986; Sharrett et al. 1982a, 1982b).
Further data are needed on estimated daily intakes from inhalation resulting from occupational
exposures.
Reliable monitoring data for the levels of zinc in contaminated media at hazardous waste sites are
needed so that the information obtained on levels of zinc in the environment can be used in
combination with the known body burden of zinc to assess the potential risk of adverse health
effects in populations living in the vicinity of hazardous waste sites.
Exposure Levels in Humans. Zinc has been detected in fingernails, toenails, hair, all tissues,
organs, skull and skeletal muscle, blood, feces, urine, sweat, and saliva (Greger and Sickles 1979;
Hambidge et al. 1972; Henkin et al. 1975a; Llobet et al. 1988a; NASNRC 1979; Prasad et al.
1963a; Prevost et al. 1985; Saltzman et al. 1990; Schroeder et al. 1967; Takagi et al. 1988;
Wastney et al. 1986; Wilhelm et al. 1991). Most of the data on occupational exposure levels of
zinc are outdated (NIOSH 1976, 1984b). Additional information on potentially exposed workers
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and exposure levels would provide a more accurate characterization of occupational exposures in
the United States. Current biological monitoring data on zinc are needed for populations
surrounding hazardous waste sites.
This information is necessary for assessing the need to conduct health studies on these
populations.
Exposure Registries. No exposure registries for zinc were located. This substance is not
currently one of the compounds for which a subregistry has been established in the National
Exposure Registry. The substance will be considered in the future when chemical selection is
made for subregistries to be established. The information that is amassed in the National
Exposure Registry facilitates the epidemiological research needed to assess adverse health
outcomes that may be related to exposure to this substance.
5.7.2 On-going Studies
No long-term research studies were located regarding the environmental fate of zinc. However,
remedial investigations and feasibility studies on the NPL sites known to have zinc contamination
are expected to be completed in the near future and may add to the current knowledge regarding
the transport and transformation of zinc in the environment. In addition, environmental
monitoring currently being conducted at NPL hazardous waste sites will likely add to the current
database on environmental levels of zinc.




The purpose of this chapter is to describe the analytical methods that are available for detecting,’
and/or measuring, and/or monitoring zinc, its metabolites, and other biomarkers of exposure and
effect to zinc. The intent is not to provide an exhaustive list of analytical methods. Rather, the
intention is to identify well-established methods that are used as the standard methods of analysis.
Many of the analytical methods used for environmental samples are the methods approved by
federal agencies and organizations such as EPA and the National Institute for Occupational
Safety and Health (NIOSH). Other methods presented in this chapter are those that are
approved by groups such as the Association of Official Analytical Chemists (AOAC) and the
American Public Health Association (APHA). Additionally, analytical methods are included that
modify previously used methods to obtain lower detection limits, and/or to improve accuracy and
precision.
Zinc is ubiquitous in both the environment and the laboratory. Since many biological and
environmental samples contain low levels of zinc, it is easy to contaminate the samples. While
analyzing samples, it is imperative that special precautions be taken to avoid sample
contamination in order to obtain accurate results and ensure the integrity of the sample. Blood
collection tubes are potential sources of zinc contamination (Delves 1981). An example of failure
to institute proper measures to control sample contamination, which led to inaccuracies in
reported data, was described by Windom et al. (1991). Methods that can be used to avoid
reporting erroneous results include interlaboratory data comparison (Galloway et al. 1983) or use
of standard reference materials, such as certified SRM 1549 (nonfat powdered milk) available
from the National Institute of Standards and Technology (Perry 1990).
6.1 BIOLOGICAL MATERIALS
Table 6-l lists the applicable analytical methods used for determining zinc in biological fluids and
tissues.
Atomic absorption spectrometry (AAS) using a furnace atomizer is a common and simple
laboratory technique. It has become the method of choice for zinc analysis in biological samples









element composition with good precision, although its sensitivity is not always good (high ppm
levels). Its principal limitation is that it requires analyzing each element separately (Szpunar et al.
1978). Graphite furnace AAS (GFAAS) has been used to determine zinc in human semen.
Recovery (96-104%) was good, and preparation by microwave wet acid dissolution was more
accurate than the standard water dilution method (Alvarado et al. 1991). AAS has also been used
to determine zinc in bloodstains on filter paper. This method is accurate, reproducible, and
acceptable for routine clinical testing using both dry ashing and direct extraction sample
preparation (Fan et al. 1991). Electrothermal AAS is more sensitive than flame AAS (FAAS)
and has been used to determine very low levels of zinc (detection limit, 0.052 µmol/L) in human
milk (Arnaud et al. 1991). Zinc concentrations in liver have been accurately quantified by FAAS.
Homogenization of tissue samples coupled with FAAS resulted in 100% recoveries, accuracies of
0-3%, and a detection limit of 0.04 mg/L (Luterotti et al. 1992).
Multi-elemental analysis has been used to detect zinc and other trace metals in biological fluids
and tissues. For determination of metallic constituents in biological samples, such as liver,
samples were digested with mixtures of different acids, volatile elements were distilled by selective
distillation, and a cleanup step was performed using ion exchange chromatography prior to assay
by neutron activation analysis (NAA) (Lievens et al. 1977). Recovery (98%) and precision
(< 10% coefficient of variation [CV]) were excellent. Although the limit of detection for zinc was
not reported, based on the reported results this method can detect levels ranging from the low- to
the sub-ppm range (Lievens et al. 1977). The NAA technique has also been used to detect zinc
in urine and blood samples. Jurgensen and Behne (1977) used the technique to measure human
serum levels of trace elements including zinc. Recovery and precision for this method are very
good. Sensitivity was not reported.
Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) is used for multi-element
determinations in blood and tissue samples. Detection in urine samples requires extraction of the
metals with a polydithiocarbamate resin prior to digestion and analysis (NIOSH 1984a). Other
satisfactory analytical methods include direct current plasma emission spectroscopy and
determination by AAS, and inductively coupled argon plasma spectroscopy-mass spectrometry
(ICP-MS) (Patterson et al. 1992; Shaw et al. 1982). Flow injection analysis (FIA) has been used
to determine very low levels of zinc in muscle tissue. This method provides very high sensitivity,
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low detection limits (3 ng/mL), good precision, and high selectivity at trace levels (Fernandez et
al. 1992b).
The use of stable isotopes or tracers to study zinc absorption in humans with subsequent analysis
by mass spectrometry has been reported in the literature. Analysis of fecal samples obtained
3 and 6 days after the administration of zinc-65 isotope in food showed that between 45% and
75% of zinc isotope was absorbed (Johnson 1982). The results indicated satisfactory detection of
the zinc-67 isotope in human feces, while the zinc-70 isotope was not as detectable. Better
precision and recovery were obtained for the zinc-67 isotope (2.4% CV; >95% recovery) than for
the zinc-70 isotope (38% CV; 71% recovery). Sample detection limits were not reported. Total
reported sample preparation time was <2 hours, and it took only 5-10 minutes to analyze each
sample on the mass spectrometer.
A practical method, based on NAA, was developed for accurate measurement of the stable
isotopes zinc-68 and zinc-70 in human plasma and red blood cells (Janghorbani et al. 1981). This
method can provide an alternative to the use of radiolabeled zinc. It is more complex and time
consuming than those used to measure radiolabeled zinc levels. As with any isotopic method,
isotope exchange may invalidate calculation of net absorption, but this potential problem was not
investigated. Precision was very good (<10%). Sensitivity and accuracy were not reported.
Radionuclide studies offer an additional method to investigate the factors that affect trace
element absorption. Radioactivity emitted by the radionuclide was measured in blood 14 days
after the oral ingestion of zinc-65 and compared with the amount of radioactivity emission
determined by whole-body counting (Watson et al. 1987). The results indicated that, where
whole-body counting facilities were not available, measurement of radioactivity emitted in blood
was a reasonable alternative for the prediction of zinc absorption. Recovery for this method was
adequate (88%); precision was acceptable (<17% CV). The limit of detection for zinc was not
reported.
6.2 ENVIRONMENTAL SAMPLES







Variations of the AAS technique are commonly used to detect zinc levels in air, water, and soil
samples, as well as in certain plant and food samples. Inductively coupled argon plasma
spectroscopy (ICP) is a recommended test method for analyzing solid waste samples to measure
zinc. Using either the ICP method or the AAS method, operators of hazardous waste
management facilities can determine whether a given sample is hazardous, based on the level of
zinc in a sample of solid waste leachate.
AAS has been used to determine zinc concentrations in natural waters (Fishman 1966). AAS is a
rapid method of measuring zinc, with the detection limit (0.005 ppm) being somewhat better than
those obtained using other methods. Recovery and precision data were not reported. A year
later, Brooks et al. (1967) demonstrated a simple extraction system consisting of only two
reagents, ammonium pyrollidine dithiocarbamate (APDC) and methyl isobutylketone (MIBK),
with subsequent analysis by AAS to measure particulate and “soluble” zinc in seawater. Sensitivity
was in the sub-ppm range, and precision was good (3% CV). Accuracy was not reported.
FAAS, coupled with microwave digestion and GFAAS, has been used to determine the
concentration of zinc in food and shellfish samples. Limits of detection ranged from 0.12 to
0.24 ppm, with recoveries ranging from 80% to 113%. Precision and recovery using microwave
digestion were comparable to traditional wet ashing and superior to dry ashing in shellfish samples
(AOAC 1984; McCarthy and Ellis 1991; Morales-Rubio et al. 1992). GFAAS was also used to
determine low levels of zinc in beer. Recovery (94-106%) and precision (4.2% CV) were
excellent. Sensitivity was not reported (Wagner et al. 1991). Energy dispersive x-ray tluorescence
(EDXRF) for multielement analysis has been used to detect zinc in dried food samples with
better precision (and a detection limit of 0.8 ppm) than AAS methods (Nielson et al. 1991).
Cathodic stripping voltammetry, also known as adsorption voltammetry, has been used to detect
various metal ions in a 10-l0 to 10-10 M range in seawater (van den Berg 1986). APDC was used
as a chelating agent for zinc. Because of the great sensitivity and specificity of APDC for zinc, it
can be detected directly in the unaltered sample. Recovery and precision data were not reported.
Similarly, differential pulse cathodic stripping voltammetry (DPCSV) and differential pulse anodic
stripping voltammetry (DPASV) after complexation with APDC have been used for determining
zinc speciation at nanomolar concentrations in ocean waters (Donat and Bruland 1990).
Recovery and precision data were not reported. Anodic stripping voltammetry (ASV) has been
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used to detect zinc and other metal ions simultaneously at trace levels in atmospheric aerosols.
This method is primarily used for small samples with very low concentrations of zinc. The limit of
detection was 13.7 ng/L, and the recovery was not reported (Casassas et al. 1991).
AAS has been used to measure heavy metals, including zinc, in various oil samples collected at
different stages of oil refining (Elson et al. 1981). These samples were prepared using three
techniques (digestion, extraction, and dilution) prior to AAS analysis; recovery from crude oil was
higher with wet digestion. Sensitivity for zinc was in the low-ppm range. Accuracy and precision
were not reported.
An ion chromatographic method has been proposed for simultaneous determination of several
elements including zinc in soil (Basta and Tabatabai 1990). In this method, after preliminary
sample treatment, the metals are separated by ion chromatography, and the separated elements
are quantitated by ultraviolet-visible detection of zinc-PAR (4-[2-pyridylazo] resorcinol) colored
complexes. The limit of detection for zinc by this method is 5 ppb in soil extract. Precision was
≤2.5% CV. Accuracy was not reported. The concentration of zinc in soil was determined by ICP
coupled with an ammonium bicarbonate-diethylenetriaminepentaacetic acid (NH4,HCO3,-DTPA)
extraction procedure. (This method is superior to AAS and calorimetric methods because of the
capacity for multielemental analysis.) This method can be used to screen soils for zinc. Limits of
detection and recovery were not reported (Boon and Soltanpour 1991).
6.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation
with the Administrator of EPA and agencies and programs of the Public Health Service) to assess
whether adequate information on the health effects of zinc is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required to assure the
initiation of a program of research designed to determine the health effects (and techniques for
developing methods to determine such health effects) of zinc.
The following categories of possible data needs have been identified by a joint team of scientists
from ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if
met would reduce the uncertainties of human health assessment. This definition should not be
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interpreted to mean that all data needs discussed in this section must be filled. In the future, the
identified data needs will be evaluated and prioritized, and a substance-specific research agenda
will be proposed.
6.3.1 Identification of Data Needs
Methods for Determining Biomarkers of Exposure and Effect. AAS is the most commonly
used analytical method to determine zinc levels in plasma, bone, fingernails, hair, and other
biological tissues and body fluids (Alvarado et al. 1991; Arnaud et al. 1991; Fan et al. 1991;
Langmyhr et al. 1979; Luterotti et al. 1992; Marks et al. 1972; NIOSH 1984a; Shaw et al. 1982;
Sohler et al. 1976; Szpunar et al. 1978; Wilhelm et al. 1991). This method generally is sensitive
enough to measure background levels in the population and levels at which biological effects
occur. The method is specific and precision is good. However, improved sensitivity and recovery
data are needed in order to better evaluate the relationship between body and environmental
exposure levels of zinc. Other methods that are specific for measuring zinc in biological fluids
and tissues include NAA, ICP-AES, FIA, and isotope tracers techniques (Fernandez et al. 1992b;
Janghorbani et al. 1981; Johnson 1982; Lievens et al. 1977; NIOSH 1984a; Watson et al. 1987).
Sensitivity and/or recovery data for these methods are needed to more fully evaluate the reliability
of these methods as predictors of environmental exposure.
Although several biomarkers for the effects of zinc have been identified (increased levels of
serum amylases and lipase, non-iron responsive anemia, and decreased HDL cholesterol levels),
these biomarkers of effect are not specific for zinc (Cotran et al. 1989; Suber 1989). Standard
laboratory tests are available that can measure these biomarkers (Henry 1984). These methods
are sensitive, accurate, and reliable enough to measure background levels in the population and
levels at which biological effects occur. The development of methods for determining biomarkers
of effect specific for zinc would be beneficial in assessing whether an individual has been exposed
to zinc.
Methods for Determining Parent Compounds and Degradation Products in Environmental
Media. Methods of adequate sensitivity and specificity are available for determining levels of zinc
in environmental media (AOAC 1984; Basta and Tabatabai 1990; Brooks et al. 1967; Casassas et
al. 1991; Donat and Bruland 1990; Elson et al. 1981; EPA 19795 1986a; Fishman 1966; McCarthy
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and Ellis 1991; Morales-Rubio et al. 1992: Nielson et al. 1991; van den Berg 1986; Wagner et al.
1991; Zoller et al. 1974). Some of these methods are precise and sensitive enough to measure
background levels in the environment and levels at which health effects occur. These methods
can distinguish between soluble zinc, insoluble zinc, and chelated zinc in water (Donat and
Bruland 1990). Studies to obtain more information on the accuracy of these methods as well as
improved sensitivity are needed to better assess the risk of exposure for these media. Research
investigating the relationship between levels measured in air, water, and soil and observed health
effects would increase our confidence in existing methods and/or indicate where improvements are
needed.
6.3.2 On-going Studies
No on-going studies were located regarding techniques for measuring or detecting zinc in
biological fluids, tissues, or environmental samples.
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7. REGULATIONS AND ADVISORIES
Zinc (fume and dust) and its compounds are on the list of chemicals appearing in “Toxic Chemicals
Subject to Section 313 of the Emergency Planning and Community Right-to-Know Act of 1986”
(EPA 1991d).
The national and state regulations and guidelines pertaining to zinc and compounds in air, water, and
food are summarized in Table 7-l. No international regulations or guidelines applicable to zinc or its
compounds were found.
ATSDR has derived an intermediate oral MRL for zinc based on hematological effects, specifically
decreased hematocrit, serum ferritin, and erythrocyte superoxide dismutase activity, in women given
supplements containing zinc gluconate for 10 weeks (Yadrick et al. 1989). The intermediate oral
MRL has been adopted as the chronic oral MRL.
EPA has derived oral reference doses (RfDs) of 0.3 mg/kg/day for zinc, 0.05 mg/kg/day for zinc
cyanide, and 0.0003 mg/kg/day for zinc phosphide (IRIS 1993). EPA has not derived an inhalation
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Acute Exposore - Exposure to a chemical for a duration of 14 days or less, as specified in the
Toxicological Profiles.
Adsorption Coefficient (Koc) - The ratio of the amount of a chemical adsorbed per unit weight of
organic carbon in the soil or sediment to the concentration of the chemical in solution at
equilibrium.
Adsorption Ratio (Kd) - The amount of a chemical adsorbed by a sediment or soil (i.e., the solid
phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the
solid phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical
sorbed per gram of soil or sediment.
Bioconcentration Factor (BCF) - The quotient of the concentration of a chemical in aquatic
organisms at a specific time or during a discrete time period of exposure divided by the
concentration in the surrounding water at the same time or during the same period.
Cancer Effect Level (CEL) - The lowest dose of chemical in a study, or group of studies, that
produces significant increases in the incidence of cancer (or tumors) between the exposed
population and its appropriate control.
Carcinogen - A chemical capable of inducing cancer.
Ceiling Value - A concentration of a substance that should ndt be exceeded, even
instantaneously.
Chronic Exposure - Exposure to a chemical for 365 days or more, as specified in the
Toxicological Profiles.
Developmental Toxicity - The occurrence of adverse effects on the developing organism that may
result from exposure to a chemical prior to conception (either parent), during prenatal
development, or postnatally to the time of sexual maturation. Adverse developmental effects may
be detected at any point in the life span of the organism.
Embryotoxicity and Fetotoxicity - Any toxic effect on the conceptus as a result of prenatal
exposure to a chemical; the distinguishing feature between the two terms is the stage of
development during which the insult occurred. The terms, as used here, include malformations
and variations, altered growth, and in utero death.
EPA Health Advisory - An estimate of acceptable drinking water levels for a chemical substance
based on health effects information. A health advisory is not a legally enforceable federal
standard, but serves as technical guidance to assist federal, state, and local officials.
Immediately Dangerous to Life or Health (IDLH) - The maximum environmental concentration
of a contaminant from which one could escape within 30 min without any escape-impairing
symptoms or irreversible health effects.




Immunologic Toxicity - The occurrence of adverse effects on the immune system that may result
from exposure to environmental agents such as chemicals.
In Vitro - Isolated from the living organism and artificially maintained, as in a test tube.
In Vivo - Occurring within the living organism.
Lethal Concentration (LO) (LCLO) - The lowest concentration of a chemical in air which has been
reported to have caused death in humans or animals.
Lethal Concentration (50) (LC50) - A calculated concentration of a chemical in air to which
exposure for a specific length of time is expected to cause death in 50% of a defined
experimental animal population.
Lethal Dose (LO)  (LDLO) - The lowest dose of a chemical introduced by a route other than
inhalation that is expected to have caused death in humans or animals.
Lethal Dose (50) (LD50) - The dose of a chemical which has been calculated to cause death in
50% of a de ined experimental animal population.
Lethal Time (50) (LT50) - A calculated period of time within which a specific concentration of a
chemical is expected to cause death in 50% of a defined experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL) - The lowest dose of chemical in a study, or
group of studies, that produces statistically or biologically significant increases in frequency or
severity of adverse effects between the exposed population and its appropriate control.
Malformations - Permanent structural changes that may adversely affect survival, development,
or function.
Minimal Risk Level - An estimate of daily human exposure to a dose of a chemical that is likely
to be without an appreciable risk of adverse noncancerous effects over a specified duration of
exposure.
Mutagen - A substance that causes mutations. A mutation is a change in the genetic material in
a body cell. Mutations can lead to birth defects, miscarriages, or cancer.
Neurotoxicity - The occurrence of adverse effects on the nervous system following exposure to
chemical.
No-Observed-Adverse-Effect Level (NOAEL) - The dose of chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse effects seen
between the exposed population and its appropriate control. Effects may be produced at this
dose, but they are not considered to be adverse.
Octanol-Water Partition Coefficient (Kow) - The equilibrium ratio of the concentrations of a
chemical in n-octanol and water, in dilute solution.
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Permissible Exposure Limit (PEL) - An allowable exposure level in workplace air averaged over
an 8-hour shift.
q1 * - The upper-bound estimate of the low-dose slope of the dose-response curve as determined
by the multistage procedure. The ql* can be used to calculate an estimate of carcinogenic
potency, the incremental excess cancer risk per unit of exposure (usually µg/L for water,
mg/kg/day for food, and µg/m3 for air).
Reference Dose (RfD) - An estimate (with uncertainty spanning perhaps an order of magnitude)
of the daily exposure of the human population to a potential hazard that is likely to be without
risk of deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL
(from animal and human studies) by a consistent application of uncertainty factors that reflect
various types of data used to estimate RfDs and an additional modifying factor, which is based on
a professional judgment of the entire database on the chemical. The RfDs are not applicable to
nonthreshold effects such as cancer.
Reportable Quantity (RQ) - The quantity of a hazardous substance that is considered reportable
under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances,
an amount established by regulation either under CERCLA or under Sect. 311 of the Clean
Water Act. Quantities are measured over a 24-hour period.
Reproductive Toxicity - The occurrence of adverse effects on the reproductive system that may
result from exposure to a chemical. The toxicity may be directed to the reproductive organs
and/or the related endocrine system. The manifestation of such toxicity may be noted as
alterations in sexual behavior, fertility, pregnancy outcomes, or modifications in other functions
that are dependent on the integrity of this system.
Short-Term Exposure Limit (STEL) - The maximum concentration to which workers can be
exposed for up to 15 min continually. No more than four excursions are allowed per day, and
there must be at least 60 min between exposure periods. The daily TLV-TWA may not be
exceeded.
Target Organ Toxicity - This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single
limited exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen - A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV) - A concentration of a substance to which most workers can be
exposed without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) - An allowable exposure concentration averaged over a normal 8-
hour workday or 40-hour workweek.
Toxic Dose (TD50) - A calculated dose of a chemical, introduced by a route other than




Uncertainty Factor (UF) - A factor used in operationally deriving the RfD from experimental
data. UFs are intended to account for (1) the variation in sensitivity among the members of the
human population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the
uncertainty in extrapolating from data obtained in a study that is of less than lifetime exposure,
and (4) the uncertainty in using LOAEL data rather than NOAEL data. Usually each of these






This chapter of the profile is a health effects summary written in nontechnical language. Its intended
audience is the general public especially people living in the vicinity of a hazardous waste site or
substance release. If the Public Health Statement were removed from the rest of the document, it
would still communicate to the lay public essential information about the substance.
The major headings in the Public Health Statement are useful to find specific topics of concern. The
topics are written in a question and answer format. The answer to each question includes a sentence
that will direct the reader to chapters in the profile that will provide more information on the given
topic.
Chapter 2
Tables and Figures for Levels of Significant Exposure (LSE)
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health effects by duration
of exposure and end point and to illustrate graphically levels of exposure associated with those
effects. All entries in these tables and figures represent studies that provide reliable, quantitative
estimates of No-Observed-Adverse-Effect Levels (NOAELs), Lowest-Observed-Adverse-Effect
Levels (LOAELs) for Less Serious and Serious health effects, or Cancer Effect Levels (CELs). In
addition, these tables and figures illustrate differences in response by species, Minimal Risk Levels
(MRLs) to humans for noncancer end points, and EPA’s estimated range associated with an upper-
bound individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. The LSE tables and figures
can be used for a quick review of the health effects and to locate data for a specific exposure
scenario. The LSE tables and figures should always be used in conjunction with the text.
The legends presented below demonstrate the application of these tables and figures. A representative
example of LSE Table 2-l and Figure 2-l are shown. The numbers in the left column of the legends
correspond to the numbers in the example table and figure.
LEGEND
See LSE Table 2-1
(1). Route of Exposure One of the first considerations when reviewing the toxicity of a substance
using these tables and figures should be the relevant and appropriate route of exposure. When
sufficient data exist, three LSE tables and two LSE figures are presented in the document. The
three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral,
and dermal (LSE Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the
inhalation (LSE Figure 2-l) and oral (LSE Figure 2-2) routes.
(2). Exposure Duration Three exposure periods: acute (14 days or less); intermediate (15 to
364 days); and chronic (365 days or more) are presented within each route of exposure. In this
example, an inhalation study of intermediate duration exposure is reported.
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(3). Health Effect The major categories of health effects included in LSE tables and figures are
death, systemic, immunological, neurological, developmental, reproductive, and cancer.
NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.
Systemic effects are further defined in the “System” column of the LSE table.
(4). Key to Figure Each key number in the LSE table links study information to one or more data
points using the same key number in the corresponding LSE figure. In this example, the study
represented by key number 18 has been used to define a NOAEL and a Less Serious LOAEL
(also see the two “18r” data points in Figure 2-l).
(5). Species The test species, whether animal or human are identified in this column. Species
(6). Exposure Frequency/Duration The duration of the study and the weekly and daily exposure
regimen are provided in this column This permits comparison of NOARLs and LOAELs from
different studies. In this case (key number 18), rats were exposed to [substance x] via
inhalation for 13 weeks, 5 days per week, for 6 hours per day.
(7). System This column further defines the systemic effects. These systems include: respiratory,
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and
dermal/ocular. “Other” refers to any systemic effect (e.g., a decrease in body weight) not
covered in these systems. In the example of key number 18, one systemic effect (respiratory)
was investigated in this study.
(8). NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at
which no harmful effects were seen in the organ system studied. Key number 18 reports a
NOAEL of 3 ppm for the respiratory system which was used to derive an intermediate
exposure, inhalation MRL of 0.005 ppm (see footnote “b”).
(9). LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest exposure level
used in the study that caused a harmful health effect. LOAELs have been classified into “Less
Serious” and “Serious” effects. These distinctions help readers identify the levels of exposure
at which adverse health effects first appear and the gradation of effects with increasing dose.
A brief description of the specific end point used to quantify the adverse effect accompanies
the LOAEL. The “Less Serious” respiratory effect reported in key number 18 (hyperplasia)
occurred at a LOAEL of 10 ppm.
(10). Reference The complete reference citation is given in Chapter 8 of the profile.
(11). CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of
carcinogenesis in experimental or epidemiological studies. CELs are always considered
serious effects. The LSE tables and figures do not contain NOAELs for cancer, but the text
may report doses which did not cause a measurable increase in cancer.
(12). Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are
found in the footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key number 18 was
used to derive an MRL of 0.005 ppm.
LEGEND
See LSE Figure 2-l
LSE figures graphically illustrate me data presented in the corresponding LSE tables. Figures help the





(13). Exposure Duration The same exposure periods appear as in the LSE table. In this example,
health effects observed within the intermediate and chronic exposure periods are illustrated.
(14). Health Effect These are the categories of health effects for which reliable quantitative data
exist. The same health effects appear in the LSE table.
(15). Levels of Exposure Exposure levels for each health effect in the LSE tables are graphically
displayed in the LSE figures. Exposure levels are reported on the log scale “y” axis.
Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in mg/kg/day.
(16). NOAEL In this example, 18r NOAEL is the critical end point for which an intermediate
inhalation exposure MRL is based. As you can see from the LSE figure key, the
open-circle symbol indicates a NOAEL for the test species (rat). The key number 18
corresponds to the entry in the LSE table. The dashed descending arrow indicates the
extrapolation from the exposure level of 3 ppm (see entry 18 in the Table) to the MRL of
0.005 ppm (see footnote “b” in the LSE table).
(17). CEL Key number 38r is one of three studies for which Cancer Effect Levels (CELs) were
derived. The diamond symbol refers to a CEL for the test species (rat). The number 38
corresponds to the entry in the LSE table.
(18). Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the
upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are
derived from EPA’s Human Health Assessment Group’s upper-bound estimates of the slope
of the cancer dose response curve at low dose levels (q1*).
(19). Key to LSE Figure The Key explains the abbreviations and symbols used in the figure.
Chapter 2 (Section 2.4)
Relevance to Public Health
The Relevance to Public Health section provides a health effects summary based on evaluations of
existing toxicological, epidemiological, and toxicokinetic information. This summary is designed to
present interpretive, weight-of-evidence discussions for human health end points by addressing the
following questions.
1. What effects are known to occur in humans?
2. What effects observed in animals are likely to be of concern to humans?
3. What exposure conditions are likely to be of concern to humans, especially around
     hazardous waste sites?
The section discusses health effects by end point. Human data are presented first, then animal data.
Both are organized by route of exposure (inhalation, oral, and dermal) and by duration (acute,
intermediate, and chronic). In vitro data and data from parenteral routes (intramuscular, intravenous,
subcutaneous, etc.) are also considered in this section. If data are located in the scientific literature, a
table of genotoxicity information is included.
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The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate,
using existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess
cancer potency or perform cancer risk assessments. MRLs for noncancer end points if derived, and
the end points from which they were derived are indicated and discussed in the appropriate section(s).
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to
public health are identified in the Identification of Data Needs section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information was available, MRLs were derived. MRLs are specific for
route (inhalation or oral) and duration (acute, intermediate, or chronic) of exposure. Ideally, MRLs
can be derived from all six exposure scenarios (e.g., Inhalation - acute, -intermediate, -chronic; Oral -
acute, -intermediate, - chronic). These MRLs are not meant to support regulatory action, but to
acquaint health professionals with exposure levels at which adverse health effects are not expected to
occur in humans. They should help physicians and public health officials determine the safety of a
community living near a substance emission, given the concentration of a contaminant in air or the
estimated daily dose received via food or water. MRLs are based largely on toxicological studies in
animals and on reports of human occupational exposure.
MRL users should be familiar with the toxicological information on which the number is based.
Section 2.4, “Relevance to Public Health,” contains basic information known about the substance.
Other sections such as 2.6, “Interactions with Other Chemicals” and 2.7, “Populations that are
Unusually Susceptible” provide important supplemental information.
MRL users should also understand the MRL derivation methodology. MRLs are derived using a
modified version of the risk assessment methodology used by the Environmental Protection Agency
(EPA) (Barnes and Dourson 1988; EPA 1989a) to derive reference doses (RfDs) for lifetime
exposure.
To derive an MRL, ATSDR generally selects the end point which, in its best judgement, represents
the most sensitive human health effect for a given exposure route and duration. ATSDR cannot make
this judgement or derive an MRL unless information (quantitative or qualitative) is available for all
potential effects (e.g., systemic, neurological, and developmental). In order to compare NOAELs and
LOAELs for specific end points, all inhalation exposure levels are adjusted for 24hr exposures and all
intermittent exposures for inhalation and oral routes of intermediate and chronic duration are adjusted
for continuous exposure (i.e., 7 days/week). If the information and reliable quantitative data on the
chosen end point are available, ATSDR derives an MRL using the most sensitive species (when
information from multiple species is available) with the highest NOAEL that does not exceed any
adverse effect levels. The NOAEL is the most suitable end point for deriving an MRL. When a
NOAEL is not available, a Less Serious LOAEL can be used to derive an MRL, and an uncertainty
factor of (1, 3, or 10) is employed. MRLs are not derived from Serious LOAELs. Additional
uncertainty factors of (1, 3, or 10 ) are used for human variability to protect sensitive subpopulations
(people who are most susceptible to the health effects caused by the substance) and (1, 3, or 10) are
used for interspecies variability (extrapolation from animals to humans). In deriving an MRL, these
individual uncertainty factors are multiplied together. Generally an uncertainty factor of 10 is used;
however, the MIX Workgroup reserves the right to use uncertainty factors of (1, 3, or 10) based on
scientific judgement. The product is then divided into the adjusted inhalation concentration or oral
dosage selected from the study. Uncertainty factors used in developing a substance-specific MRL are
provided in the footnotes of the LSE Tables.





